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ABSTRACT 
Burkholderia cepacia is an aerobic Gram- negative bacterium originally described as 
the cause of soft rot in onions but now recognised as a serious human pathogen most 
notably in patients with cystic fibrosis (CF), the most common, fatal inherited disease 
affecting Caucasian populations. Bacteroides fragilis, a Gram- negative commensal 
associated with the mucosal surface of the human colon, is the most frequently 
isolated anaerobic bacterium from clinical specimens and is increasingly implicated as 
an important source of endotoxin in gut- derived sepsis. Previously, both organisms 
were considered to pose little hazard to human health and consequently, their 
pathogenesis and virulence factors are poorly understood. The cell surface 
components of a bacterium are classic virulence determinants and the influence of 
growth environment on the plasticity of the bacterial surface is well -established. This 
thesis considers the environmental regulation and biological activity of putative 
virulence factors for both organisms. 
Initial studies focused on the expression and antigenicity of the cell surface 
components; lipopolysaccharide (LPS), exopolysaccharide (EPS) and outer membrane 
from several representative strains. To determine the influence of growth 
environment, these components were investigated under different culture conditions 
and extraction methods. Results demonstrated that as with other Gram- negative 
organisms, the composition of outer membrane proteins of both B. cepacia and 
B. fragilis were influenced by cultural conditions with bacteria inducing or repressing 
protein structures presumably to influence overall permeability and survival. The EPS 
and LPS of B. fragilis also varied with environmental growth condition. 
Interestingly, extraction method was found to influence the LPS structure of 
B. cepacia including the loss of the distinctive rough LPS phenotype of an 'epidemic' 
strain. 
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B. cepacia and B. fragilis exhibited a greater biological activity than previously 
recognised both in terms of endotoxicity and cytokine induction. For B. cepacia the 
capacity to induce the proinflammatory cytokines TNF -a and IL -8 from several cell 
types was significantly, and unexpectedly, higher compared to the other major CF 
pathogen, Pseudomonas aeruginosa. This enhanced inflammatory potential of 
B. cepacia was not due to a more efficient LPS signalling pathway. As both CF 
pathogens appeared to induce TNF -a in a similar manner, the combined effect of 
both species was examined. Surprisingly, when P. aeruginosa was present in 
increasing amounts compared to B. cepacia, cytokine levels were down -regulated. 
These results indicate that B. cepacia has a major potential to cause immune - 
mediated damage and concurrent colonisation with P. aeruginosa may modulate this 
effect. For B. fragilis cytokine levels were compared to Escherichia coli, a 
facultative anaerobic commensal considered of great importance in gut- derived 
sepsis due to its extremely active LPS. TNF -a levels induced by B. fragilis were 
20 -fold lower than E. coli. However, considering the predominance of Bacteroides 
species in the gut, outnumbering facultative organisms by 20 -300 fold, results imply 
that as a population B. fragilis may possess as much biological potential as E. coli. 
Thus, B. fragilis may play a vital role in gut- derived sepsis. The relevance of these 
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1.1 THE BACTERIAL CELL SURFACE IN PATHOGENESIS 
1.1.1 PATHOGENESIS 
Bacterial pathogenesis can be defined simply as the mechanisms involved in the 
development of a disease. In a small number of disease states caused by 
microorganisms, pathogenesis can be attributed to a single element, but in the 
majority of cases damage usually occurs as a result of a complex mixture of 
interactions involving both microbial and host factors. 
1.1.2 BACTERIAL VIRULENCE DETERMINANTS 
For a bacterium to be able to cause disease it must be able to gain entry into or onto a 
suitable host site, survive and multiply, resist the host defence mechanisms and 
damage the host tissue (Mims et al, 1995). Components of a bacterium that have the 
potential to harm a host are described as bacterial virulence determinants and can be 
divided into two main types; cell surface determinants (structural components of the 
bacterial cell envelope) or extracellular determinants (products made and secreted by 
a bacterial cell). 
Figure 1.1 shows the structure of a typical Gram-negative cell. The cell surface 
structures relevant to this thesis- lipopolysaccharide, outer membrane and 




Lipopolysaccharide (LPS) consists of three covalently linked, biochemically and 
antigenically distinct regions; lipid A, core oligosaccharide and 0- antigen. Lipid A is 
a hydrophobic compound embedded in the outer leaflet of the outer membrane and 
acts to anchor the entire LPS molecule to the cell surface. The core oligosaccharide 
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links the lipid A to the hydrophilic 0- antigen, which extends outwards from the 
bacterial cell into the surrounding environment. This description of LPS structure 
represents a typical smooth -type LPS (S -LPS). Bacteria can also possess rough -type 
LPS (R -LPS) which is characterised by the absence of 0- antigen and, in some cases, 












GRAM-NEGATIVE CELL ENVELOPE 
Figure 1.1 The Cell Surface of a Gram -negative Bacterium. 
LP = lipoprotein; LPS = lipopolysaccharide; P = protein; PL = phospholipid 
(Adapted from Hancock & Poxton, 1988) 
Lipid A 
The lipid A moiety is an essential structural component of the LPS molecule as lipid A 
minus mutants are not viable. Indeed, natural free lipid A can only be acquired by 
chemical degradation, as enzymes capable of cleaving the polysaccharide -lipid bond 
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have yet to be isolated (Rietschel et al, 1993). The structure of lipid A has been 
elucidated using mainly R -LPS from the Enterobacteriaceae. In Escherichia coli, the 
lipid A structure comprises a 13 -1,6- linked glucosaminyl -glucosamine disaccharide 
backbone, substituted with a phosphoryl group at position 4 of the non -reducing 
sugar and at position 1 of the reducing glucosaminyl residue. Both sugar residues are 
also substituted at positions 2 and 3 with primary acyl groups joined through amide 
and ester linkages (Galanos & Luderitz, 1984; Rietschel et al, 1993). This general 
structure forms the basis of most lipid A moieties. Variations that occur generally 
involve the length of substituted fatty acid residues, the type and distribution of fatty 
acid substituents and the presence of additional substituents of the phosphoryl 
residues (Poxton & Arbuthnott, 1990). Variations in acylation patterns can further 
differentiate the lipid A region into one possessing either an asymmetrical or a 
symmetrical fatty acid distribution pattern (Rietschel et al, 1993). Despite these 
potential variations, lipid A remains the most structurally conserved of all LPS 
regions. 
Core oligosaccharide 
The core oligosaccharide of LPS consists of an inner and outer region. The inner 
core region is characterised by the presence of two unusual sugars L- glycero -D- 
manno- or D- glycero -D- manno -heptose and 3- deoxy -D- manno- 2- octulosonic acid 
(Kdo) as well as phosphate and ethanolamine (Poxton & Arbuthnott, 1990). The 
inner region is linked to the lipid A component via an a- linked Kdo residue which 
itself may have substituents of extra Kdo or heptose residues (Rietschel et al, 1993). 
The structure of the inner core region is generally conserved between species. The 
outer core region consists of the common hexoses, D- glucose, D- galactose and N- 
acetyl-D-glucosamine and is positioned closest to the 0- antigen region. 
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0- Antigen 
The 0- antigen (0 -Ag) region is the most variable component of LPS and comprises 
long chains of repeating oligosaccharide units, interlinked by glycosidic bonds. The 
nature, linkage, sequence, and substitution of individual residues within a repeating 
unit can vary, giving rise to an enormous range of possible structures (Doran, 1992). 
The 0 -Ag region is characteristic of a bacterial strain and forms the basis of bacterial 
serotype specificity, which can be used as a means of identification. The potential for 
antigenic variation in the 0- antigen region is exemplified by the fact that over 160 
serotypes have been described in E. coli, compared to only 5 different core types 
(Rietschel et al, 1993). 
Biological activity 
Approximately 100 years ago, the word 'endotoxin' was introduced to describe a 
poisonous material, bound to the bacterial body and differing from the exotoxins, that 
induced severe pathophysiological reactions in experimental animals (Rietschel et al, 
1993). Today, endotoxin is used almost synonymously with LPS. LPS may be 
defined in terms of a specified molecular structure whereas the word endotoxin often 
incorporates a broader functional role. For the purpose of this thesis, LPS and 
endotoxin will be interchangeable unless otherwise stated. 
LPS is well- established as the most virulent of all bacterial cell surface determinants 
and is responsible for many diverse biological effects, including pyrogenicity, shock 
and mitogenicity (Table 1.1). 
The toxicity of LPS is attributed to the lipid A portion as this region is capable of 
reproducing all the biological effects observed when LPS is administered to 
experimental animals. However, the lethality associated with lipid A is highly 
dependent on structure. Indeed, certain bacterial species (e.g. Bacteroides) are said 
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Table 1.1 Biological effects of lipopolysaccharide 
Pyrogenicity Activation of complement 
Lethal toxicity Activation of clotting factors 
Circulatory and vascular damage B -cell mitogen 
Hypotension Induction of cytokines 
Shwartzman reaction Induction ofprostaglandins 
(Poxton & Arbuthnott, 1990) 
to possess LPS of low endotoxicity whilst other species (e.g. E. coli) have LPS of 
high endotoxicity, reflecting the fatty acid composition and phosphate substitution of 
the lipid A moiety (Poxton & Arbuthnott, 1990). To determine the specific parts of 
lipid A responsible for endotoxicity, experiments were performed on lipid A partial 
structures and lipid A analogues. From these studies it was deduced that full 
endotoxic activity required a lipid A region containing two (3 -1,6- linked 
D- glucosamine residues, two phosphoryl groups and six fatty acids in a defined 
arrangement as found in E. coli. Different structures such as monophosphoryl lipid A 
or deacylated lipid A demonstrated a reduced toxicity (Doran, 1992). 
Although the lethality associated with LPS is ascribed to lipid A, its hydrophobic 
nature means that the complex is insoluble. It is therefore worth stressing that full 
biological activity is dependent on sugars present in the inner core, which allow 
dispersal in aqueous solutions. Indeed, in recent years the inner core region has been 
recognised as being of great significance for the biological activity and function of 
LPS. The basis for this is not yet understood although it may be due to a Kdo- 
dependent conformational change of lipid A (Rietschel et al, 1993). 
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The 0-antigen region also plays an important role in the biological function of LPS. 
0-Ag deficient rough mutants can be 1000 times less virulent than their smooth 
counterparts, implying that the 0-Ag can influence the virulence potential of the LPS 
(Poxton & Arbuthnott, 1990). The 0-Ag may also be involved in inhibiting 
complement activity and providing protection against phagocytosis (Rietschel et al, 
1993). 
LPS is an amphipathic molecule, containing both a hydrophobic (lipid A) and 
hydrophilic (0-Ag) region. Other amphiphiles are present in bacterial cell envelopes, 
for example, lipoprotein and enterobacterial - common antigen (ECA) and they share 
some common properties with LPS. Structurally, ECA consists of a glycerol 
phosphate backbone with attached fatty acids but the lipid portion is much less 
complex and significantly different from LPS (Rietschel et al, 1993). These structural 
diversities may explain why LPS is capable of causing lethal toxicity whereas other 
amphiphiles present in the bacterial cell surface appear to lack such potential. 
1.1.4 OUTER MEMBRANE 
Structure 
Gram- negative bacteria possess a complex cell envelope, distinct from Gram- positive 
bacterial envelopes by possession of both an inner and outer membrane. The inner 
membrane of Gram- negative bacteria is similar in structure to the cytoplasmic 
membrane found in Gram- positive bacteria (Poxton, 1993). However, the outer 
membrane is characteristic of Gram -negative species and is constructed from 
phospholipids, proteins (OMPs) and LPS. In enteric bacteria approximately 40% of 
the outer surface is LPS and 60% is protein (Benz, 1988). The LPS is closely 
associated with the outer membrane and the packing of the lipid A component into the 
bilayer results in a more viscous, rigid membrane structure compared to the inner 
membrane. Proteins may be present as major or minor proteins present in the inner or 
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outer leaflet of the bilayer, lipoproteins or forming transmembrane channels termed 
porins. Porins are usually found as trimers, bound non -covalently to the 
peptidoglycan layer and allow passage of essential hydrophilic nutrients into the cell 
(DiRienzo et al, 1978). 
LPS and porins function together as a selective barrier, separating the environment 
from the delicate workings of the bacterial cell; hydrophobic molecules are kept out 
whilst hydrolytic enzymes and binding proteins found in the periplasm are retained. 
However, the pharmaceutical industry has exploited this selective barrier by designing 
antimicrobials that compete with low molecular weight solutes for transfer through a 
porin, thus gaining access to the inside of the cell (Benz, 1988). 
Biological activity 
The bacterial outer membrane is a functioning component of normal cell physiology 
and is essential for viability, by allowing transfer of ions, vitamins and carbohydrates. 
Furthermore, in conditions of nutrient stress, bacteria can alter the biosynthesis and 
expression of OMPs to aid survival. Indeed, the ability to vary OMP antigens is a 
powerful method to escape the host's antibody- dependent defence mechanisms. 
The outer membrane also possesses a degree of pathogenic potential by acting as an 
adhesin and as a receptor site for siderophores. Iron is an essential requirement for 
bacterial survival. In vivo most extracellular iron is bound to host proteins such as 
transferrin and lactoferrin leaving only minute amounts free in the host tissue. 
Bacterial siderophores act as iron -chelators and compete for essential iron with the 
host (Guerinot, 1994). By possessing OMPs functioning as siderophore receptors, 
the bacteria can effectively compete for the iron needed to survive in an otherwise 
iron -depleted environment. 
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Adherence to host tissue is an important step in the initiation of pathogenesis by 
allowing bacteria to gain a stable hold before colonisation. For example, some 
Neisseria gonorrhoeae species that do not possess adhesive pili are still able to bind 
cells by virtue of an OMP adhesin, termed OM protein II or P II. Gonococcal species 
expressing P II are associated with infection localised to urogenital mucosa (Schwalbe 
et al, 1985) and have several other important virulence attributes, including improved 
attachment to buccal epithelial cells, increased serum resistance, increased resistance 
to penicillin and fusidic acid and increased attachment to leucocytes (Lambden et al, 
1979). 
Some bacterial species, for example Yersinia and Shigella, are invasive pathogens, 
capable of entering a cell, multiplying and then destroying it. OMPs have been 
proposed as important virulence determinants in this invasive process, although how 
the OMPs contribute is not clearly understood. One theory is that some OMPs 
manipulate the host cytoskeleton to provoke uptake, whilst others are required for 
transport of essential invasion plasmid antigens (Maurelli, 1992). 
Peptidoglycan 
Sandwiched between the inner and outer membrane is a layer of peptidoglycan which 
confers rigidity and shape on the bacterial cell. The peptidoglycan layer is associated 
with porins from the outer membrane and a small lipoprotein which binds the outer 
membrane to the peptidoglycan. The structure, attachment and biological functions of 
peptidoglycan are well- documented and the reader is referred to the following articles 
(Schleifer & Kandler, 1972; Clarke & Dupont, 1991; Johannsen, 1993). 
1.1.5 SURFACE APPENDAGES 
Inserted into the outer membrane of many Gram -negative bacteria are two further 
structures or appendages; fimbriae (pili) and flagella. Both fimbriae and flagella are 
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composed of subunits of a single protein (pilin and flagellin respectively), that are 
aggregated to form tight helical chains. Bacteria may possess several types of 
fimbriae that differ in thickness, length and antigenic specificity. They are shorter and 
thinner than flagella and function as adhesins in aqueous environments, to particulate 
material and to host cells (Krogfelt, 1990). Flagella may be present on the bacterial 
surface as a single polar appendage (monotrichous) or as numerous fibres 
(peritrichous). Furthermore, flagellin proteins from different species vary in amino 
acid composition and are highly immunogenic, forming the basis of another serotyping 
scheme (Poxton & Arbuthnott, 1990). Flagella are responsible for motility, 
particularly in response to chemoattractants or repellants, a characteristic which is of 
extreme importance to bacterial survival. 
1.1.6 EXOPOLYSACCHARIDE 
Structure 
Extracellular polysaccharides or exopolysaccharides (EPS) are secreted by many 
bacterial species to form either loosely associated slime or a discrete layer of 
mucilaginous material termed a capsule (Whitfield & Valvano, 1993). EPS may be 
divided into homopolysaccharides or heteropolysaccharides. Homopolysaccharides 
are composed of a single repeating sugar unit, for example, the slime produced from 
Streptococcus mutans consists entirely of D- glucose. Heteropolysaccharides are more 
commonly found and contain repeating units of two or more sugar monomers. A 
large number of heteropolysaccharides have been described, with many different sugar 
components identified. Monomers may include neutral sugars such as D- glucose and 
D- galactose, amino sugars, for example N- acetyl -D- glucosamine and uronic acids such 
as D- glucuronic acid. The latter group confers an acidic property on the EPS as do 
some non -sugar substituents such as acetate, formate and pyruvate (Whitfield & 
Valvano, 1993; Sutherland, 1985). 
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Biological activity 
The role of EPS in adhesion has been described for many bacteria including oral 
streptococci (Loesche, 1986), staphylococci (Christensen et al, 1982), common 
environmental strains (Costerton et al, 1987) and freshwater and marine bacteria 
(Allison & Sutherland, 1987). Initially, the bacterial cell binds to a surface through 
non -specific adhesion. Cell division produces new daughter cells that also bind so 
ultimately an adherent microcolony embedded within an EPS biofilm develops 
(Costerton et al, 1987). 
In may instances, establishment of a biofilm represents the main role for EPS: 
protection. EPS is, by its physical nature, highly hydrated and thus protects against 
desiccation. For pathogens, EPS also affords protection against phagocytosis and the 
action of phage, antibodies and antibiotics, by the simple fact that the biofilm is too 
extensive to engulf or penetrate. In large biofilms, insoluble salts produced by 
bacteria may become trapped in the EPS matrices and form crystallised 'stones' within 
the colonised host organ (Costerton et al, 1987). 
The classic example of EPS as a virulence determinant is alginate, an unusual 
acetylated exopolysaccharide produced by mucoid Pseudomonas aeruginosa (section 
1.2). EPS has also been reported to induce abscesses, as observed with the capsule of 
Bacteroides fragilis (section 1.5) and to act as a camouflage mechanism against host 
immune defences, such as occurs with the K1 antigens of E. coli (Poxton & 
Arbuthnott, 1990). 
1.1.7 CELL SURFACE HYDROPHOBICITY 
The combination of structures associated with the cell envelope bestows on the 
bacterial surface a relative degree of hydrophobicity. Cell surface hydrophobicity 
plays an important part in three aspects of bacterial infection; adhesion, phagocytosis 
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and opsonization (Absolom, 1988). For initial adhesion and orientation of bacteria to 
a substrate, such as host tissue, the more hydrophobic the cell surface the more readily 
the bacterium can bind (Dalhback et al, 1981). For example, in enteropathogenic 
E. coli, masking of EPS and LPS with hydrophobic fimbriae promotes adhesion to 
intestinal epithelial cells (Smyth et al, 1978). However, a high level of cell surface 
hydrophobicity also promotes phagocytosis. This could be explained in part by non- 
specific adsorption of antibody onto the bacterial surface; the more hydrophobic the 
bacteria, the more IgG is adsorbed, thus augmenting cell surface hydrophobicity and 
increasing the chances of phagocytosis (Stjernström et al, 1977, Absolom, 1988). 
1.1.8 EXTRACELLULAR VIRULENCE DETERMINANTS 
Extracellular virulence determinants comprise extracellular enzymes and exotoxins. 
Exoenzymes, such as mucinases, collagenases, hyaluronidases, lipases and 
haemolysins, to name but a few, are capable of causing host tissue damage by virtue 
of their degradative properties and can promote the spread of bacteria into deeper 
tissues (Talaro & Talaro, 1993). Exotoxins are the classic extracellular virulence 
factors. In some cases they may be almost singularly responsible for the development 
of disease, for example botulism. Toxins exert their action by damaging an essential 
metabolic cell function and act on a variety of systems including mucosal epithelial 
cells, subepithelial tissues and major internal organs (Poxton & Arbuthnott, 1990). 
The cell surface of a gram- negative bacterium comprises several closely associated 
elements, each with a discrete structure, function and level of pathological potential. 
Together with extracellular virulence determinants, the cell envelope imparts on the 
bacterium the ability to cause disease and thus plays an important role in pathogenesis. 
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1.2 ENVIRONMENTAL REGULATION OF THE BACTERIAL 
CELL SURFACE. 
The microenvironment surrounding a bacterium can be highly variable in terms of 
chemical and physical factors, such as oxygen concentration, pH, osmolarity and 
temperature. Many bacteria will encounter several different environmental conditions 
during their life cycle and must be able to respond and adapt to any change if they are 
to survive. Adaptive responses in bacteria are central to many cellular systems and 
are tightly controlled by complex pathways. The best -characterised regulatory 
process is signal transduction, where bacteria 'sense' environmental stimuli through 
membrane -bound sensory proteins. The sensor proteins, in turn, phosphorylate and 
activate a regulatory response protein to mediate an appropriate adaptive reaction, 
usually by control of gene transcription. (Gross, 1993). 
The bacterial cell surface plays a major role in pathogenesis and, as such, is flexible to 
allow survival. Indeed, the bacterial surface is far from a rigid structure but is 
constantly adapting to new environmental parameters. LPS, OMPs, EPS and thus 
their corresponding functions, complement resistance, adhesion, invasion, biofilm 
formation, protection etc., are all well- documented cases of environmentally -regulated 
bacterial virulence systems. Many fascinating examples are covered in depth in the 
following reviews; Stock et al, 1989; Gross, 1993; Maurelli, 1989; Miller et al, 1989). 
Examples are provided here simply to emphasise the plasticity of the bacterial cell 
surface structures relevant to this thesis. 
Exopolysaccharides 
One of the classic examples highlighting sensory regulation of bacterial virulence is 
the control of the exopolysaccharide alginate, produced by mucoid Pseudomonas 
aeruginosa. Alginate is a 13,1 -4- linked mannuronic -guluronic acid 
heteropolysaccharide, the production and secretion of which leads to the distinctive 
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mucoid phenotype almost exclusively associated with chronic pulmonary infections of 
Cystic Fibrosis (CF) patients (Pedersen, 1992). The use of phenotypic and genotypic 
typing systems has shown that initial colonisation in CF patients is due to typical non - 
mucoid strains and that mucoid variants gradually come to predominate as a result of 
in vivo conversion (Govan & Nelson, 1992). These observations suggest that the 
production of alginate by P. aeruginosa is an adaptation to the specialised conditions 
in the CF lung, allowing the bacteria to survive inside the host and conferring an 
advantage to the bacterium in the host -pathogen fight. Indeed, alginate is a key factor 
in the pathogenesis of CF due to both its adhesive properties and in the formation of 
microcolonies and biofilms that block phagocytosis and ultimately lead to immune - 
mediated damage and bronchial obstruction. It has been speculated that many 
P. aeruginosa strains, under conditions of increased osmolarity, nitrogen limitation or 
dehydration (conditions thought to be prevalent in the CF lung), increase transcription 
of three key alginate biosynthesis genes, algD, algC and a/gR (Deretic et al, 1990; 
Zielinski et al, 1992). Thus, alginate production is up- regulated only under certain 
environmental conditions, which is of obvious benefit, as constitutive expression 
would place a considerable energy drain on the pathogen. 
Environmental regulation of alginate biosynthesis is a complex genetic process 
involving many regulatory proteins and processes, such as, AlgR, an orthodox 
response regulator and one component of a bacterial signal transduction system, 
AlgP, a histone -like protein controlling nucleoid structure, DNA supercoiling and muc 
mutations which are conducive to the mucoid phenotype (Deretic & Konyecsni, 1990; 
Drlica & Rouviere- Yaniv, 1987; Dorman, 1991; Govan et al, 1992). Indeed, such is 
the intricacy of alginate regulation that control of mucoidy has become a model 
system for analysing environmental modulation of bacterial virulence determinants. 
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Outer membrane proteins 
When grown in environmentally -stressed conditions, Gram- negative bacteria alter the 
porin composition of their outer membrane, to change their overall permeability and 
aid survival. OMPs are regulated in response to a number of environmental stimuli 
including temperature, carbon source, phosphate and iron starvation (Mekalanos, 
1992). Not all cases of OMP regulation involve porin function, in some instances the 
OMPs induced are invasive proteins (Maurelli, 1989) or iron -binding proteins (Miller 
et al, 1989) vital to pathogenesis. 
Lipopolysaccharides 
Several bacterial species including E. coli, P. aeruginosa and Serratia marcescens 
alter 0-Ag chain length in different growth media. Temperature, osmolarity, pH, 
carbon source, and ion concentration have all been reported to cause appreciable 
changes in 0-Ag length as determined by SDS -PAGE (McGroarty & Rivera, 1990, 
Weiss et al, 1986). These changes obviously alter the bacterium's ability to resist host 
defences including in particular the action of complement. 
Environmental sensors and regulators from different bacterial signal transduction 
systems share a high degree of sequence homology, thus, the components of a single 
pathway are not exclusive to each other but can interact with other systems to allow a 
greater level of flexibility and control (Stock et al, 1989). For example, an orthodox 
histidine -kinase osmosensor, OmpR, may substitute for A1gR in activating the algD 
promoter, under conditions of high osmolarity (Berry et al, 1989). Furthermore, the 
bifunctional enzyme A1gC plays a pivotal role in regulating the loss of LPS 0-Ag in 
mucoid P. aeruginosa CF isolates, by switching carbon metabolism from LPS 
biosynthesis to alginate production (Ye et al, 1994). This 'cross- talking' between 
systems can allow interpretation of multiple signals and subsequent co- ordinated 
regulation of several genes. 
14 
1.3 THE HOST IMMUNE SYSTEM IN PATHOGENESIS 
Bacterial pathogenesis involves an ongoing two -way fight for survival between 
microbe and host. One of the major 'battles' involves the host's immune response, a 
defensive system which has evolved and adapted to protect the host against infection 
but which the microbe must resist if it is to survive. 
1.3.1 THE IMMUNE RESPONSE AGAINST BACTERIAL PATHOGENS 
In humans, the immune response to an invading microbe can be separated into two 
functional divisions; innate immunity and adaptive immunity. 
Innate immunity 
Innate immunity is characterised by non -specific defences which individuals possess 
all their life. Innate immunity can be divided further into those mechanisms that act 
immediately and non -specific mechanisms that have to be induced and appear early in 
the infection process. 
The first stage of innate immunity, the immediate response, consists of pre -existing 
defence mechanisms that have no need for induction. For example, our body surfaces, 
which are defended by epithelial cells that provide a barrier by means of chemical (low 
pH in stomach, fatty acids on skin, degradative enzymes e.g. lysozyme), 
microbiological (competition with normal flora) and mechanical (tight junctions 
between cells) mechanisms. The alternative pathway of complement is also 
considered an immediate response mechanism as the complement proteins required 
for the complement cascade are continually present in our plasma (Janeway & 
Travers, 1994). 
If a potential pathogen successfully survives the immediate response and penetrates 
the epithelial barrier, the host's early defences are induced, although these mechanisms 
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remain non -specific. The most important response in the early induced phase is the 
secretion of cytokines. Cytokines are proteins or glycoproteins that can act on 
numerous cell types both locally and systemically, to initiate a variety of inflammatory 
reactions (Rees, 1991). The local and systemic effects of cytokine induction_ shall be 
discussed in detail in section 1.3.6 -7. A group of proteins collectively termed acute 
phase proteins are also induced in the early phase of infection. Produced in the liver, 
acute phase proteins can bind to the surface of a wide range of bacteria, facilitating 
the activation of complement and promoting bacterial uptake by phagocytic cells 
(Janeway & Travers, 1994). 
Adaptive immunity 
Most of the bacteria that humans encounter are successfully destroyed by our innate 
immune mechanisms. However, if after approximately four days an infection remains, 
components of the host's adaptive immunity can be detected. Adaptive immunity 
differs from innate immunity by consisting of specific defences that are acquired 
during the lifetime of an individual against specific pathogens. In other words, 
adaptive immunity involves immunological memory and generates a lasting, protective 
response. This type of immunological defence is highly important as it allows the host 
to respond much more rapidly, intensely and specifically on subsequent encounters 
with the pathogen. Antibodies are the crux of adaptive immunity, able to initiate the 
classical pathway of complement and, more importantly, provide a mechanism 
through which the host can recognise all pathogens. Antibodies per se shall not be 
discussed here although reference to them and, in particular, to their specific binding 
of cell surface structures shall be made in the following sections. 
1.3.2 INTERACTION OF BACTERIA AND THE HOST IMMUNE SYSTEM 
Many of the defences used by bacteria to resist the host immune mechanisms involve 
cell surface structures referred to in section 1.1. For example, EPS can inhibit 
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phagocytosis and OMP profiles may change to alter the microbe's adhesive properties 
or permeability to antibiotics. 
The interaction between the bacterial cell surface and the host's immune system is very 
complex, as exemplified by the host's multiple responses to endotoxin. Low dose 
exposure to LPS released from gut- associated bacteria or in low -level infection may, 
ironically, be important in the development of lymphoid organs and innate immunity, 
thus priming the host to resist bacterial infection (Manthey & Vogel, 1992). LPS is 
also a potent stimulator of cytokines which are essential for the development, 
maintenance and regulation of immunity. However, the pathological damage resulting 
from overproduction of cytokines following systemic or high dose endotoxin 
exposure is extremely severe and potentially fatal. 
The following sections shall describe in more detail the steps involved in the LPS - 
induced stimulation of cytokines and the clinical consequences of cytokine 
overproduction. It should be noted, however, that other bacterial cell surface 
structures may play a significant role in cytokine release. EPS has already been 
implicated in the induction of tumour necrosis factor (Otterlei et al, 1993) and the 
outer membrane will undoubtedly be important in contributing to LPS presentation 
and thus, indirectly, LPS binding. It should also be emphasised that cytokines can be 
induced from nearly every cell type in the mammalian body. 
1.3.3 LPS -INDUCED RELEASE OF CYTOKINES 
LPS receptor binding 
The first step in LPS- induced cytokine secretion is the binding of endotoxin to host 
cells. Initially, three main LPS- receptors were proposed; CD18 antigens, a scavenger 
receptor and CD 14. 
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The CD18 antigens or leucocyte integrins, comprise a family of three cell - surface 
glycoproteins; lymphocyte function associated antigen (LFA -1), complement receptor 
CR -3 and p150,95. Each member consists of two non -covalently bound chains, a 
n -chain that is identical in all three receptors and an a -chain unique to each molecule 
(Wright, 1991). The ability of CD18 antigens to bind LPS has been determined by 
examining macrophages from individuals with a genetic deficiency in CD18. The 
CD18- cells were found to be unable to recognise free LPS or unopsonized E. coli 
cells (Wright et al, 1989). In addition, the use of R -LPS mutants demonstrated that 
the CD18 receptor recognised the lipid A region (Wright & Jong, 1986). 
The scavenger receptor is a trimeric, transmembrane glycoprotein able to recognise a 
wide variety of ligands including analogues of lipid A. Found in large quantities in the 
liver, it was proposed that the scavenger receptor would be well positioned to bind 
endotoxin entering the circulation from the gut, as might occur following intestinal 
injury (Wright, 1991). 
Although the scavenger receptor and CD18 antigens are all capable of binding LP S 
and are, therefore, endotoxin receptors, studies in which these molecules were 
blocked or absent found that cytokine secretion was not affected, showing these 
receptors to be unnecessary for secretory responses (Wright et al, 1990a). It is now 
thought that the CD18 family and the scavenger receptor play a vital role in the 
clearance and detoxification of LPS (and thus Gram- negative bacteria) by stimulating 
phagocytic engulfment (Wright, 1991). 
CD14, a 55kD glycoprotein expressed on the surface of monocytes, macrophages and 
neutrophils, has also been proposed as an endotoxin receptor. Experiments using 
monoclonal antibodies (MAbs) to deplete macrophage cell surface proteins identified 
CD14 as an essential component for the binding of an LPS -plasma protein (LBP) 
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complex (Wright et al, 1990b). Lipopolysaccharide binding protein (LBP) is a 60kD 
glycoprotein present in normal serum at levels less than 0.5p.g/ml which increase over 
one hundred fold after the induction of the acute phase response (Schummann et al, 
1990). LBP can bind efficiently to lipid A from both R- and S -LPS and to the lipid A 
precursor IVA. Indeed, LBP can bind lipid A when LPS is in a variety of physical 
forms including immobilised on microtiter plates, electrophoresed to nitrocellulose 
and contained in defined buffers and serum (Tobias et al, 1989). In contrast, partial 
lipid A structures such as the diacyl glucosamine phosphate, lipid X, are bound very 
poorly and no binding is observed for Kdo, DNA, RNA, heparin or phospholipids, 
indicating that LBP requires an intact lipid _ A structure for optimal binding. The 
concentration of LBP present in normal serum is sufficient to increase significantly 
LPS -induced cytokine secretion, whereas LBP alone does not induce detectable 
increases in cytokine mRNA or protein. In the absence of LBP, LPS can still bind to 
CD14 albeit weakly and much more slowly. Expression of CD14 is essential for the 
function of LBP as neutralising MAbs to CD14 inhibit the cellular responses of 
LPS -LBP complexes (Dentener et al, 1993). 
CD14 is also found as a soluble form present in serum (sCD14) and accounts for 
approximately 99% of the total CD14 content (Hailman et al, 1994). sCD14 is 
capable of binding LPS and inducing cellular responses and it is speculated that 
sCD14 enables cells that do not express the membrane form of CD14 (for example 
endothelial cells) to be LPS- responsive. The role of LBP in LPS binding to sCD14 is 
thought to be primarily as a catalyst, as LBP dissociates from the LPS-sCD14 
complex. 
Figure 1.2, shows the best -characterised model of endotoxin receptor binding to date. 
In high concentrations, LPS molecules clump together due to their amphipathic nature 
in the host's aqueous environment (Schands & Chun, 1980). The ability of LBP to 
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bind strongly to lipid A (dissociation constant 10-9M) forces the disaggregation of the 
lipopolysaccharide clump into monomers to form LPS -LBP complexes (Tobias et al, 
1989). CD14 can recognise and bind the LPS -LBP complexes and initiate secretory 
responses. Recently, CD14 mutants have been used to demonstrate that amino acids 
57 -64 are required for LPS binding (McGinley et al, 1995; Juan et al, 1995). In 
addition, residues 91 -108 in LBP have been identified as forming at least part of the 
LPS- binding site (Taylor, 1995). Interestingly, both regions can, independently, form 
part of a high amphipathic domain similar to the amphipathic loops of the antibiotic 
polymyxin B and Limulus anti -LPS factor, molecules also capable of LPS binding 
(Juan et al, 1995). Further information is awaited to confirm whether amphipathic 
domains are a prerequisite for LPS binding. 
LPS can bind to a variety of other molecules, including the enzyme lysozyme, 
polymyxin B, bactericidal/permeability increasing protein (a trace plasma protein 
sharing 44% homology with LBP) and an 80kD protein tentatively suggested as 
another potential endotoxin receptor (Takada et al, 1994). The 8010 protein has 
been shown to be membrane localised and is present on all LPS- responsive cells (Lei 
& Morrison, 1988). Further characterisation and binding studies with this 80kD 
protein are required to assess its importance as an endotoxin receptor. 
Intracellular signalling 
The second stage in endotoxin- induced cytokine secretion is the transformation of the 
LPS binding stimulus into an intracellular signal stimulating cytokine release. The 
mechanism by which the LPS -LBP /CD14 pathway functions in intracellular signalling 
is not yet understood. Two models have been proposed; LPS -LBP binding to CD14 
directly stimulates the cell or CD14 acts as a holding or transfer protein, facilitating 
the interaction of LPS with another signalling molecule (Figure 1.2). 
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Evidence has been obtained to support both models. For the former theory, studies 
have shown that certain anti -CD14 MAbs can mimic the effects of LPS (Schutt et 
al,1988). However, at present, biochemical and structural evidence favours the latter 
model. The CD14 receptor does not transverse the membrane but is instead anchored 
by a glycosylphosphatidylinositol (GPI) tail (Gegner et al, 1995). GPI -anchored 
proteins are unlike the G- linked proteins normally required for eukaryote signalling. 
The mechanism by which a GPI -protein initiates an intracellular signal is not known, 
as experiments replacing the GPI anchor with transmembrane domains have shown 
the GPI tail to be unnecessary for signal transduction, suggesting that CD14 interacts 
with another, as yet unknown, receptor to initiate the secretory response (Lee et al, 
1993). Furthermore, as soluble CD14 must bind to a cell surface protein in order to 
initiate a response, it is probable that membrane CD14 transduces the signal in the 
same way (Frey et al, 1992). 
It seems probable that LPS binding to CD14 alters the protein conformation, allowing 
the complex to interact with a transmembrane receptor. The transmembrane receptor 
could then transform LPS binding into an intracellular signal by activating a complex 
interactive network of kinases, similar to signal transduction in bacteria. Indeed, LPS 
binding is known to induce rapid tyrosine phosphorylation in several proteins 
including a serine /threonine protein (MAP kinase) known to be important in cell 
proliferation (Manthey & Vogel, 1992). However, the identification of the tyrosine 
kinase that phosphorylates the MAP protein remains unknown. 
An additional complicating factor in the LPS signalling scenario is that in the absence 
of LBP and CD14, LPS- induced secretory responses still occur. CD14-independent 
signalling pathways have been suggested by several workers although, as yet, no 
conclusive candidates have been found (Lynn et al, 1993). It is likely that future 
studies on eukaryotic cell surface proteins will identify further LPS receptors and 
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intracellular signalling pathways. It is therefore worth emphasising that although 
CD14/LBP is the best characterised LPS signalling pathway to date, it is not unique. 









Figure 1.2 LPS receptor binding and intracellular signalling. (A) LPS and LBP 
bind to form an LPS -LBP complex. (B) sCD14 recognises the LPS -LBP complex 
and binds LPS. LBP acts as a catalyst and dissociates. (C) The membrane form of 
CD14 recognises and binds the whole LPS -LBP complex. (D) CD14 may transduce 
the LPS binding stimuli direct. (E) CD14 acts as a holding protein for LPS and 
transduces the binding stimuli via a transmembrane receptor. 
LPS = lipopolysaccharide; LBP = lipopolysaccharide binding protein; 
sCD 14 = soluble CD 14; mCD 14 = membrane -bound CD 14 
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Cytokine release 
The final step after an intracellular signal has been produced is the release of 
cytokines. Two major cytokines, tumour necrosis factor a (TNF -a) and interleukin 1 
(IL -1) are preformed, held within the cell membrane, and rapidly secreted. In 
contrast, the majority of cytokines require the derepression of regulatory genes prior 
to cytokine synthesis (Rees, 1991). LPS- inducible genes possess enhancer regions 
that can be bound by proteins such as NF -1(13. In the normal state NF-KB is repressed 
by another protein, IxB. Upon activation due to LPS stimulation, IxB is 
phosphorylated and the NF -K13 heterodimer dissociates and translocates to the 
nucleus where it binds upstream of genes possessing the appropriate enhancer region, 
thus initiating transcription. The protein kinase involved in the phosphorylation of 
IKB is unknown (Manthey & Vogel, 1992). 
The following sections will concentrate on the two major cytokines relevant to this 
thesis, TNF -a and IL -8, and emphasise their role in both the local and systemic effects 
of cytokine release. It is important to stress, however, that any one cytokine is just 
part of a complex biological network, interacting with many other immunological 
mediators to prevent microbial infection. 
1.3.4 TUMOUR NECROSIS FACTOR -a 
Tumour necrosis factor alpha (TNF -a) is a 17kD polypeptide existing as three 
identical subunits and secreted from a variety of cells (Smith & Baglioni, 1987) 
(Figure 1.3). Initially, TNF -a was named cachectin due to its role in inducing the 
cachectic or wasted state which may accompany chronic parasitic and viral infection 
or cancer. As the name suggests, TNF -a has also been shown to cause necrosis in 
experimental tumours and had seemed promising as an effective treatment for cancer 
(Rees, 1991). However, in clinical trials, TNF -a inhibited tumour growth in only a 
few patients and was associated with a variety of toxic effects, including fever, 
23 
hypotension, and leukopenia; symptoms also associated with endotoxic shock 
(Creagan et al, 1988). Indeed, TNF -a is now considered to be a primary mediator of 
endotoxic shock and is one of the first cytokines induced in serum following LPS 
administration (Manthey & Vogel, 1992). The actions of TNF -a are extremely 
varied, affecting numerous cell types as shown in Figure 1.3. Due to the extensive 
literature on the subject, only the most important points are summarised. 
Release of TNF -a from macrophages does not require the presence of other 
cytokines, although an important property of TNF -a is the ability to induce other 
cytokines, and in some cases, upregulate its own production (Manthey & Vogel, 
1992). TNF -a induces cytokine production by binding to specific, high affinity cell 
surface receptors; a 55kD and a 75kD protein named TNFR1 and TNFR2 
respectively. The majority of host cell types and tissues express both receptors 
although TNFR1 is preferentially expressed on epithelial cells whereas TNFR2 is 
more abundant on cells of myeloid origin (Ding & Porteu, 1992). The extracellular 
domains of the two TNF receptors share 28% homology and can be divided into four 
cysteine -rich repeats. In comparison, the intracellular regions show no apparent 
similarity, suggesting that the two receptors signal using different pathways (Tartaglia 
& Goeddel, 1992). 
It is proposed that at low concentrations, TNF preferentially binds to the high affinity 
receptor TNFR2. At higher levels, TNF can bind to TNFR1, due to either increased 
local concentration (as a result of binding to TNFR2 at the surface) or due to 
increased release of TNF -a from cells (Tartaglia & Goeddel, 1992). Using receptor 
antagonists, TNFR1 has been shown to signal a range of biological activities, 
including cytotoxicity, induction of NF -1(13 and antiviral activity. Thymocyte and 
cytotoxic T- lymphocyte proliferation have been attributed to TNFR2. Crosslinking of 
the receptors and, after binding, internalisation and degradation of the cytokine have 
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also been suggested as important components of the activation process. Experiments 
using anti -TNFR MAb fragments (Engelmann et al, 1990) and agents inhibiting 
receptor internalisation and lysosomal processing (Kull & Cuatrecasas, 1981) have 
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Similar to LPS stimulation of cytokines, once TNF -a has bound to its receptors a 
signal is transduced across the membrane to activate intracellular biochemical 
pathways. Messenger proteins within the cell including the transcription factor 
NF-KB associate with promoter sequences upstream of TNF- inducible genes to 
initiate transcription (Vassalli, 1992). 
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TNF -ß or lymphotoxin shares 28% homology with TNF -a, and shows similar 
properties associated with inflammation and anti -tumour activity. Furthermore, both 
cytokines compete for the same receptors and can displace each other. TNF -ß, 
however, is a 25kD glycoprotein, produced only by lymphocytes and is induced much 
later in the inflammatory response (Chaturvedi et al, 1994). It is speculated that the 
lack of homology between the binding regions of TNF -a and TNF -13 indicates 
different receptor binding conformations, leading to the initiation of different 
biological events. 
1.3.5 INTERLEUKIN -8 (IL-8) 
Interleukin -8 (IL -8) is a basic 8.4kD protein produced by a variety of cells including 
monocytes, macrophages, fibroblasts and keratinocytes in response to both LPS and 
TNF -a. IL -8 belongs to a family of low molecular weight peptides called chemokines 
which act as chemoattractants for immune cells and play a vital role in the 
inflammatory response. Members of the chemokine family fall into two broad groups, 
a and ß, distinguished by chromosomal location, minor differences in amino acid 
sequence and target cells. IL -8 is an example of an a- chemokine, located on human 
chromosome 4 (Oppenheim et al, 1991), and characterised by the amino acid 
arrangement -C -X -C -, where C corresponds to a cysteine residue and X any other 
amino acid (Leibler et al, 1994). 13- chemokines are found on human chromosome 17 
and have the cysteine residue structure -C -C -. a- chemokines possess chemotactic 
activity for neutrophils, lymphocytes and basophils, whereas 13- cytokines attract 
monocytes (Leibler et al, 1994). The cellular effects of IL -8 are shown in Figure 1.4. 
Approximately one hour after TNF -a stimulation, IL -8 mRNA levels increase, 
reaching a maximum after three hours. Site mutagenesis has established the region of 
the IL -8 gene from -94 to -71bp to be the minimum sufficient for conferring 
responsiveness to TNF -a. This region resembles a potential binding site for 
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transcription factors such as NF -KB. In addition, studies using cycloheximide 
indicated that the induction of TL -8 mRNA occurs despite the absence of new protein 
synthesis, suggesting that a repressor may be involved in negative regulation of IL -8 
(Oppenheim et al, 1991). 
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Figure 1.4 Biological properties of IL-8. 
Once induced, IL -8 can interact with its own high- affinity receptor, an integral 
membrane protein present on the surface of neutrophils and T- lymphocytes and 
comprising seven membrane -spanning helices, capable of activating G proteins 
(Janeway & Travers, 1994). IL -8 binding to its receptor rapidly phosphorylates two 
cytosolic proteins of 48kD and 65kD, known previously to be phosphorylated by 
other chemoattractants. The 48kD and 65kD proteins are therefore thought to play a 
vital role in the signal transduction of leucocyte migration (Oppenheim et al, 1991). 
Rapid recycling of the IL -8 receptor is also thought to be essential for the chemotactic 
response of neutrophils, as internalisation of the IL -8- receptor complex transmits 
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intracellular signals leading to alteration of the actin cytoskeleton, which is known to 
be involved in the motile response (Downey et al, 1994). 
1.3.6 LOCAL RESPONSE TO CYTOKINE SECRETION 
A local bacterial infection results in the local release of cytokines, initiating the 
inflammatory process and so minimising the spread and damage of infection. 
Inflammation occurs as a result of three main changes to local blood vessels; an 
increase in blood flow, an increase in vascular permeability and an increase in 
expression of cell surface adhesion molecules that bind to circulating monocytes and 
polymorphonuclear leucocytes (neutrophils, basophils, eosinophils). 
TNF -a plays an important early role in the local release of cytokines and is a primary 
mediator of inflammation. On exposure to TNF -a and other inflammatory mediators, 
endothelial cells induce expression of a number of cell surface adhesion molecules 
including three transmembrane glycoproteins; P- selectin, E- selectin and ICAM -1. In 
response to mediators such as histamine and thrombin, P- selectin is very rapidly 
mobilised onto the endothelial cell surface. E- selectin is induced in response to 
TNF -a but as it requires de novo mRNA and protein synthesis, expression is delayed 
(Springer, 1994). Interaction of the two selectin molecules with the carbohydrate 
moiety, sialylated Lewis x, present on circulating neutrophils, monocytes and 
T- lymphocytes, allows the leucocytes to adhere weakly to the blood vessel wall. This 
initial labile adhesion lets leucocytes 'roll' in the direction of blood flow and permits a 
stronger binding, dependent on the interaction between ICAM -1 and the leucocyte 
integrin LFA -1 (previously mentioned in section 1.3.3 as a member of the CD18 
family) present on the phagocytic cell surface (Lawrence & Springer, 1991; Springer, 
1994). In the resting state, LFA -1 has a relatively low affinity for ICAM -1, however, 
the presence of IL -8 triggers a conformational change in LFA -1 to increase greatly its 
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ability to bind to ICAM -1 (Janeway & Travers, 1994). Thus, in the presence of IL -8, 
leucocytes are held firmly attached to the endothelium (Figure 1.5). 
The next stage in inflammation is diapedesis, where leucocytes move out of the blood 
vessels into infected tissues, a process requiring changes to the blood vessel walls. 
TNF -a increases vascular permeability and vascular diameter, which allows the 
attached leucocyte to cross the endothelial wall. The process of diapedesis involves 
another cell surface adhesion molecule, CD31, a member of the same family as 
ICAM -1. CD31 is constitutively expressed on all endothelial junctions and on 
leucocytes. It is thought that mediators such as histamine stimulate phosphorylation 
of CD31 to modulate cytoskeletal interactions and so permit leucocyte movement 
(Bevilacqua, 1993). Chemokine binding to proteoglycan molecules in the 
extracellular matrix directs leucocytes to invading bacteria where immune cells can 
phagocytose and remove the microbes. The whole process is shown in Figure 1.5. 
IL -8 therefore plays a major part in the inflammatory process. Firstly, IL -8 arrests the 
circulation of the cell. Secondly, release of IL -8 and other chemokines forms a 
concentration gradient directing the leucocyte cell migration to the infection focus. 
Thirdly, chemokines activate their respective target cells; thus, cells are not only 
brought to infection sites but are simultaneously armed to deal with any pathogens 
they encounter (Janeway & Travers, 1994). 
Endothelial cells also express molecules that trigger local blood vessel occlusion, with 
excess fluid drained to the regional lymph nodes, thereby preventing the spread of 








Figure 1.5 Mechanisms of the inflammatory process. (A) Weak adhesion of 
leucocytes to the vascular endothelial surface is mediated via E- selectin and s -Le', 
allowing neutrophils to roll in the direction of the blood flow (B) The presence of 
IL -8 mediates a strong binding between ICAM -1 and LFA -1 holding the leucocytes in 
place. (C) Leucocytes move out of the blood vessels. (D) Immune cells migrate to 
the site of infection along the chemokine concentration gradient. 
s -Le' = sialylated Lewis x; LFA -1 = lymphocyte function associated antigen; 
ICAM -1 = intracellular adhesion molecule. 
(Adapted from Janeway & Travers, 1994) 
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1.3.7 SYSTEMIC RESPONSE TO CYTOKINE SECRETION 
Once invading bacteria spread from the initial infection site into the circulation cells 
throughout the body may respond and release cytokines. The mechanisms governing 
systemic release of cytokines are the same as those that function locally. However, 
the consequences of systemic cytokine release are catastrophic and often fatal. The 
term 'sepsis' has traditionally been used to define the systemic response to infection. 
However, it is worth stressing that a systemic inflammatory response can arise in the 
absence of detectable infection; non -infectious causes include pancreatitis, ischaemia 
and trauma. The term 'systemic inflammatory response syndrome' (SIRS), was 
proposed at a consensus conference of chest physicians in 1991 to describe the 
systemic inflammatory process, independent of its cause (Bone et al, 1992). In this 
thesis, the terms sepsis and SIRS shall be used interchangeably for this systemic 
disease. 
As described for the local release of cytokines, TNF -a causes an increase in vascular 
permeability and diameter. If this occurs systemically, the endothelium cannot repair 
itself and the systemic loss of plasma volume from the circulation leads to sustained 
hypotension, characteristic of septic shock (Bone, 1993). If Gram- negative bacterial 
infection is confirmed, this condition may sometimes be referred to as 'endotoxic 
shock' because of the key role endotoxin plays in initiating this process. 
TNF -a also has a central role in endotoxin- induced coagulation activation and 
ultimately disseminated intravascular coagulation (DIC), another key characteristic of 
septic shock. TNF -a induces the expression of a membrane glycoprotein, called 
tissue factor, on monocytes and endothelial cells; involved in the initiation of the 
extrinsic pathway of coagulation (deBoer et al, 1992). Increased levels of cytokines 
also leads to a marked rise in activated factor XII, which results in fibrinogen to fibrin 
conversion, and in circulating markers for the generation of thrombin (Levi et al, 
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1993). As a result of systemic stimulation of blood coagulation, fibrin is generated 
and deposited, leading to the formation of microthrombi in various organs, platelets 
and the coagulation factors II, V and VII are consumed in excess, and the 
complement system is activated by both the classical and alternative pathway (Bone, 
1993). As with the cytokine network, overstimulation of the complement cascade can 
have deleterious effects on the host. For example, complement activation products 
such as C5a induce vasodilation, cooperate with cytokines in the stimulation of tissue 
factor expression on endothelial cells and activate neutrophils (Carson & Johnson, 
1990; deBoer et al, 1992). Increased chemotaxis of neutrophils can lead to 
pulmonary leukostasis, a lesion important in the development of the adult respiratory 
distress syndrome (ARDS), a further complication of sepsis appearing in 
approximately 80% of cases (Callery et al, 1991). 
Ultimately the major organs, kidney, liver, heart and lung, are compromised by the 
failure of normal perfusion. Multiple organ dysfunction syndrome (MODS) or 
multiple organ failure (MOF) is the net result of a bodily state out of control and 
unless effective treatment is received, the outcome is likely to be fatal. 
In summary, overwhelming Gram- negative bacterial infection can initiate a continuous 
or systemic release of cytokines leading to a complicated series of severe and often 
fatal consequences. Ironically, features of the cytokine network that make it so 
valuable in containing local infection are precisely those that allow it to play a central 
role in the pathogenesis of sepsis. However, as evolution has deemed to keep 
cytokines, their value locally must outweigh the consequences of systemic release. 
Levels of TNF -a are also increased significantly in other clinical conditions associated 
with inflammation and autoimmunity, including rheumatoid arthritis, systemic lupus 
erythematosis, AIDS, leprosy, leishmaniasis and cystic fibrosis. Thus, sepsis is not the 
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only condition where massive cytokine release is important, although it remains the 
best documented to date. 
1.3.8 TREATMENT OF SEPSIS 
Mortality rates of septic patients who develop the complications of shock and MODS 
can reach up to 90% (Bone, 1993). As a result, several new therapeutic strategies 
have been proposed to combat this systemic disease. The main target areas for 
treatment focus on the primary mediators of sepsis; LPS and cytokines, although 
advances in antimicrobial therapy and medical support aimed at reducing infection in 
the intensive care setting are also important. - The three main strategies are discussed 
below. 
Anti -LPS therapy 
The interaction of endotoxin with host cells is a primary event in sepsis. It is 
therefore logical to prevent the initial binding step. Antibodies against the 0-Ag 
region of LPS are highly protective against infection, increasing opsonisation, 
phagocytosis and clearance of both LPS and whole bacteria. However, due to the 
variability and specificity of O -Ag regions between different bacteria, 0-Ag antibodies 
are of limited commercial use as a broad spectrum therapeutic strategy (Baumgartner 
& Glauser, 1993). 
Protective antibodies directed against the lipid A -core region of LPS would, in 
contrast, be effective against a wide range of Gram- negative bacteria. Two anti -lipid 
A MAbs have been the subject of large scale clinical trials; a human IgM MAb HA-1A 
and a murine IgM MAb E5. Unfortunately, neither MAb was found to afford 
significant protection to sepsis patients, although interestingly, in both cases 
subgroups of patients showed a trend towards improved survival (Lynn & Cohen, 
1995; Baumgartner & Glauser, 1993). For example, the first phase 3 trial using 
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HA -1A appeared to protect patients with shock, but only when they were bacteraemic 
(Ziegler et al, 1991). Based on current clinical data, neither HA-1A or E5 can be 
recommended for treatment of sepsis and more studies are required to establish the 
benefit of anti -lipid A treatment. 
Lipid A analogues, due to their altered structure and lower toxicity, have been used as 
competitive endotoxin antagonists. Lipid x was found to inhibit LPS- induced 
neutrophil priming (Lynn & Golenbock, 1992) but as a weak LPS antagonist showed 
no protection in a canine model of sepsis (Danner et al, 1993). Lipid IVA is a better 
antagonist but requires a five to ten fold (w /w) excess to completely block the effects 
of LPS (Lynn & Golenbock, 1992). Thus, administration of lipid IVA would be 
difficult due to the large infusions of lipid required. The most promising LPS 
analogue is monophosphorylated lipid A (MPL), which reduces the haemodynamic 
effects, cytokine levels and mortality associated with subsequent endotoxin challenge 
(Astiz et al, 1993). 
Alternative lipopolysaccharide binding proteins, such as the LBP homologue BPI that 
can bind and neutralise the biological effects of LPS may be a further anti -LPS 
measure. BPI has a greater affinity for LPS compared to LBP and can compete 
effectively with LBP for binding (Lynn & Golenbock, 1992). Preclinical studies with 
recombinant BPI (rBPI) have shown to protect against endotoxaemia in animal 
models and a large -scale multicentre trial is now being planned (Kohn et al, 1993). 
Unfortunately, rBPI has a short half life and, therefore, would need to be administered 
by continuous infusion. 
Anti -LPS therapy would be of most benefit when administered early, before the 
initiation of inflammatory mediators and widespread vascular damage, or 
prophylactically to high -risk patients to prevent continued cytokine release. The main 
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disadvantage of anti -LPS therapy, however, is that it is specific to Gram- negative 
infection. Gram- positive bacteria also cause sepsis (Bone, 1994) and in such cases, 
any anti -LPS therapy would be redundant. 
Anti -Cytokine therapy 
The clinical problems associated with sepsis result from cytokine release, thus 
strategies aimed at preventing secretion or removing excess cytokines from the 
circulation would be worthwhile. Furthermore, anti -cytokine therapy would aid SIRS 
patients regardless of the clinical insult; Gram- negative bacteria, Gram- positive 
bacteria, non -bacterial microbes, trauma, burns and injury. TNF -a and IL -1 are the 
major cytokines generated during sepsis, playing a pivotal role in the immunological 
cascade. Consequently, the majority of anti -cytokine therapy has been directed 
against TNF -a and IL -1. For the purpose and relevance of this thesis only anti -TNF 
therapy will be detailed. 
Both polyclonal and monoclonal antibodies to TNF -a have been shown to be 
protective against septic shock in animal models, although this effect is seen only 
when the antibodies are administered before or together with endotoxin challenge 
(Beutler et al, 1985, Tracey et al, 1987, van der Poll et al, 1994). If the antibodies 
are received two to three hours after challenge, less protection is observed (Silva et 
al, 1990). 
MAbs to TNF -a have, however, been tested in clinical trials. Indeed, the results of a 
large scale, multi -centre, phase 3 clinical trial were recently published (Abraham, et al, 
1995). Results showed a reduction in mortality in patients who received the MAb 
after just three days, and a continued trend at twenty -eight days, but overall, there 
was no significant difference in mortality between placebo and MAb treated patients. 
Similar to trials with LPS MAbs, the apparent trend in decreased mortality was 
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attributed to a subgroup of patients. In this case, improved survival occurred in 
patients with shock; in non -shock patients there was no increased survival. As this 
treatment appears to benefit only certain patients, further clinical studies are required 
to define the role of TNF -a MAbs in sepsis therapy. 
TNFR1 and TNFR2 are shed from the surface of immune cells to give soluble, 
circulating derivatives; sTNFR1 and sTNFR2. The use of sTNF receptors to 
consume excessive TNF production has been advocated and in earlier studies these 
proteins appeared to offer protection against sepsis and endotoxaemia (Van Zee et al, 
1992). Unfortunately, results from a phase 2 and 3 trial suggested that mortality was 
actually higher in patients receiving the treatment compared to a placebo group (Lynn 
& Cohen, 1995). 
IL -8 is also a potential target for sepsis therapy and indeed, in a rabbit model, a MAb 
to IL -8, WS -4, inhibited neutrophil- mediated lung injury following reperfusion of 
pulmonary ischemic tissue (Seikido et al, 1993). However, no data is yet available on 
anti -IL -8 therapy in humans. 
Endogenous regulators 
The cytokine network is a tightly regulated system and includes 'negative' cytokines, 
that act to downregulate or counteract the effects of pro -inflammatory mediators such 
as TNF -a. IL -4 and IL -13 are closely linked genetically and share limited sequence 
homology (20 -25 %) (Minty et al, 1993). In addition, both are products of activated 
T- lymphocytes and, more importantly, have anti -inflammatory effects on human 
endothelial cells and monocytes. In experiments, IL -4 and IL -13 have been shown 
not only to inhibit cytokine secretion but also LPS- and TNF -a- induced tissue factor 
expression (Herbert et al, 1993). As previously outlined in section 1.3.7, tissue factor 
initiates blood coagulation and ultimately DIC. IL -10 can block in vitro production of 
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cytokines, including TNF -a, as well as enhance levels of sTNFR (Leeuwenberg et al, 
1994). In a murine model assessing the use of IL -10 in endotoxaemia, it was found 
that pretreatment with IL -10 before LPS challenge was protective against sepsis. 
Currently IL -10 is being evaluated in phase 2 clinical trials (Gérard et al, 1993). 
Thus, all three anti -inflammatory cytokines represent a potentially important therapy 
in regulating uncontrolled immune responses. 
Treatments against different components of the coagulation pathway and MAbs 
against selectins, integrins and other adhesion molecules have all been used as 
prospective therapies (Ridings et al, 1995). In addition, a more extreme approach, 
involving the removal of circulating endotoxin and inflammatory mediators by plasma 
or whole blood exchange, has been tried experimentally. Although only small -scale 
clinical trials have used this extreme treatment and little data is available, early results 
are encouraging (Lynn & Cohen, 1995). To date, no suggested treatment for septic 
shock has conferred an undisputed benefit to patients and indeed, due to the 
complexity of the disease, a combination of treatments may prove to be the best 
strategy as was demonstrated in a model ofP. aeruginosa sepsis (Cross et al, 1993). 
1.4 BURKHOLDERIA CEPACIA 
1.4.1 TAXONOMY 
Burkholderia cepacia has been described by several different synonyms. Originally 
termed Pseudomonas cepacia, this organism has been called Pseudomonas kingii, 
Pseudomonas multivorans and Eugonic Oxidiser 1. In 1992 seven species of the 
Pseudomonas rRNA homology group II were regrouped into the new genus 
Burkholderia on the basis of cellular lipid and fatty acid composition, 16S rRNA and 
DNA -DNA homology (Yabuuchi et al, 1992; List No. 45, 1993). For the purpose of 
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this thesis, the name Burkholderia cepacia will be used. At present, the members of . 
the genus Burkholderia are B. cepacia (type species), B. gladioli, B. mallei, 
B. pseudomallei, B. picketti, B. caryophylli, B. solanacearum, and recently added to 
the group, B. plantarii, B. glumae, B. vandii (Urakami et al, 1994) and 
B. cocovenenans (Zhao et al, 1995). 
The general characteristics of B. cepacia include the following features: 
Gram- negative, non -spore forming, aerobic rod, motile with a respiratory metabolism 
and typically catalase and oxidase positive. Various non -fluorescent pigments may be 
produced and poly -13- hydroxalkanoates can be accumulated as reserve materials. The 
optimal temperature for growth is 30 -35 °C (Palleroni, 1984). B. cepacia has 
considerable nutritional versatility with some strains even able to utilise penicillin G as 
a sole carbon and energy source (Beckman, 1979). B. cepacia strains have been 
shown to possess multiple replicons, plasmids and insertion sequences (Cheng & 
Lessie, 1994; Rodley et al, 1995) that may account for some of this versatility. At 
first, B. cepacia was considered a ubiquitous organism sharing similar environmental 
niches to P. aeruginosa. Indeed the natural habitat of B. cepacia has been reported as 
soil, water and vegetation (Holmes, 1986). However, a recent study has 
demonstrated that true environmental strains of B. cepacia are rather difficult to 
isolate and surprisingly, quite rare (Butler et al, 1995). The following sections 
describe both the beneficial role and the disease states in which B. cepacia is 
important. 
1.4.2 BENEFICIAL ROLE OF B. CEPACM 
B. cepacia as a biological control agent 
Concern for the environment, public safety and increasing numbers of pesticide - 
resistant pathogens has raised interest in using alternative methods of plant disease 
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control. One such method is the use of biological control agents (BCA), a method in 
which B. cepacia has gained considerable attention. 
B. cepacia produces the antimicrobial compounds pyrrolnitrin, aminopyrrolnitrin, 
monochloroaminopyrrolnitrin, altericidins, cepalycins, cepacin A and cepacin B 
(McLoughlin et al, 1992, Jayaswal et al, 1993, Abe & Nakazawa, 1994). Studies 
have shown that these compounds have an antagonistic effect against both bacterial 
and fungal phytopathogens and are capable of suppressing a wide range of plant 
diseases including sunflower wilt disease (McLoughlin et al, 1992), potato rot 
(Burkhead et al, 1994), tobacco wilt disease (Aoki et al, 1991) and blue and grey 
mould in apples and pears (Janisewicz & Roitman, 1988). 
B. cepacia as a decontaminant of soils 
In addition to the bactericidal and fungicidal activity of B. cepacia, some strains are 
able to break down herbicides, pesticides and industrial waste material. 
Trichloroeythlene (TCE) and 2,4,5, -trichlorophenoxyacetic acid (2,4,5, -T; the 
principle herbicide in 'agent orange') are just two highly volatile, toxic, organic 
solvents known to disperse through soil, from the original waste site, threatening both 
soil life and underground water supplies. The documented persistence of these 
chemicals reflects the fact that many microbes are unable to degrade these 
compounds, leading to cumulative pollution effects. 
By using the chemicals as a sole source of carbon and energy, strains of B. cepacia 
have been shown to degrade both TCE and 2,4,5, -T (Folsom et al, 1990). Indeed, 
B. cepacia degraded more than 90% 2,4,5 -T from heavily contaminated soil 
(20,000ppm) within six weeks. This rate is between 200 - 20,000 times greater than 
other known degrading bacteria (Kilbane et al, 1983). 
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1.4.3 B. CEPACIA IN DISEASE 
B. cepacia as a phytopathogen 
B. cepacia was first reported in 1950 as the causative agent of 'sour skin', a bacterial 
rot in onion bulbs (Burkholder, 1950). In the report, infected onions were described 
as slimy, discoloured and producing a sour or vinegar -like odour. Infection was 
thought to occur through wounds, produced by cutting of the onion tops during 
harvest time. No evidence was obtained for spread to healthy bulbs, and young 
onions, potato tubers and narcissus bulbs, inoculated with B. cepacia also showed no 
symptoms. 
B. cepacia in nosocomial infections 
In humans, B. cepacia has been reported in opportunistic infections such as 
necrotising pneumonitis, macerated wound lesions, urinary tract infections, peritonitis 
and bacteraemia. In the majority of these cases, B. cepacia infection was traced to 
contamination of hospital water and disinfectant solutions (Table 1.2). For example in 
one outbreak described by Berkelman et al (1982), ten patients had B. cepacia 
recovered from their peritoneal fluid after dialysis treatment, during a three month 
period. The infective source was found to be the water reservoir in two automatic 
dialysis machines. Inadequate cleaning and emptying of the water supplies had 
allowed sustained growth of B. cepacia. 
B. cepacia has also been associated with foot rot in soldiers training in swamps 
(Taplin et al, 1971). Sampling of the swamp water confirmed the presence of 
B. cepacia and highlights once more the organisms predilection for moist, water - 
based sources. 
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Table 1.2 Episodes of B. cepacia nosocomial infections 









Tap water & Chlorhexidine (D) 




Blood Gas Analyser 
Intravenous Infusates 
Basset et al, 1970 
Craven et al, 1981 
Sobel et al, 1982 
Decicco et al, 1982 
Gelbart et al, 1976 
Henderson et al, 1988 
Thong et al, 1975 
D = disinfectant 
B. cepacia in Chronic Granulomatous Disease 
Chronic granulomatous disease (CGD) is a neutrophil disorder in which cells do not 
produce oxidative reactive intermediates such as hydrogen peroxide, normally 
required for effective intracellular killing and degradation. Indeed, although infecting 
organisms may be readily engulfed by CGD leucocytes, the organisms can survive 
intracellularly and actually prime the host for infection (Bottone et al, 1975). Patients 
with CGD are thus immunocompromised and appear particularly susceptible to 
B. cepacia infection, normally presenting as pneumonia. The strong association 
between B. cepacia and CGD might be explained by production of catalase, an 
enzyme known to destroy the reduction products of oxygen (O 'Neill et al, 1986). 
In conclusion, B. cepacia may exist as a phytopathogen and, ironically, as a potential 
biological control agent and decontaminant of soil. Clinically, B. cepacia infections 
are relatively infrequent, requiring a defective immune system and /or arising from 
contamination. However, in recent years B. cepacia has come to prominence as a 
major threat to patients with cystic fibrosis (CF). Before discussing the role of 
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B. cepacia in CF the following section will describe the physiology and pathogenesis 
of this important disease. 
1.4.4 CYSTIC FIBROSIS 
Cystic fibrosis is the most common lethal inherited disease among the Caucasian 
population with a frequency of 1 in 2500 live births; 6000 people are affected in the 
UK alone with 50,000 patients worldwide (Bye et al, 1994). 
The CF gene 
In 1938, Anderson gave the first comprehensive clinical description of CF and within 
a few years recognised the disease as an autosomal, recessive inherited syndrome 
(Anderson & Hodges, 1946). However, it was only in 1985 that the genetic locus of 
CF was mapped, to chromosome 7 (White et al, 1985), and in 1989 the CF gene 
cloned (Riordan et al, 1989). The CF gene product, termed the cystic fibrosis 
transmembrane conductance regulator (CFTR) was identified as a regulated chloride 
channel when in vitro experiments showed that cells, transfected with CFTR cDNA, 
expressed increased chloride transport (Anderson et al, 1991 a). 
Since the discovery of CFTR over 400 CF- associated mutations have been reported. 
These mutations can be grouped into four broad classes; defective protein production, 
defective protein processing, defective regulation and defective conductance. The 
most common CFTR mutation ÁF508 (so called because of a phenylalanine deletion 
at residue 508) accounts for around 70% of all CF mutations and results in defective 
protein processing (Shrimpton et al, 1991). It is proposed that the failure to traffic 
CFTR to the correct cellular location is a result of incorrect folding. Interestingly, 
experiments delivering CFTR ÁF508 to the plasma membrane show that the protein 
retains some function (Welsh & Smith, 1993). 
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The cellular defect 
The cellular defect in CF results from dysfunctional chloride channel activity. In 
healthy epithelial cells sodium ions are actively absorbed into the cell and chloride ions 
are actively transported out into the luminal area. Water follows the direction of ion 
transport in order to maintain the osmotic balance. In CF epithelial cells, decreased 
secretion of chloride ions and hyperabsorption of sodium ions results in the net 
transport of water out of the lumen and the subsequent production of dehydrated 
viscous mucus (Boucher et al, 1986; Bye et al, 1994), which leads to the clinical 
features of the disease. 
Clinical features of CF 
Cystic fibrosis is characterised by the accumulation of dehydrated mucus resulting in 
the blockage of exocrine glands and commonly presenting as pancreatic, 
gastrointestinal, genitourinary and pulmonary abnormalities. 
Pancreatic disease is a common feature of CF with the majority of patients suffering 
from pancreatic enzyme insufficiency. Pancreatic enzymes normally assist in the 
digestion and absorption of food in the small intestine, but in CF the enzymes cannot 
be transported due to blockage of pancreatic ducts with mucus (Bye et al, 1994). If 
uncorrected, the lack of pancreatic enzymes leads to failure to thrive due to fat and 
protein malabsorption (Boat et al, 1989). Pancreatic enzyme supplements have been 
used by CF patients for many years to relieve the symptoms of maldigestion. 
Meconium ileus results from a failure to pass meconium in the first few days of life 
and occurs in 5 -10% of CF newborns. It is believed to be caused by a failure to 
secrete pancreatic enzymes and therefore incomplete digestion of dehydrated 
intestinal contents. Obstruction of the bowel also occurs in older children and adults, 
termed meconium ileus equivalent, and is again associated with sticky, undigested 
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intestinal contents (Bye et al, 1994). Other CF- associated gastrointestinal conditions 
include rectal prolapses (occurring in around 20% of young CF children) and 
intussusception (Green, 1993). 
Male infertility is a characteristic of CF affecting more than 95% of male patients. 
Intrauterine obstruction of the genital tract with thickened mucus results in altered 
Wolffian duct structures, with the vas deferens, epididymis and seminal vesicles 
atrophic, fibrotic or completely absent (Tussig et al, 1972). Fertility in female CF 
patients is not commonly affected, although the dehydrated cervical mucus may 
impede normal sperm migration (Kapito et al, 1973). CF breast milk has been found 
to be essentially normal (Alpert & Cornier, 1983). 
Pulmonary disease in the form of debilitating exacerbations of respiratory infection is 
the major cause of morbidity and mortality in CF. The lungs of CF patients are 
histologically normal at birth (Accurso, 1995) although the primary pathogenic 
events, accumulation of mucus secretions and respiratory infection, have been shown 
to occur in the first few months of life (Boat et al, 1989; Armstrong et al, 1995). 
Mucosal obstruction of the small airways impairs mucociliary clearance, predisposing 
CF patients to chronic bacterial infection although surprisingly, the spectrum of 
microorganisms associated with CF is limited. Generally, Staphylococcus aureus 
appears in infancy, Haemophilus influenzae in early childhood, followed by 
Pseudomonas aeruginosa in early adolescence. Burkholderia cepacia is most 
common in the late teens (Govan & Nelson, 1992). 
Bacterial infection in CF 
Prior to 1950, S. aureus was the major cause of death in CF but today can be 
effectively treated by aggressive antibiotic therapy. Indeed, long -term anti - 
staphylococcal therapy has been implemented in some CF centres, upon diagnosis of 
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CF, in an attempt to prevent pulmonary damage and subsequent colonisation by 
H. influenzae and P. aeruginosa. However, the efficacy of such a strategy has been 
debated and remains controversial; retrospective studies have shown a correlation 
between anti -staphylococcal therapy and increased incidence of other CF pathogens, 
in particular P. aeruginosa, and hence a poorer prognosis (Bauemfriend et al, 1987). 
S. aureus produces a number of potential virulence determinants including coagulase, 
catalase, haemolysins, exotoxins, teichoic acid and EPS. However, only the latter two 
determinants, which play a role in the adherence to pulmonary epithelial cells, have 
any defined role in CF pathogenesis (Govan & Nelson, 1992). 
Less information is available on the non -capsulate H. influenzae CF isolates, probably 
due to the difficulty in cultivating this fastidious organism. However, it is known that 
H. influenzae has increased mucosal adherence, excretes a heat -labile substance to 
inhibit cilia motion and produces factors to stimulate mucus secretion, possibly 
including histamine (van Alphen et al, 1995). 
P. aeruginosa remains the leading CF pathogen colonising up to 90% of patients and 
once established is very rarely eradicated. P. aeruginosa strains produce many 
virulence factors including exotoxin A and S, haemolysin -phospholipase C, elastase 
and proteases, all thought to play a role in early colonisation by interfering with host 
defence mechanisms (Vasil, 1986, Hoiby et al, 1990). A major virulence determinant 
of P. aeruginosa is alginate (section 1.2). The production of alginate and subsequent 
biofilm formation protects bacteria from antibiotics, phagocytic cells and antibodies, 
and leads to the formation of immune complexes causing substantial immune - 
mediated damage through release of neutrophil elastase, myeloperoxidase and free 
oxygen radicals (Hoiby et al, 1990). Longitudinal antibody studies have shown that 
high and rising anti -P. aeruginosa antibodies are associated with a poor prognosis 
(Hoiby et al, 1990; Winnie & Cowan, 1991). Current treatment is aimed at 
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preventing colonisation by non -mucoid strains, using antibiotics such as tobramycin 
and ciprofloxacin (C. Doherty, personal communication). However, it is unfeasible to 
totally protect CF patients from such a ubiquitous organism. In the long term, 
vaccination may be the best solution for inhibiting this organism. Colonisation by 
B. cepacia is discussed in section 1.4.5. Rarer pathogens isolated from CF sputa 
include Aspergillus fumigatus, Mycobacterium tuberculosis and Stenotrophomonas 
maltophilia. 
As a consequence of repeated cycles of obstruction, infection and inflammation, 
irreversible pulmonary tissue damage occurs. Lung function progressively declines 
with each exacerbation, leading eventually bronchiectasis, hypercapnoea and cor 
pulmonale. Ultimately, pulmonary failure occurs and is the primary cause of more 
than 90% of deaths in CF patients (Gilligan, 1991). Several other pulmonary 
complications may arise, including asthma, pneumothorax and haemoptysis (Green, 
1993). At autopsy the air spaces are overinflated, the bronchioles are often 
obliterated and bronchiectactic cysts are extensive (Boat et al, 1989). 
Treatment of CF 
At present no cure for CF is available although numerous therapies can improve life 
expectancy including pancreatic supplements, physiotherapy and antibiotics. With the 
advances of molecular medicine, the discovery and cloning of the CF gene has led to 
genetic diagnosis and screening of CF and, more excitingly, the prospect of gene 
therapy. The crux of gene therapy is to deliver CFTR DNA safely and efficiently into 
affected epithelial cells and thus restore chloride channel activity long term. 
Currently, there are two gene therapy strategies, one advocating the use of liposomes 
as DNA carriers and the other using adenoviruses. Both treatments have advantages 
and problems. The adenoviruses can target and deliver the CFTR DNA package 
efficiently, as viruses enter cells as part of their natural lifecycle. However, worries 
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remain about genetic stability and the potential for an immunogenic response. 
Liposomes do not cause an immune reaction and are safe for use with no indicated 
side effects. Unfortunately, delivery of DNA by natural uncharged liposomes is 
inefficient and even using cationic liposomes to aid uptake, targeting the correct cells 
remains a problem. Both therapeutic strategies have been used in phase 1 clinical 
trials involving CFTR cDNA delivery to nasal epithelium. Results indicate increased 
chloride movement and negligible inflammation (Crystal et al, 1994; Caplen et al, 
1995). Further results are eagerly awaited. 
Discovery of the CF gene has also led to the development of transgenic CF mice by 
several groups (Higgins & Trezise, 1992). The Edinburgh CF mouse, produced by 
targeted insertional mutagenesis, displays several key CF characteristics including 
pulmonary, gastrointestinal and genitourinary disease and can facilitate pathological, 
bacteriological and therapeutic studies (Dorin et al, 1992). 
Using current techniques, gene therapy could truly benefit only very young children 
who have little or no pulmonary scarred tissue. Once the cycle of inflammation and 
scarring is established, the use of gene therapy may be of limited use in an inadequate, 
injured lung. At present the only way to extend the life of CF patients with end stage 
respiratory failure appears to be through lung transplantation. 
Since the first successful heart-lung transplant (HLT) in a CF patient in 1985 over 120 
similar operations have been performed in the UK. As with any major surgery risks 
are considerable but at present 70% of CF patients survive 1 to 2 years post- 
operatively (Higgenbottam et al, 1992). Although not a cure for CF, the majority of 
patients achieve a better quality of life after transplantation. Unfortunately, infection 
in the transplanted organs remains a major cause of mortality, with P. aerzuginosa and 
B. cepacia commonly involved (Noyes et al, 1994). In one report (Snell et al, 1993) 
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examining 24 double lung transplant patients, B. cepacia was the cause of 14 bouts of 
pneumonia, 4 empyemas, 1 lung abscess, 1 suppurative pericarditis and 5 cases of 
sinusitis. Furthermore, ten patients who were B. cepacia colonised before transplant 
grew this bacterium post -operatively, with an additional five patients also colonised. 
Out of the fifteen B. cepacia -positive patients, seven died (five due to sepsis) whereas 
no patient with only P. aeruginosa died. 
A few decades ago CF individuals died in infancy; today, through better management 
and understanding of the disease, patients can expect to live into their twenties and 
thirties. However, this encouraging picture has been completely devastated by the 
emergence of B. cepacia. 
1.4.5 B. CEPACIA IN CYSTIC FIBROSIS 
In the early 1980's, several North American cystic fibrosis (CF) centres reported a 
disturbing increase in B. cepacia isolates from CF sputa. During the five year period 
from 1978 to 1983, B. cepacia associated CF deaths rose from 9% to 55% 
(Thomassen et al, 1985). At that time, UK centres reported no B. cepacia problem 
but by the early 1990's, several areas were seriously affected. In Edinburgh alone the 
prevalence of B. cepacia had reached over 25% by 1992 and since then B. cepacia 
has been held responsible for the majority of CF deaths. Initially, P. aeruginosa 
colonisation was thought to 'prime' the CF lung for acquisition of B. cepacia. 
However, over 35% of B. cepacia -positive CF patients in Edinburgh are not co- 
colonised with P. aeruginosa, highlighting the pathogenicity of B. cepacia in its own 
right. The devastating impact of B. cepacia on the CF community is characterised by 
three unusual features, multiresistance, transmission and 'cepacia syndrome', 
properties not observed with any other major CF pathogen. 
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Multiresistance 
B. cepacia strains are inherently resistant to numerous antibiotics including 
aminoglycosides, ß- lactams and anti -pseudomonal penicillins. Even when sensitivity 
has been demonstrated in vitro, administration of commonly used CF antimicrobial 
drugs does not eliminate or reduce B. cepacia in vivo, although a decrease in pro - 
inflammatory markers may occur (Elborn et al, 1994). 
Transmission 
An early feature of B. cepacia in CF was the rapid spread and high colonisation rate 
of this organism, culminating in the realisation that certain B. cepacia strains were 
highly transmissible and responsible for 'epidemic' outbreaks. Indeed, one such 
'epidemic' strain, isolated from an Edinburgh CF patient, has colonised several CF 
individuals both within the same clinic and in other UK CF centres. Recent data from 
DNA -based fingerprinting and sequence analysis has shown the Edinburgh epidemic 
strain to be identical to a highly transmissible strain isolated in Toronto (Johnson et al, 
1994; Sajjan et al, 1995). 
Tablan et al (1987a) identified several factors that increased the risk of acquisition of 
B. cepacia including; increased severity of underlying disease, increasing age, having a 
sibling colonised with B. cepacia and hospitalisation within the previous six months. 
However, fears arising from the spread of B. cepacia led to the introduction of a 
controversial world -wide segregation policy separating B. cepacia colonised from 
non -colonised patients as the only effective method of reducing transmission rates and 
cross -infection. It is therefore vital that laboratories remain vigilant in their 
monitoring of CF sputa and, most importantly, accurately identify this organism, so 
patients are not wrongly segregated or placed at undue risk. For example, one study 
demonstrated only 36 out of 115 laboratories investigated, were able to isolate and 
identify B. cepacia from seeded sputum samples (Tablan et al, 1987b). 
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The development of selective media for the isolation and growth of B. cepacia 
together with improved genetic typing systems such as pulsed field gel electrophoresis 
and ribotyping has helped epidemiological monitoring (Gilligan et al, 1985; Anderson 
et al, 1991b; Kostman et al, 1992). In particular, the use of DNA -based 
fingerprinting techniques has provided compelling evidence for person -to- person 
transmission and nosocomial acquisition of B. cepacia. LiPuma et al (1990) provided 
the first scientific evidence for person -to- person transmission, occurring between two 
CF patients attending a residential summer camp. However, the study did not identify 
whether transfer occurred directly through droplet spread or indirectly via shared 
equipment. The isolation of B. cepacia from the air of rooms occupied by colonised 
CF patients supports the proposal of aerosol dissemination (Humphreys et al, 1994). 
With regard to the spread of the Edinburgh/Toronto epidemic strain in the UK, 
transmission was shown to be due to close social contact such as attendance at 
meetings, summer camps and at a fitness class (Govan et al, 1993). Thus, segregation 
policies need to encompass both social and hospital contacts, with hygiene practices 
by patients and carers brought to the highest standards possible to prevent cross - 
infection. 
Epidemiological studies have demonstrated probable transmission routes, although the 
underlying mechanisms of spread, particularly those of 'epidemic' strains, remain 
unclear. Recent studies of B. cepacia fimbriae (pili) have addressed this issue. 
Goldstein et al, (1995) demonstrated that B. cepacia strains produce five distinct 
classes of pili, mesh, cable, filamentous, spine and spike. Further investigations have 
revealed a correlation between transmission rates and fimbrial structure, in particular 
the expression of cable pili by the Edinburgh/Toronto strain, arguably the most 
transmissible lineage described to date. Non -epidemic CF strains, in general, produce 
the filamentous fimbriae, non -CF clinical isolates the spine fimbriae and environmental 
isolates the spike fimbriae. Type I or mesh fimbriae are constitutively co- expressed as 
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peritrichously arranged dense mats with either cable, filamentous, or spike fimbriae 
(Goldstein et al, 1995). This important new finding leads to exciting possibilities, not 
only for evaluating the safety of B. cepacia strains but also in preventing further 
transmission with a cable vaccine or neutralising anti -cable antibody. However, it 
must be stressed that not all transmissible strains possess cable pili, therefore, other 
transmission factors must exist. 
Cepacia syndrome 
The third, and perhaps most worrying problem associated with B. cepacia acquisition 
is the inability to predict the clinical outcome. Although some B. cepacia -colonised 
CF patients have asymptomatic carriage and others show a slow and progressive 
decline in lung function, similar to P. aeruginosa colonisation, 20 -30% of B. cepacia- 
positive individuals succumb to a rapid, and usually fatal, pulmonary decline 
associated with necrotising pneumonia and complicated on occasion by septicaemia 
(Thomassen et al, 1985; Rosenstein & Hall, 1980; Isles et al, 1984). The latter 
clinical outcome is unique amongst CF pathogens and has thus been termed 'cepacia 
syndrome'. 
At present, segregation appears to have reduced the spread of B. cepacia colonisation 
(Thomassen et al, 1986) but the social and psychological burden on CF communities 
has been severe. Progress into understanding the pathogenesis of B. cepacia has been 
made but important questions remain; for example, why do different CF patients 
colonised by the same strain show variable clinical outcome? Identification of 
transmission factors such as cable pili may explain why some strains are more 
transmissible, but it must be emphasised that it is not only epidemic strains that 
correlate with the 'cepacia syndrome'. Indeed, the first reported B. cepacia- associated 
death in a CF patient in the UK, a 9 -year old girl, was caused by an apparently non - 
epidemic isolate (Glass & Govan, 1986). Unfortunately, the patient still showed a 
dramatic decline and ultimately died. In contrast, the first patient to acquire the 
epidemic strain in Edinburgh has shown little deterioration six years after colonisation. 
Progress into understanding the epidemiology of B. cepacia has been achieved but the 
pathogenic mechanisms involved in B. cepacia infection remain poorly defined and 
need to be addressed urgently. The following sections describe the mechanisms that 
may allow B. cepacia to prosper in the CF lung: potential virulence factors and host 
defence mechanisms. 
1.4.6 B. CEPACIA CELL SURFACE VIRULENCE DETERMINANTS 
Lipopolysaccharide 
The LPS of B. cepacia strains are similar to the established structure described in 
section 1.1.3. The lipid A region is based on the classic 3 -1,6- linked D- glucosamine 
disaccharide, with phosphoryl groups attached at positions 1 and 4' expressed as 
either two different phosphodiester residues or with one phosphate present in the 
monoester configuration (Cox & Williamson, 1991). 
Initial analytical studies on B. cepacia LPS debated the relative absence of Kdo. In 
1979, Manniello et al found no Kdo present in five B. cepacia strains tested. In 1989 
Straus et al detected Kdo in two out of ten strains and a year later in all six isolates 
tested although Kdo concentrations were low. A recent finding is that some Kdo can 
be substituted by Ko (D glycero- a- D- talo -2- octulosonic acid) the hydroxylated form 
of Kdo (Kawahara et al, 1994), which is also found in the LPS of B. pseudomallei 
and some Legionella species (Wilkinson & Pitt, 1995). This finding points to the 
presence of only one Kdo residue in B. cepacia LPS and may account for the previous 
difficulty in assaying this compound. Glucose, rhamnose and heptose are the major 
components present in the core (Manniello et al, 1979) but surprisingly isolated core 
structures show no phosphorus residues present (Cox & Wilkinson, 1991). 
52 
The 0- Antigen is the best -characterised region of B. cepacia LPS with seven serotype 
groups now identified (Heidt et al, 1983). To date all the polymers tested are linear 
with di- or tri- saccharide repeating units. Some of the 0 -Ag structures have been 
found in other bacteria, for example the 03 serotype structure has been reported in 
P. aeruginosa and Serratia marcescens (Cox & Wilkinson, 1989a). 
B. cepacia LPS may be expressed as either a rough or smooth phenotype (McKevitt 
& Woods, 1984) and strains do not appear to undergo a smooth to rough transition as 
occurs with P. aeruginosa in CF. A major role for LPS in B. cepacia pathogenesis 
has yet to be defined, although a complex composed of surface carbohydrate, LPS 
and protein was shown to produce extensive lung pathology in rats, with the toxicity 
attributed to the LPS component (Straus et al, 1989). In addition, the continued 
presence of LPS may cause inflammatory lung damage as described in section 1.3. 
Outer membrane proteins 
B. cepacia produces five major outer membrane proteins; A (56kD), B (38kD), C 
(37kD), D (28kD) and E (2lkD). OMP C and D are the most abundant proteins and 
have recently been shown to form a diffusion porin by non -covalent association 
(Gotoh et al, 1994). As with other Gram -negative bacteria, B. cepacia can alter its 
OMP profile in response to different environmental conditions (section 1.2). 
Magnesium- depleted cells show a much simpler OMP profile compared to iron - 
limited or nutrient broth -grown cells in which new OMPs are induced (Anwar et al, 
1983). These changes undoubtedly contribute to increased resistance to antibiotics 
and host defence mechanisms, as has been proposed for serum resistance (Butler et al, 
1994). The outer membrane also contains some unusual polar lipids although how 
they contribute to the biological properties of the cell surface has yet to be determined 
(Cox & Wilkinson, 1989b). 
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The inherent antimicrobial resistance of B. cepacia is thought to be due to reduced 
outer membrane permeability. The small size of B. cepacia porins (Parr et al, 1987), 
decreased expression of both OMP C and D ( Aronoff, 1988) and inducible 
ß- lactamases are associated with high level ß- lactam resistance (Aronoff & Labruzzi, 
1986). Similarly, chloramphenicol resistance is believed to be due to decreased outer 
membrane permeability (Burns et al, 1989). In addition, the low concentration of 
phosphate and Kdo residues in the LPS of B. cepacia limits the number of anionic 
sites required for effective binding by cationic antibiotics (Cox & Williamson, 1991). 
B. cepacia produces at least three siderophores, pyochelin, cepabactin and 
azurechelin, which enable the organism to compete for iron within the host (Sokol et 
al, 1992). Pyochelin associates with a 14kD binding protein in iron -limiting 
conditions, with the other two siderophores thought to perform a supplementary role 
when pyochelin- mediated iron translocation is impaired. Pyochelin production has 
been tentatively associated with mortality in CF patients. Sokol (1986) found that 
although half of the clinical isolates studied were pyochelin negative, 86% of 
pyochelin- producing strains were from patients with severe infection. 
Exopolysaccharides 
Strains of B. cepacia deficient in glucose dehydrogenase (Gcd) have been shown to 
produce large amounts of EPS in the presence of excess glucose (Sage et al, 1990). 
In addition, both Gcd negative and positive strains accumulated EPS when the carbon 
substrate was changed from glucose to mannitol or glycerol. The EPS produced was 
not an obvious mucoid EPS such as alginate (B. cepacia strains have been shown to 
be alg D negative by PCR analysis; Nelson et al, 1994) but consisted of galactose, 
glucose, mannose, glucuronic acid and rhamnose in the ratio 2:1:1:1:1 (Sage et al, 
1990). Environmental conditions have been shown to influence EPS production with 
maximum polymer expressed in conditions of 2% glucose, 0.4M NaCl and a 
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temperature of 354C (Allison & Goldsbrough, 1994). However no correlation has 
been found between the ability of B. cepacia to produce EPS and colonisation of the 
respiratory tract 
Extracellular virulence determinants 
B. cepacia does not appear to produce a classic exotoxin although several 
extracellular enzymes have been identified including a protease, haemolysin and 
gelatinase. None of the exoenzymes are thought to play a major role in pathogenesis, 
although, the production of a 2510 lipase enzyme has been reported to reduce 
phagocytosis of B. cepacia in rat alveolar macrophages (Straus et al, 1992). Several 
biological properties have been found to be expressed more frequently in B. cepacia 
CF strains compared to non -CF controls such as production of catalase, ornithine 
decarboxylase, reduction of nitrate to nitrite and hydrolysis of urea (Gessner & 
Mortensen, 1990) but the role of these factors in CF pathogenesis has yet to be 
established. 
Therefore, with the exception of an apparent role for cable pili in transmission, no 
potential virulence determinant in B. cepacia has yet been conclusively demonstrated. 
However, as discussed in section 1.2, environmental stimuli may play a part in 
'switching on' a more virulent form of cell surface structure or extracellular 
compound. 
1.4.7 THE HOST IMMUNE SYSTEM IN CF 
The following section describes the immune response in the CF lung and the major 
host defence systems as outlined in section 1.3.1. 
Innate immunity- immediate protection 
In the healthy lung, mucus glands and goblet cells provide a mucus blanket which 
traps aerosolised bacterial particles and in combination with the upward beating of 
55 
cilia transports and removes inhaled irritants (Piedra & Ogra, 1986). However, in the 
CF lung, although cilia morphology is normal, accumulation of dehydrated, thickened 
mucus impairs effective mucociliary clearance allowing colonisation of the lower 
airways. 
At an early stage, invading microbes are exposed to alveolar macrophages which may 
eliminate the bacteria by non -specific phagocytosis. However, the production of 
lipase by B. cepacia has been reported to impair this process (Straus et al, 1992). 
Alveolar macrophages are primarily located at the interstitium, alveolar epithelium and 
bronchopulmonary lumen and constitute 80 -90% of effector cells. Normally, alveolar 
macrophages have a half life of around seven days but activation by bacterial stimuli 
can considerably reduce this (Piedra & Olgra, 1986). 
Innate Immunity -early induced protection 
In the CF lung, chronic exposure to bacterial products such as LPS results in 
continued cytokine release and hence a continued inflammatory response, a 
characteristic feature of CF pulmonary disease. Alveolar macrophages are stimulated 
by microbial pathogens and other agents to produce pro -inflammatory cytokines, 
including TNF -a and IL -8, which in turn attract a huge neutrophil influx into the CF 
lung. Neutrophil release of oxygen radicals, lysosomal enzymes and the granule 
protease elastase, into the bronchopulmonary microenvironment causes pronounced 
pulmonary tissue damage (Warner, 1992). TNF -a contributes to the excessive 
release of enzymes and neutrophil degranulation with a statistically significant 
correlation between TNF -a levels and granulocyte elastase -al proteinase inhibitor 
complexes (Suter et al, 1989). Continuous activation of the complement and clotting 
cascade by TNF -a amplifies the inflammatory response. In addition, phagocytosis 
and presentation of bacteria by alveolar macrophages to T- lymphocytes produces 
cytokines which stimulate antibody production by B- lymphocytes (Warner, 1992). 
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The inability of the host immune system to eliminate the bacterial infection contributes 
to the continuous inflammation and vicious cycle of CF that ultimately culminates in 
pulmonary failure. The whole process is summarised in Figure 1.6 and is described in 
general terms in section 1.3. 
Chronic Bacterial Colonisation 
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(Adapted from Warner, 1992) AM = Alveolar Macrophage 
Figure 1.6 The host immune response in CF 
TNF -a and IL -8 levels have been measured in S. aureus- and P. aeruginosa- colonised 
CF patients and several studies have reported a strong association between increasing 
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sputum, plasma and faecal levels of cytokines and pulmonary deterioration (Greally et 
al, 1993; Wilson et al, 1993; Dean et al, 1993; Briars et al, 1995). Raised TNF -a 
concentrations have also been correlated with nutritional decline in CF, suggesting 
that continuous secretion of TNF -a acts not only as a major mediator of lung injury 
but also plays a cachectic role, contributing to the weight loss seen in CF patients. 
Thus, as described in section 1.3, overstimulation of the host immune system may do 
as much, if not more, damage to the host than to the microbial pathogen per se. 
Although most CF pathogens remain localised to the pulmonary area, the heavy and 
continued antigenic stimulation may cause some cytokine leakage into the circulation. 
Fortunately, the clinical features of systemic cytokine release are rarely observed, 
indicating that there is no primary systemic immune deficiency associated with CF. 
However, bacteraemia and septicaemia have been reported in some B. cepacia- 
colonised patients, associated with 'cepacia syndrome', suggesting that in certain hosts 
the break down of pulmonary defences and/or a massive local cytokine release causes 
an uncontrollable cytokine 'spill over' into the circulation. Recent clinical data 
confirms the pronounced inflammatory response of B. cepacia- compared to 
P. aeruginosa- colonised CF patients with B. cepacia individuals exhibiting higher 
levels of the inflammatory markers neutrophil elastase and C reactive protein (an 
acute phase protein) both shown to be correlated with increased TNF -a (Elborn et al, 
1994). To date, however, there has been no direct study on the interaction of 
B. cepacia and the cytokine network and consequently, this potential association 
forms a major part of this thesis. 
Adaptive immunity 
Studies investigating the antibody response to B. cepacia have shown 
immunoglobulins from all three major classes, IgG, IgM and IgA, to be produced 
against a range of cell surface antigens; LPS, pili and OMP (Butler, 1994). High 
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antibody levels against P. aeruginosa are often associated with poor clinical condition 
and are prognostic of a serious decline. In contrast, however, investigations into 
B. cepacia antibodies have shown no protective or prognostic value. For example, 
some B. cepacia -colonised CF patients produce enormous antibody titres and remain 
clinically unaffected whilst others decline. Similarly, some B. cepacia CF individuals 
deteriorate so rapidly that there is not enough time to mount a significant antibody 
response (Butler, 1994). However, B. cepacia antibodies have been suggested as a 
form of immunotherapy. A recent report proposes an antibody directed against a 
conserved 30kD OMP as a protective strategy against further decline (Burnie et al, 
1995). 
Interestingly, when antibiotic therapy has failed, administration of intravenous 
gammaglobulin has been used successfully to control B. cepacia exacerbations (Dr. J. 
Govan, personal communication). The efficacy of such preparations may be due to 
increasing the levels of anti -LPS or anti -OMP antibodies although these antibodies are 
normally present in significant numbers. This leads to speculation that the 
immunoglobulin mixture contains antibodies capable of neutralising inflammatory 
mediators such as TNF -a. 
In conclusion, the interaction of microbe and host enables B. cepacia to become 
established in the respiratory tract. However, the mechanisms that allow this are 
poorly understood and once again highlight the need for more information on 
B. cepacia pathogenesis. One unresolved theory is that B. cepacia is an intracellular 
pathogen and therefore escapes the immune system and primes the host for infection. 
Studies in our laboratory are pursuing this theory. 
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1.5 BACTEROIDES FRAGILIS 
1.5.1 TAXONOMY 
In 1989, the genus Bacteroides was restricted to include only Bacteroides fragilis and 
closely related species based on rRNA and DNA homology (Shah & Collins, 1989). 
The new classification was an attempt to tighten the membership of the genus and 
prevent its use as a repository for any anaerobic Gram- negative rod; previous 
definitions of the Bacteroides genus have included 12 (Duerden, 1990), 23 
(Holdeman et al, 1977) or 40 members (Holdeman et al, 1984), with 50 species 
recognised at the time of reclassification (Moore et al, 1985). At present, the genus 
Bacteroides consists of ten species; B. fragilis (type species), B. caccae, 
B. distasonis, B. eggerthii, B. merdae, B. ovatus, B. stercoris, B. thetaiotaomicron, 
B. uniformis and B. vulgatus. The taxonomic position of B. variabilis remains 
uncertain although on biochemical and physiological data it is likely that this organism 
also belongs to the Bacteroides genus (Shah & Gharbia, 1993). 
The general characteristics of B. fragilis include the following features; Gram - 
negative, obligate anaerobe, non -motile, non -spore forming rod. B. fragilis is a 
fermentative, saccharolytic, chemoorganotrophic organism able to grow in the 
presence of bile. Nutritionally, B. fragilis requires sulphates, magnesium, citrate and 
small amounts of peptone and glucose to grow. Haemin and vitamin K may also 
stimulate growth. B. fragilis is normally found as a commensal in the gastrointestinal 
tract of man and the following section describes its role as part of the normal colonic 
flora. 
1.5.2 B. FRAGILIS AS A COMMENSAL 
The human gastrointestinal tract is rapidly colonised after birth with large numbers of 
bacteria obtained from the mother and surrounding environment. It is postulated that 
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facultative anaerobes such as E. coli are the primary colonisers, creating a reduced 
atmosphere to permit subsequent colonisation by obligate anaerobes (Hentges, 1993). 
In healthy adults, although the oesophagus, empty stomach and upper small intestine 
remain sterile, both the mucosal surface of the large intestine and the intestinal 
contents are heavily colonised by anaerobes, with the Bacteroides species the 
predominant genus. Indeed, of the 1011 -1012 bacteria present per gram of colonic 
contents, anaerobes outnumber aerobes by a factor of 100 -1000:1 (Patrick, 1993). 
Quantitatively, the Bacteroides faecal microflora and epithelium -associated microflora 
have been reported to differ. Namavar et al (1989) in comparing the frequency of 
bacteria in faeces and colonic tissue found B. vulgatus to be the most common 
Bacteroides isolate in faeces at 45 %, with B. fragilis accounting for only 4 %, fewer 
than for B. uniformis (22 %), B. thetaiotaomicron (15 %) and B. distasonis (9 %). In 
contrast, sampling of the colonic tissue isolated B. fragilis most frequently at 43 %, 
compared to only 25% for B. vulgatus and 10% for the other Bacteroides identified. 
These results imply that of the Bacteroides species, B. fragilis is the most closely 
associated with the gut mucosa, which may account for the high incidence of this 
organism in intra- abdominal infections (section 1.5.3.). 
Commensal bacteria in the intestine act not only to protect this site against 
colonisation by non -indigenous organisms but also aid in the digestion and absorption 
of food. Bacteroides species are saccharolytic, capable of hydrolysing a wide range 
of polysaccharides including, xylans, glucans, pectins, galactomannans and even host - 
derived mucins (Shah & Gharbia, 1993; Hentges, 1993). The primary end products of 
polysaccharide fermentation are short chain fatty acids which can be absorbed from 
the gut to act as potential energy substrates (Drasar & Duerden, 1991). B. fragilis 
also attacks nitrogenous compounds and deconjugates bile acids (Bokkenheuser, 
1993), although fermentation products of both processes have been implicated in 
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cancer (section 1.5.3.). Thus, Bacteroides fragilis participates in both colonisation 
resistance and the degradation of undigested foodstuff as a normal part of the 
intestinal microflora. 
1.5.3 B. FRAGILIS IN DISEASE 
The indigenous flora comprises virtually the only source of Gram- negative anaerobic 
bacteria involved in human infection, with B. fragilis the species most frequently 
isolated from clinical samples. The following section focuses on the disease states in 
which B. fragilis is known or thought to be involved. 
B. fragilis in Inflammatory Bowel Disease 
The immune system in the healthy gut has efficient self -regulatory mechanisms to 
prevent an uncontrollable inflammatory response in reaction to the huge number of 
antigens. However, there are a number of GI inflammatory disorders, including 
ulcerative colitis and Crohn's disease, which together are referred to as Inflammatory 
Bowel Disease (IBD). Although both diseases are characterised by inflammation of 
the mucosa due to an infiltrate of cytokines, leukotrienes, macrophages, lymphocytes 
and neutrophils, in ulcerative colitis only the superficial submucosa is inflammed, 
whereas in Crohn's disease the inflammation extends into the deeper layers of the 
bowel wall (Podolsky, 1991a). 
The causes of IBD remain unknown although increasing evidence supports the theory 
that chronic IBD is the result of a dysfunctional immune system manifested by 
overproduction of mucosal cytokines (Casiniraggi et al, 1995). TNF -a, IL -1, IL -6 
and interferon -y have all been implicated as pathologically important in IBD 
(Woywodt et al, 1994). However, the mechanisms of this immune imbalance remain 
obscure. The improvement of Crohn's disease patients in response to metronidazole 
administration implies an important role for the anaerobic flora (Borriello, 1991). 
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Furthermore, as the sera of Crohn's disease patients exhibit increased levels of anti - 
bacteroides antibodies, an autoimmune reaction to a gut- derived bacterial antigen has 
also been proposed (Tvede et al, 1983). Complications associated with IBD include 
toxic megacolon, fistulas, abscesses and arthritis. A recent study has proposed a 
direct link between Bacteroides species and IBD- associated arthritis (Lichtman et al, 
1995). IBD also appears to predispose patients to developing colonic cancer with a 
six -fold increase in risk association compared to controls (Podolsky, 1991b). 
B. fragilis in colonic cancer 
Colonic cancer is most common in North America, Australia and Northern and 
Western Europe, with Asia, Africa and Central and Southern America having 
relatively few cases (Hill, 1991). From epidemiological studies it is widely believed 
that environmental factors play the largest part in increasing the risk of developing 
colonic cancer, with diet one of the most important features. Numerous studies have 
demonstrated that the risk of colonic cancer is related to the amount of meat or fat in 
the diet (Armstrong & Doll, 1975; Lui et al, 1979) whereas conversely, a strong 
protective effect is associated with green -leafy vegetables, correlating with the diet of 
the countries of incidence (Hill, 1991). 
B. fragilis, as a commensal, produces metabolic byproducts that are potentially 
important in human carcinogenesis. Indeed, there is a correlation between the number 
of Bacteroides species per gram of faeces and the risk of colonic cancer (Hill, 1991). 
The bile acids cholic and chenodeoxycholic acid are degraded by B. fragilis into the 
aromatic compounds deoxycholic and lithocholic acid and the amino acids tyrosine 
and tryptophan are also metabolised into volatile phenols, all implicated as 
carcinogens (Bokkenheuser, 1993). Several lines of evidence favour the involvement 
of bile acid metabolites in particular; I) bile production is stimulated in the presence of 
a high fat 'Western' diet, 2) the faecal bile acid concentration is directly related to 
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adenoma size and 3) higher levels of bile acid byproducts and receptors are present in 
colonic cancer patients compared to controls (Hill, 1991). 
The involvement of B. fragilis in colonic cancer and IBD has yet to be conclusively 
demonstrated, although the circumstantial evidence does postulate a role for this 
organism as an enteric pathogen. However, B. fragilis is most commonly associated 
with extraintestinal infections that arise from mucosal injury caused by trauma, burns, 
rupture, a penetrating wound or abdominal surgery. 
B. fragilis in peritonitis and abscess formation 
The peritoneal cavity is the most common site of contamination from indigenous 
bacteria with only a few millilitres of spilled intestinal contents, commonly resulting 
from organ perforation, required to deliver billions of bacteria into an otherwise sterile 
site. Infection arising from bacterial contamination comprises two phases. Initially, 
peritonitis, or inflammation of the peritoneal membrane may occur, which if left 
untreated is usually fatal. In survivors, intra- abdominal abscesses can form secondary 
to infection (Duerden, 1994). Generally, the purulent material recovered from abscess 
cavities is polymicrobial, consisting of a facultative anaerobe such as E. coli and an 
obligate anaerobe such as B. fragilis (Tally, 1993). Indeed, B. fragilis is isolated 
from the majority of abscess cases including intra- abdominal, vaginal, perianal, and 
brain abscesses (Patrick, 1993). 
Synergism between E. coli and B. fragilis is thought to function in two ways. 
Initially, while the peritoneal cavity is well -oxygenated, facultative anaerobes 
metabolise the oxygen supplies and thus provide conditions for surviving obligate 
anaerobes to dominate. B. fragilis as one of the most oxygen- tolerant of obligate 
anaerobes is therefore particularly well suited for abscess formation. Secondly, the 
first line of defence against the infecting bacteria is phagocytic cells and the presence 
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of B. fragilis is thought to impair the phagocytic killing of facultative strains (Tally, 
1993). This synergistic relationship was confirmed in initial studies in which bacteria 
were implanted either alone or in combination in a rat model of intra- abdominal 
infection. It was found that although mortality was restricted to animals receiving 
E. coli in the inocula, abscess formation did require the presence of both a facultative 
and obligate anaerobic strain. Abscesses did not form in response to B. fragilis alone 
(Onderdonk et al, 1976). These results therefore suggested that facultative organisms 
caused the peritonitis- associated deaths and together with obligate anaerobes were 
responsible for the formation of intra- abdominal abscesses. However, these studies 
used unencapsulated strains of B. fragilis. 
In contrast, Onderdonk et al (1977) found that implanting encapsulated B. fragilis 
strains alone resulted in abscess formation. Furthermore, implantation of purified 
B. fragilis capsular material alone, or in combination with the previously used 
unencapsulated strains, also caused abscess formation. Abscesses formed in response 
to the capsule were bacteriologically sterile but histologically identical to abscesses 
formed in response to intact bacteria. The importance of EPS in the pathogenesis of 
abscess formation was highlighted by one study in which 75% of B. fragilis abscess 
isolates were found to possess a capsule compared to only 11% of faecal isolates 
(Brook et al, 1992). Capsular material is therefore an abscess -potentiating agent. 
Other material previously identified as conducive to abscess formation include bran, 
mucin and autoclaved colonic contents all of which comprise polysaccharides (Finlay - 
Jones et al, 1991). 
The mechanisms by which complex polysaccharides enhance abscess formation is not 
clearly understood although recent work into the structure of B. fragilis capsule has 
provided some clues. The capsule produced by B. fragilis comprises two distinct 
polysaccharide units with oppositely charged amino and carboxyl/phosphate groups. 
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Alteration of the positive or negative charge on the capsule impairs the ability of 
encapsulated strains to form abscesses; conversely, the addition of an amino and 
carboxyl group to a neutral polysaccharide transforms the EPS into an abscess - 
inducing material (Tzianabos et al, 1992). Therefore, bacterial EPS possessing 
oppositely charged groups is important in the pathogenesis of abscess formation. 
B. fragilis in SIRS 
In many SIRS patients bacteria cannot be detected in the circulation and it is now 
becoming increasingly recognised that in these cases the source of endotoxin is likely 
to be the gut. Following insults such as burns or trauma the onset of shock may 
reduce the splanchnic circulation leading to intestinal ischaemia and a breakdown of 
the mucosal barrier. Bacteria and their products, including LPS, can then readily 
translocate to the systemic circulation via the portal vein to the liver (Runcie & 
Ramsay, 1990). Consequently, macrophages in the liver (Kupffer cells) may be 
activated, releasing cytokines and, as a result, inducing the symptoms associated with 
sepsis (section 1.3). Thus a critically ill patient may be diagnosed as 'septic' but with 
no obvious source of infection. 
B. fragilis is the most common cause of anaerobic bacteraemia, but has lower 
incidence rates compared to E. coli, P. aeruginosa and Gram- negative cocci (Peraino 
et al, 1993). It has generally been assumed that E. coli, with its highly biologically 
active LPS, would play the major role in SIRS. B. fragilis possessing a weak 
endotoxin (10 -1000 fold less active than E. coli) has been thought to be of little 
significance. However, as there is 100 -1000 fold more Bacteroides than E. coli in the 
normal flora, the biological potential of LPS from Bacteroides species must be 
equivalent to that from E. coli. Thus Bacteroides species may play a vital role in 
SIRS where there is no obvious foci of infection and should not be disregarded. 
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1.5.4 B. FRAGILIS CELL SURFACE VIRULENCE DETERMINANTS 
Lipopolysaccharide 
The structure of B. fragilis LPS is based on the normal enterobacteriaceae template 
described in section 1.1.3. but displays many variations when compared to E. coli 
LPS. The lipid A region of B. fragilis LPS comprises a typical glucosamine 
disaccharide backbone but has different fatty acid substitutions. The fatty acids are 
longer (15 -17 carbons compared to C 12-C16 for E. coli), are branched hydroxylated 
and non -hydroxylated (not present in E. coli) and number only five per lipid A 
molecule (six in E. coli). In addition, in B. fragilis lipid A there is only one phosphate 
substituent; the phosphate group present on position 4 of the non -reducing sugar is 
missing (Lindberg et al, 1990). 
Kdo was initially thought to be absent as negative results were obtained in 
conventional assays. Indeed, Kdo deficiency had been previously defined as a 
taxonomic criterion for these bacteria (Hofstad, 1974). However, subsequent studies 
have indicated the presence of a phosphorylated form of Kdo which is unreactive in 
standard tests (Beckman et al, 1989). The sugars D- galactosamine, D- glucose, 
D- galactose, L- rhamnose and D- glucosamine have been detected in B. fragilis LPS 
with a 0,1,6- linked D- galactosyl oligosaccharide chain the immunodominant structure 
(Lindberg et al, 1990). 
Despite many studies, there remains conflicting views on the LPS phenotype of 
B. fragilis. Poxton and Brown (1986) showed strains of B. fragilis on SDS -PAGE 
gels to comprise a series of closely spaced bands characteristic of S -LPS. In contrast, 
Lindberg et al (1990) failed to detect the characteristic smooth ladder pattern and 
proposed B. fragilis LPS to comprise lipid A, core and a short 0 -Ag chain but no 
long repeating units. However, B. fragilis MAb have been produced that react 
against a ladder pattern confirming the findings of Poxton and Brown (Patrick, 1993). 
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These discrepancies may be due not only to the extraction method used by the 
researchers but also the culture conditions, particularly as the closely associated 
capsular polysaccharide of B. fragilis is known to be very dependent on 
environmental conditions. 
It is likely that the structural difference between B. fragilis LPS and E. coli LPS 
accounts for their variable toxicity. However, B. fragilis LPS has been reported as a 
potent inducer of DNA replication in B- lymphocytes and hence an inducer of 
polyclonal antibody production (Hofstad et al, 1993). Furthermore, the sheer volume 
of B. fragilis LPS present in the intestine confers a great potential to cause serious 
disease, as suggested for this organism in SIRS. 
Outer membrane proteins 
Few studies have investigated the OMP profile of B. fragilis but reports have shown 
the induction of novel OMPs under conditions of iron -limitation, including an 
immunogenic 44kD protein (Otto et al, 1990). Under iron -limited conditions 
B. fragilis uses haem from either haemoglobin or haptoglobin- haemoglobin as the sole 
source of iron with haem- binding protein complexes (HBP- complexes) involved in 
haem uptake. Four proteins of approximately 60kD, 58kD, 49kD and 35kD have 
been identified as haem- binding proteins (Otto et al, 1994). The iron -repressible 
44kD OMP is required for a functional HBP- complex but the exact role of the protein 
remains unknown. Siderophore production in B. fragilis has not yet been detected 
although this organism may possess mechanisms for the uptake of siderophores from 
other intestinal bacteria such as E. coli (Patrick, 1993). B. fragilis as with all 
members of the Bacteroides genus is resistant to several antibiotics including some 
cephalosporins and penicillins. The production of 13- lactamases by B. fragilis is one 




Recent studies have revealed the B. fragilis capsule to comprise two distinct, ionically 
linked polysaccharide units, termed polysaccharide A and B. Both units are co- 
expressed on the surface of B. fragilis cells in the ratio 1:3.3. Structural analysis of 
the individual units revealed polysaccharide A to consist of a tetrasaccharide repeating 
unit with one free amino and one carboxyl group conferring zwitterionic properties on 
this molecule. Polysaccharide B comprises a hexasaccharide unit with one positive 
and two negative groups conferring a net positive charge to the polymer (Tzianibos et 
al, 1992). 
In concurrent but unrelated studies, the size and antigenicity of the B. fragilis capsule 
has been shown to be heterogeneous in a wild -type population, and found to be 
extremely sensitive to environmental factors (Patrick & Reid, 1983; Patrick et al, 
1986). A population of a single B. fragilis isolate may possess a large fibrous 
network (or capsule), a small fibrous network or an electron dense layer, as 
distinguished by electron microscopy. Furthermore, studies using MAbs raised 
against the capsular structures, revealed that the different components were not 
merely varying amounts of the same material but antigenically distinct compounds 
(Patrick, 1993). 
Fimbriae 
B. fragilis can successfully attach to host epithelial cells through the possession of 
fimbriae. Fimbrial structures were observed in 82% of B. fragilis strains found in the 
normal flora, 20% more than any other Bacteroides species (Brook et al, 1992), and 
enabling B. fragilis to attach more readily to the colonic mucosa. Thus, B. fragilis is 
in a prime position to translocate in response to mucosal injury, which may be one 
factor for this organisms clinical dominance over the other Bacteroides members. 
Interestingly, of B. fragilis abscess isolates, 81% possessed fimbriae compared to only 
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6% of bacteraemia isolates (Brook et al, 1992). It is possible that B. fragilis can 
modulate fimbriae production, and hence virulence, in relation to environmental 
conditions. 
Extracellular factors 
B. fragilis produces both an exotoxin and numerous extracellular enzymes including 
hyaluronidase, DNase, lipase, protease and neuraminidase. Although these hydrolytic 
enzymes are capable of degrading host tissue, it appears the enzymic activity is 
somehow localised, thereby preventing rapidly spreading destruction (Duerden, 
1994). Recently, the exotoxin has been purified as a 20kD polypeptide containing a 
zinc- binding epitope, characteristic of a metalloprotease. The exotoxin does show 
cytotoxic activity but can be easily inhibited by metal chelators (Moncrief et al, 1995). 
The role of this toxin in B. fragilis pathogenesis has still to be defined. 
The need for specialised equipment and the difficulty in the growth and identification 
of anaerobic organisms has led to an underestimate of the number of anaerobic 
infections. B. fragilis is primarily considered to be a commensal and has largely been 
ignored with regards to infection and disease. However, B. fragilis along with other 
members of the genus are becoming increasingly recognised as more than 'innocent 
bystanders' with recent studies confirming their role as serious opportunistic 
pathogens. The close association of the various cell surface components, 
susceptibility to environmental changes and within- strain variation has given rise to 
confused and contradictory reports on the potential virulence determinants of 
B. fragilis. More work on anaerobic organisms is required if the pathogenesis of 
B. fragilis infection is to be resolved. 
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AIMS OF THIS THESIS 
In the past two decades, increasing scientific and clinical evidence has elevated two 
apparently harmless Gram- negative bacteria, Burkholderia cepacia and Bacteroides 
fragilis, to the status of human pathogens, capable of causing a serious threat to 
human health. For B. cepacia the main concern is the pulmonary colonisation of CF 
patients and for B. fragilis the potential role of the Bacteroides population in intra- 
abdominal sepsis and SIRS. As both organisms were considered previously to be of 
little significance in human disease, our knowledge of the virulence factors and 
pathogenesis of B. cepacia and B. fragilis is limited, particularly with regards to the 
interaction with the human host. The main aim of this thesis was to extend our 
understanding of the pathogenesis of B. cepacia and B. fragilis, by examining possible 
virulence factors and microbe -host interactions. To achieve the aim of this joint 
project the following four main areas were investigated for both organisms; 
1) To characterise the expression and antigenicity of the cell surface virulence 
determinants: lipopolysaccharide, exopolysaccharide and outer membrane proteins. 
2) To investigate the influence of relevant environmental conditions on the induction 
of new, or production of altered, cell surface components which may play a vital role 
in survival and pathogenesis. 
3) To investigate the biological activity of B. cepacia and B. fragilis cell surface 
determinants, focusing on their endotoxicity and cytokine inducing ability from a 
range of clinically important cell types. 
4) In addition, taxonomically and pathogenically related controls were examined to 
distinguish any variation between strains and species which may provide clues to 
pathogenic methods in vivo. 
Results obtained from the above experiments could then be used to ascribe further the 
role of these organisms in infection. 
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CHAPTER 2 




Bacterial strains used in this thesis are listed in Table 2.1 and were obtained from the 
Cystic Fibrosis Laboratory (CFL) collection or Microbial Pathogenicity Research 
Laboratory (MPRL) collection, both at the Department of Medical Microbiology, 
University of Edinburgh. 
Bacterial identification 
Bacterial identification was performed by Mrs C. Doherty for CFL strains and by Mr 
R. Brown for MPRL strains. All CFL isolates were identified by API 20NE system 
(bioMerieux, Marcy l'Etoile, France). In addition, strains of B. cepacia were analysed 
by bacteriocin typing as described by Govan & Harris (1985) and by genotypic typing 
using Pulsed Field Gel Electrophoresis (PFGE CHEF Bio -Rad Laboratories Inc., CA, 
USA). Bacteroides strains were identified by biochemical and physiological analysis 
(Brown et al, 1995). 
Maintenance of bacterial strains 
Bacteria were maintained at -70oC in 10 %(w /v) skimmed milk (Oxoid, L31 Unipath 
Ltd., Basingstoke, Hants., UK.). Bacterial suspensions were prepared by emulsifying 
several colonies in 1 ml volumes of skimmed milk in 2m1 cryotubes (NUNC, Inter 
Med, Kamstrup, Denmark). Fresh growth cultures were obtained from -700C after 
bacteria had been subcultured a maximum of four times. Fresh maintenance cultures 
were prepared at approximately five monthly intervals. 
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Table 2.1 Bacterial strains used in this thesis 
Strains obtained from CFL Origin 
Burkholderia cepacia C1359" 
Burkholderia cepacia C1409 
Burkholderia cepacia C1504 
Burkholderia cepacia ATCC 17762 
Burkholderia cepacia J762 
Burkholderia cepacia C1732 
Burkholderia cepacia C1744 
Burkholderia cepacia J2395 
Burkholderia cepacia J2540 
Burkholderia cepacia ATCC 29424 
Burkholderia cepacia J366 
Burkholderia gladioli ATCC 10248 
Pseudomonas aeruginosa C1250 
Pseudomonas aeruginosa PAO 1 
Pseudomonas aeruginosa J3 5 
Pseudomonas aeruginosa J36 
Pseudomonas aeruginosa J37 




Urinary Tract Infection 
Wound Infection 
CDC Pseudobacteraemia 







Genetic Type Strain 
Derivative of PAO 1 
Derivative of PAO 1 
Derivative of PAO 1 
Derivative of PAO 1 
a a highly transmissible strain isolated from several CF centres (Govan et al, 1993) 
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Strains obtained from MPRL Origin 
Bacteroides fragilis NCTC 9343 
Bacteroides fragilis MPRL1504 
Bacteroides vulgatus MPRL 1651 
B. thetaiotaomicron NCTC 10582 
Bacteroides uniformis MPRL 1721 
Escherichia coli 018K 





A.S. Cross, Walter Reed Army Institute 
for Research, Washington D.C., USA 
2.1.2 PREPARATION AND STERILISATION OF CULTURE MEDIA 
Chemicals used throughout this thesis were of Analar Grade from BDH (Merck Ltd., 
Dorset, UK.) unless otherwise stated. All solutions were made with pyrogen -free 
water obtained from a Milli -Q Reagent Grade Water System (Millipore Corporation, 
Molshiem, France) and sterilised by autoclaving at 121 °C /15psi for 15min unless 
otherwise stated. 
2.1.3 MEDIA USED FOR CFL STRAINS 
Nutrient rich medium 
a) Nutrient yeast broth (NB +YE) was Oxoid No.2 supplemented with 0.5 %(w /v) 
yeast extract (Difco Laboratories, Michigan, USA). 
b) Nutrient agar (NA) was Columbia agar base (Oxoid) 
c) Pseudomonas cepacia selective medium (CEP; Mast Laboratories, Bootle, UK.). 
d) Pseudomonas Isolation agar (PIA; Difco). 
e) Onion -agar medium (OA) was developed because of the phytopathogenic nature of 
B. cepacia to onions. The medium was prepared as follows; two onions were peeled, 
diced and homogenised until a thick suspension was obtained. The mixture was filter 
sterilised and added at a concentration of 5 %(v /v). 
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Minimal medium 
a) Malka medium A (MA; Robert-Gero et al, 1970) was prepared by the following 
recipe: -Solution A: Na2HPO4 (73.4g/1); KH2PO4 (32.4g/1) 
Solution B: MgSO4.7H20 (20.5g/1) 
Solution C: 50% (w /v) Glucose 
Solution D: FeSO4.7H20 (1.83g/1) 
Solution E: (NH4)2SO4 (50g/1) 
All solutions were filter sterilised. Solutions A, B and E were stored over 5 %(v /v) 
chloroform and to solution D one drop of concentrated hydrochloric acid was added. 
To prepare 1 litre of Malka A medium, 20m1 of solutions A, B, C and E and 1 ml of 
solution D were added to 919m1 of sterile pyrogen -free water. 
b) Malka A + 50 %(v /v) serum (MA +S) was used to mimic a physiological medium. 
Sheep serum (Moredun Animal Diseases Research Institute, Gilmerton Road, 
Edinburgh) was heat inactivated at 560C for 30min to destroy any complement that 
may have interfered with bacterial growth. 
c) Nitrogen -limited medium (Malka B) was MA with solution E substituted with 
1%(v/v) 1M KNO3 
d) High osmolarity medium (Malka D) was MA with the addition of 6 %(v /v) 5M 
NaCI. 
e) Nitrogen -limited/high osmolarity medium (Malka H) was MA with the changes 
associated with both Malka B and D. 
Malka A medium was used as the basal medium to which ingredients were either 
added, taken away or substituted in order to produce the desired environmental 
change as shown below. 
f) Iron -limited medium was MA minus solution D and with the addition of 1 mM of 
the iron chelator ethylenediamine- N,N'- diacetic acid; EDDA (Sigma, St. Louis, USA). 
g) Magnesium -limited medium was MA with 0.1 %(v /v) solution B. 
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h) Phosphate -limited medium was MA with 0.1 %(v /v) solution A. 
i) Semi -solid medium was MA with 0.4 %(w /v) agar. 
j) Alcohol- enriched medium was MA with the addition of 5 %(v /v) ethanol. 
k) Carbon -limited medium was MA with the substitution of solution C with 1 %(w /v) 
mannose. 
To prepare Malka agar plates 2 %(w /v) agar was added to pyrogen -free water, 
autoclaved and the Malka solutions and supplements added as before. 
Phosphate buffered saline (PBS) was made by dissolving 1 PBS tablet (Oxoid) in 
100m1 of pyrogen -free water and sterilised by autoclaving. 
Aerobic bacteria were grown at 370C overnight with broth cultures shaken in an 
orbital incubator at 180 rev. min-'unless otherwise stated. All cultures were checked 
for purity by both Gram stain and streaking for single colonies on blood agar plates. 
2.1.4 MEDIA USED FOR MPRL STRAINS 
Nutrient rich medium 
a) Proteose Peptone Yeast extract medium (PPY; Holbrook et al, 1977) comprised; 
Protease Peptone (Oxoid) 20g/1; 
Yeast Extract (Difco) 10g/1; 
Sodium chloride 5g/1 
3.75 %(w /v) L- cysteine hydrochloride 20m1/1 
2 %(w /v) Sodium carbonate 20m1/1 
Haemin (250mg/m1) + Menadione (50mg/m1) 20m1/1 
b) Columbia Agar with Horse Blood (BA) was supplied ready -made from Oxoid 
Minimal medium 
a) Van Tassell & Wilkins' medium (VT &W) (Van Tassell & Wilkins, 1978) was 
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prepared by the following recipe: - 
Solution A: (NH4)2504 (2g/1); Sodium citrate (0.5g/1); Vitamin B12 (5µg/1); 
KH2PO4 (7g/1); K2HPO4 (8g/1). The pH was adjusted to pH 6.93 
Solution B: MnC12.4H2O (10mg/1); ,MgC12.6H2O (20mg/1); FeC13.6H2O 
(0.3mg/1); CaC12.2H2O (30mg/1) 
Solution C: 10 %(w /v) Glucose 
Solution D: 5 %(w /v) L- cysteine hydrochloride 
Solution E: 10 %(w /v) NaHCO3 
Solution F: Haemin made up in 0.1M NaOH (5mg/1) 
Solutions A -E were autoclaved and solution F was filtered sterilised. To prepare 1 
litre of VT &W medium, 350m1 of solution A, 500m1 of solution B, 100ml of solution 
C, 10m1 of solution D and 1 ml of solution E were mixed together. 
VT &W was used as the basal medium to which ingredients were added, taken away 
or substituted in order to produce a desired environmental change as shown below. 
b) VT &W + 50 %(v /v) serum (VT &S). Sheep serum was heat inactivated as 
described above for MA +S. 
c) Iron -deficient media was VT &W minus FeC13.6H2O and the addition of 1mM of 
the iron chelator EDDA. 
d) Bile- enriched media was VT &W with the addition of 0.5 %(w /v) Bile salt solution 
(Oxoid). 
e) Cysteine -enriched media was VT &W with the addition of a further 0.5 %(w /v) 
L- cysteine hydrochloride. 
Media used for anaerobic growth was prereduced overnight and anaerobic bacteria 
grown overnight in a Forma Scientific Anaerobic System Cabinet, model 1024 (Forma 
Scientific, Ohio, USA) in a 10% CO2, 10% H2, 80% N2 atmosphere unless otherwise 
stated. All cultures were checked for purity by both Gram stain and streaking for 
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single colonies on blood agar plates. 
2.1.5 ANTISERA 
Polyclonal antisera to B. cepacia was obtained from the CFL serum collection. Initial 
serum came from either CF patients (sera prepared by Mrs C. Doherty, Department of 
Medical Microbiology, University of Edinburgh) or from Dutch rabbits inoculated 
with heat -killed whole bacteria (sera prepared by Dr. S. Butler, formerly Department 
of Medical Microbiology, University of Edinburgh). When using serum from a CF 
patient the bacteriology of the patient was taken into account. 
Polyclonal antisera to B. fragilis was obtained from the MPRL serum collection. 
Initial serum was from rabbits inoculated with whole bacteria (sera prepared by Mr R. 
Brown, Department of Medical Microbiology, University of Edinburgh). 
2.1.6 EQUIPMENT 
Equipment used in this thesis is indicated in the relevant section of text. 
2.2 METHODS 
2.2.1 INFLUENCE OF ENVIRONMENTAL CONDITIONS ON BACTERIAL 
SURVIVAL AND GROWTH 
Nutrient changes and atmosphere 
Bacteria were patch inoculated onto the various minimal media as described in section 
2.1.3 for CFL strains. Plates were incubated at 37°C in one of the following four 
atmospheres; 
Aerobic: as normal 
Microaerophillic: a 4% 02/96% CO2/H2 or 4% 02/96% N2 atmosphere was produced 
in a gas jar system as described by Collee & Marr (1989). Air was evacuated to a 
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pressure of 24" Hg and refilled with either a 10% CO2190% H2 background or 80% 
N2 background. 
Anaerobic: a 10% CO2 /10% H2 /80% N2 atmosphere was used as described for 
maintenance of anaerobic cultures. 
Survival, growth and changes in colony morphology were monitored every 24h over a 
four day period. 
PH 
B. cepacia strains (C1359, C1409, J366, J762, C1732 and C1744) were inoculated 
onto OA, CEP, and MA agar plates; the pH of the MA media was preadjusted to pH 
7.0, 6.3, 5.55, 5.0 and 4.0. pH changes occurring during growth were monitored 
every day for eight days using a combination pH electrode (Fisons, Loughborough, 
UK). 
Antibiotics 
The minimum inhibitory concentration (MIC) of the antibiotics metronidazole and 
chloramphenicol against the B. fragilis strains NCTC 9343 and MPRL 1504 was 
ascertained by the serial discontinuous concentration tube method as described by 
Scott (1989). The MIC for the two B. fragilis strains on BA plates (kindly supplied 
by Mr R. Brown, Department of Medical Microbiology, University of Edinburgh) was 
used as an initial test concentration for the antibiotics. VT &W medium was prepared 
with 8 times -1 /16 times the BA- determined MIC of the antibiotics. 
B. fragilis strains grown overnight in 1Oml PPY were diluted 1:100 in VT &W 
medium and incubated for a further 3h. When the bacteria had reached mid -log phase 
three drops of the bacterial suspension was added to each dilution tube. VT &W 
media without any added antibiotic or bacterial suspension were used as controls. 
The tubes were incubated anaerobically overnight and the MIC defined as the lowest 
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concentration of antibiotic that inhibited visible growth. 
2.2.2 PREPARATION OF LPS 
Proteinase K method 
LPS was prepared by the Proteinase K digestion method as described by (Hitchcock 
& Brown, 1983). Bacteria grown overnight in 10m1 broth culture were harvested by 
centrifugation and washed twice in PBS at 4000 g for 15min. The bacterial 
suspension was diluted in PBS to give an optical density (OD5251,,,,) of between 0.5 -0.6 
as measured by a Pye Unicam SP600 spectrophotometer. Aliquots (1.5m1) were 
placed in eppendorf tubes and centrifuged at 10,000 g for 3min in a Microcentaur 
centrifuge. The pellet was then resuspended in 541.1 of double -strength sample buffer 
and heated at 100°C for 10min in a boiling water bath. Once cooled, 10111 of a 
2.5mg/ml solution of proteinase K (protease Type XI, Sigma) in double - strength 
sample buffer was added and the mixture incubated at 600C for lhour. The sample 
was stored at -20°C until required. 
Phenol water (PW) method 
This procedure was based on the hot aqueous phenol method of Westphal and 
Luderitz (1954) as described by Hancock & Poxton (1988). No plastic material was 
used during this procedure. 
Bacteria grown overnight in five litres of medium were harvested and washed twice in 
PBS at 10,000 g for 15min in a Sorvall RC -5B centrifuge (Dupont UK Ltd., 
Stevenage, UK). The resulting pellet was frozen at -20°C, lyophilised (Edwards 
Modylo freeze dryer, Edwards High Vacuum Ltd., Surrey, UK) and weighed. 
The lyophilised pellet was resuspended to a 5 %(w /v) solution and heated to 67°C in a 
water bath. An equal volume of 90 %(w /v) aqueous phenol was also heated and 
added to the cell suspension. The mixture was stirred every minute for 15min and 
cooled in an ice -bath for 30min to allow initial separation of the phenol and water 
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phase. To complete the separation, the mixture was centrifuged at 10,000 g for 
15min in a Sorvall centrifuge. The upper aqueous phase was collected, transferred to 
pre -boiled dialysis tubing (3- 20/32 "; Medicell International Ltd., London, UK.) and 
dialysed against running tap water until the smell of phenol was no longer detectable 
(approximately 24h). Insoluble material was removed by centrifugation at 10,000 g 
for 15min. For crude LPS extracts, the dialysate was then freeze -dried, weighed and 
stored in a sterile container at -20 °C until required. The lower phenol layer from 
B. cepacia C1359, C 1409 and P. aeruginosa C1250 were also collected, dialysed and 
lyophilised. 
For further purification of the LPS, the dialysed extracts were concentrated by rotary 
evaporation (Buchi Rotavapor -RE 111, Switzerland) to approximately one -fifth the 
original volume and ultracentrifuged (Sorvall ultracentrifuge- OTD65B, Dupont) at 
100,000 g for 3h. The resulting pellet was resuspended in 5m1 of pyrogen -free water 
using a syringe fitted with a 23 -gauge needle. The final LPS solution was freeze - 
dried, weighed and stored in a sterile container at -20 °C until required. 
Phenol chloroform petroleum spirit (PCP) method 
This method is based on the procedure described by Galanos et al (1969) but 
incorporates the ether -acetone precipitation of LPS as described by Qureshi et al 
(1982). No plastic material was used during this procedure. 
Bacteria were grown, harvested and lyophilised as described for the PW preparations. 
The extraction solution (PCP) consisted of a 90 %(w /v) phenol, chloroform and 
petroleum spirit (boiling point 40 °C -60 °C) mixture in the ratio 2:5:8 by volume. 
Dried bacteria were resuspended in 25 %(w /v) PCP, stirred for 2 min at 4 °C and 
centrifuged at 10,000 g for 15min. The supernate was filtered through Whatman 
No.1 filter paper (Whatman International Ltd., Maidstone, UK) into a round bottom 
flask and the pellet re- extracted using PCP as before. The filtered supernates were 
pooled and the chloroform and petroleum spirit (volatile solvents) removed by rotary 
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evaporation. To precipitate the LPS six volumes of diethyl ether -acetone in the ratio 
1:5 by volume were added to the remaining one volume of phenol solution and left to 
stand for at least 30min. The LPS was sedimented by centrifugation at 10,000 g for 
15min and washed twice in the diethyl ether /acetone mixture and twice in diethyl 
ether alone. The final pellet was dried by leaving the ether to evaporate for 48h in a 
fume cupboard. The dried pellet was resuspended in pyrogen -free water, dialysed 
against running tap water for 48h and finally lyophilised. 
Periodate- treated and Proteinase K- treated LPS samples 
To 10011l of PW -LPS sample (5mg/m1), l00111 of 0.1M sodium periodate was added 
and the mixture stored at room temperature in the dark overnight. Excess periodate 
was removed by adding S0µ1 of ethylene glycol and the sample stored at -200C until 
required. 
To 150111 of LPS sample (5mg/m1) 3011l of proteinase K (2.5mg diluted in lml 
0.125M Tris -HC1) was added and heated at 600C for 1h. 
2.2.3 PREPARATION OF OUTER MEMBRANES 
Bacteria were grown in 500m1 of medium overnight. Cells were harvested and 
washed twice in PBS at 8000 g for 15min in a Sorvall centrifuge. The pellet was 
resuspended in 5m1 pyrogen -free water and broken by sonication (Microson, 
Ultrasonic Cell Disrupter, Heat Systems -Ultrasonics Inc., NY, USA) by ten lmin 
bursts with five 30 second intervals at an amplitude of 8 -10µm. Unbroken cells were 
removed by centrifugation at 4,000 g for 10min. Outer membranes were derived by 
solubilisation by addition of 0.5ml of 7 %(v /v) solution of Sarkosyl, 0.1mM of 
phenylmethylsulphonylfluoride was added as a protease inhibitor. Outer membranes 
were collected by ultracentrifugation for 1h at 50,000 g. Pellets were washed in 5m1 
of water, ultracentrifuged as before and finally resuspended in lml of pyrogen -free 
water by repeated passage through a 23 -gauge needle and stored at -200C until 
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required. Protein content in the samples was determined by the Folin assay of Lowry 
et al (1951) and adjusted to give a protein concentration of 800pg/ml. 
2.2.4 PREPARATION OF ALGINATE 
An overnight culture (300m1) of a mucoid P. aeruginosa (C1250) was centrifuged at 
20,000 g for 1h and the supernate transferred to a sterile beaker. Two volumes of 
acetone were added, to separate out the alginate, and the mixture left overnight. The 
resulting precipitate was washed twice in ethanol at 10,000 g for 15min before 
redissolving in pyrogen -free water. The alginate was reprecipitated as before and left 
overnight. Once redissolved in pyrogen -free water the solution was dialysed against 
running tap water for 48h and in 21 of pyrogen -free water containing 1mM EDTA 
overnight. The EDTA solution was changed three times with pyrogen -free water and 
the final dialysate frozen and lyophilised. 
2.2.5 POLYACRYLAMIDE GEL ELECTROPHORESIS (PAGE) 
Lipopolysaccharide samples 
LPS samples were added to gels at 2011l per track for silver -staining or 4511l per track 
for immunoblotting. Proteinase K samples prepared as described in section 2.2.2. and 
PW and PCP samples (5mg/m1) mixed with an equal volume of double - strength 
sample buffer, were heated at 100°C for 5min. LPS separation was performed on 
14 %(w /v) acrylamide gels omitting SDS from both the separating and stacking 
buffers. 
Outer membrane samples 
OM samples were added to gels at 4011l per track. Samples were heated to 100°C for 
5min prior to addition to a gel. OM separation was performed on 10 %(w /v) 
acrylamide gels with SDS included in both buffers. 
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LPS and OM preparations were separated on polyacrylamide gels using the buffer 
system of Laemmli (1970) with the following solutions used: 
a) Double strength sample buffer (pH6.8) comprised 0.125M Tris -HC1, 4 %(w /v) 
sodium dodecylsulphate (SDS), 20 %(v /v) glycerol, 2 %(v /v) 2- mercaptoethanol and 
0.002 %(w /v) bromophenol blue. 
b) Double -strength separating buffer (pH8.8) comprised 0.75M Tris -HC1 and 
0.2 %(w /v) sodium dodecylsulphate SDS. 
c) Double strength stacking buffer (pH6.8) comprised 0.25M Tris -HC1 and 0.2 %(w /v) 
SDS. 
d) 40 %(w /v) Acrylamide comprised 100g acrylamide and 2.7g methylene bis 
acrylamide. 
e) Electrode buffer (pH8.3) comprised 0.025M Tris, 0.192M glycine and 0.1 %(w /v) 
SDS. 
The volume of reagents required to prepare polyacrylamide gels of various acrylamide 
concentrations is shown in Table 2.2. 
The separating gel (14% or 10 %) and stacking gel (4 %) were prepared as shown in 
Table 2.2, and degassed to remove any air bubbles prior to the addition of the 
TEMED and APS. Once poured, the separating gel was overlaid with water - 
saturated butan -2 -ol and left to set. After removal of the butan -2 -ol, the stacking gel 
was poured on top of the separating gel, a 20 well comb inserted, and once the gel 
had set, the comb was removed and the gel apparatus placed into an electrophoresis 
tank. Samples were loaded into the wells of the stacking gel and electrophoresed 
through the stacking gel at a constant 60V and through the separating gel at a 
constant 150V until the dye front had run approximately 9cm. After electrophoresis, 
the samples were visualised by either staining the gel or immunoblotting after transfer 
to nitrocellulose sheets. 
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Table 2.2 Preparation of polyacrylamide gels 
Reagent Stacking gel Separating gel 
4% 14% 10% 
Pyrogen -free water 3.5 3.45 6.95 
Separating buffer 17.5 17.5 
Stacking buffer 5.0 
40 %(w /v) acrylamide 1.0 12.25 8.75 
TEMED (NNNN'- tetramethyl -1,2- diaminoethane) 0.02 0.05 0.05 
Ammonium persulphate (APS) (15mg/m1) 0.5 1.75 1.75 
(Hancock & Poxton, 1988) 
2.2.6 SILVER STAINING FOR VISUALISING LIPOPOLYSACCHARIDE 
This procedure is based on the method of Tsai & Frasch (1982) as described by 
Hancock & Poxton (1988). The following solutions were used: 
a) Fixative solution comprised 7 %(v /v) acetic acid and 25 %(v /v) propan -2 -ol. 
b) Oxidising solution comprised 1.05g periodic acid in 150m1 pyrogen -free water 
containing 4ml of fixative. 
c) Ammonical silver nitrate solution comprised 1.4ml ammonia solution and 21m1 of 
0.36 %(w /v) sodium hydroxide to which 4m1 of 19.4 %(w /v) silver nitrate was slowly 
added with mixing. The solution was made up to 100ml with pyrogen -free water. 
d) Developing solution comprised 200m1 formaldehyde solution containing 10mg 
citric acid. 
After overnight soaking in fixative, gels were oxidised for 15min in freshly prepared 
periodic acid solution. Gels were then washed in four changes of distilled water over 
a period of 3h and silver- stained for LPS by the addition of freshly- prepared 
ammonical silver nitrate solution for 15min. Over a period of 40min the gels were 
washed in at least four changes of distilled water. The LPS was visualised by adding 
200m1 of freshly prepared developing solution. The above steps were carried out on a 
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shaking platform. Once the desired staining intensity was reached gels were washed 
thoroughly in distilled water. 
2.2.7 COOMASSIE BLUE STAINING FOR VISUALISING PROTEINS 
This procedure is based on the method described by Hancock & Poxton (1988). The 
following solutions, made up in distilled water, were used: 
a) Solution 1 comprised 25 %(v /v) propan -2 -ol, 10 %(v /v) acetic acid and 0.05 %(w /v) 
Coomassie brilliant blue R -250 (Bio -Rad). 
b) Solution 2 comprised 10 %(v /v) propan -2 -ol, 
0.005 %(w /v) Coomassie blue. 
c) Solution 3 comprised 10 %(v /v) acetic acid and 0.025 %(w /v) Coomassie blue. 
d) Solution 4 comprised 40 %(v /v) methanol and 10 %(v /v) acetic acid. 
e) Solution 5 comprised 10 %(v /v) acetic acid. 
After overnight soaking in solution 1 gels were placed sequentially through solutions 
2 -5 for 60min each. All steps were carried out on a shaking platform. 
10 %(v /v) acetic acid and 
2.2.8 IMMUNOBLOTTING 
This procedure is based on the method of Towbin et al (1979) as described by 
Hancock & Poxton (1988). The following solutions were used: 
a) Immunblot transfer buffer (pH8.3) comprised 6g of Tris, 29g of glycine and 500m1 
of methanol in two litres distilled water. 
b) Tris buffered saline (TBS; pH7.5) comprised 4.84g Tris and 58.48g sodium 
chloride in two litres distilled water. 
c) Tween -Tris buffered saline (TTBS) comprised TBS with 0.025 %(v /v) Tween -20. 
d) Blocking solution comprised TBS with 3 %(w /v) gelatin. 
e) Antibody diluent comprised TBS with 1 %(w /v) gelatin. 
f) Polyclonal antisera for the first antibody was obtained from either the CFL serum 
collection or from the MPRL serum collection. Sources of the antisera are indicated 
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in section 2.1.5 and in the relevant result section. Peroxidase- labelled anti -rabbit or 
anti -human antibody conjugate (IgG) was diluted 1:1000 as according to the 
manufacturers' instructions (Sigma). 
f) Horseradish peroxidase (HRP) colour development solution comprised 30mg HRP 
colour reagent (Bio -Rad EIA Purity Grade) dissolved in 1Oml of methanol, added to 
50m1 TBS containing 30µ1 hydrogen peroxide. 
Samples were separated by PAGE as described above. The gel was placed on a 
ScotchbriteTM pad of a blotting apparatus and covered by a nitrocellulose membrane 
(0.2pm pore size, Schleicher & Schuell, Dassel, Germany) presoaked in immunoblot 
transfer buffer. The immunoblot cassette was closed sandwiching the gel and 
nitrocellulose sheet between the ScotchbriteTM pads and placed in an immunoblotting 
tank. Care was taken to expel any air bubbles from the cassette system that may have 
interfered with transfer. Antigens were transferred from the gel to the nitrocellulose 
membrane overnight at 10 -12V; a constant current of 40mA. 
The nitrocellulose membrane was washed in TBS for 10min and placed in blocking 
solution for 45min, before incubating with a 1:200 dilution of the first antibody for 3h. 
The nitrocellulose membrane was washed briefly in distilled water before two 1Omin 
washes in TTBS. The nitrocellulose membrane was then incubated for 1h with the 
HRP- conjugated second antibody. After washing as before, the binding of antibody 
to separated antigenic determinants was visualised by addition of the HRP colour 
solution until the required intensity was reached. All the above steps took place on a 
shaking platform. The nitrocellulose membrane was washed thoroughly in distilled 
water, blotted dry and stored in the dark. 
2.2.9 PERCOLL DISCONTINUOUS DENSITY CENTRIFUGATION 
This method was described by Patrick & Reid (1983). Percoll (Pharmacia LKB, 
Uppsala, Sweden) was diluted to 80 %, 60 %, 40% and 20 %(v /v) solutions using 
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0.15M NaCl. Starting with the 80% solution and working sequentially, 1ml of each 
solution was carefully layered (80% at the bottom) into 70 x 20mm sterile glass tubes. 
A 1 ml sample of an overnight bacterial culture was carefully applied to the top of the 
20% layer and the gradient centrifuged at 3000 g for 15min in a bench centrifuge, 
allowing the bacteria to sediment according to their buoyant density. 
2.2.10 CELL SURFACE HYDROPHOBICITY 
Cell surface hydrophobicity was determined by Hydrophobic Interaction 
Chromatography (HIC). This procedure is based on the method described by Smyth 
et al (1978) and uses the following solutions: 
a) Octyl sepharose CL -4B ( Pharmacia) was used as the non -polar ligand. 
b) Sepharose CL -4B (Pharmacia) was used to correct for non -specific adsorption. 
c) Binding buffer comprised 50mM phosphate buffer (0.2mo1/l NaH2PO4 + 0.2mo1/1 
Na2HPO4) containing 1.7M (NH4)2SO4 
d) The gel slurry referred to throughout this section comprised 75 %(v /v) binding 
buffer and either 25 %(w /v) Octyl sepharose or Sepharose. 
Preparation of the HIC columns 
To a disposable polystyrene chromatography column, 2mm in diameter, (Pierce & 
Warner Ltd., Chester, UK), 2m1 of degassed water was added and a polyethylene disc 
pushed to the bottom of the column. The water was removed and 2ml of degassed 
pre -swollen gel slurry added. A polyethylene disc was added to the top of the slurry, 
the column capped to prevent drying out and the gel slurry left to settle for 30min. 
Columns were prepared fresh on the day of use or overnight for anaerobic reduction. 
Determination of bacterial cell surface hydrophobicity by HIC. 
Bacteria grown overnight in 10m1 of broth were harvested and washed twice in sterile 
binding buffer. Bacteria were resuspended in buffer to give 104cfu /ml. Aliquots 
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(2m1) of bacterial suspension were added to the column and the eluate collected in 70 
x 20mm sterile glass tubes. To ensure adequate wash -through of cells 2m1 of binding 
buffer was also added and the eluate collected in the same glass tube. Retention of 
cells by the columns was determined by the difference in viable counts between the 
initial suspension and the column eluate. All counts were performed in duplicate. 
2.2.11 ROCKET IMMUNOELECTROPHORESIS (RIE) 
This procedure is described by Hancock & Poxton (1988). The following solutions 
were used: 
a) Electrophoresis buffer comprised two solutions; 
Solution 1 comprised 1.3 %(w /v) barbitone sodium and 0.2 %(w /v) barbitone. 
Solution 2 comprised 5.6 %(w /v) glycine and 4.5 %(w /v) Tris. 
Equal volumes of solutions 1 and 2 were mixed and the pH adjusted to 8.8. 
b) Agarose gel comprised 1.5 %(w /v) agarose, 25 %(v /v) electrophoresis buffer and 
1 %(w /v) Triton X -100. 
c) Stain comprised 0.5 %(w /v) Coomassie blue R -250, 45 %(v /v) ethanol and 
10 %(v /v) acetic acid made up in distilled water. 
d) Destain comprised the stain as in c) above but omitted the Coomassie blue dye. 
A 50mm square sheet of GelbondTM (Pharmacia) was placed hydrophilic side up on to 
a glass plate and laid on a flat level table. To a 3ml aliquot of molten agarose at 
50°C, 0.5ml of polyclonal antiserum, obtained from either the CFL or MPRL serum 
collection was added, taking care that the agarose had sufficiently cooled so the 
antibodies were not destroyed. The agarose was cast onto the GelbondTM square and 
left to set. Up to six 3mm diameter wells were cut into the middle of the agarose and 
loaded with 201,1 of LPS or OM sample. 
Gels were placed in an electrophoresis tank with the wells set perpendicular to the line 
of current. Presoaked wicks of Whatman No.1 filter paper were used to connect the 
edges of the gel to the electrophoresis buffer and a current of 100mA applied for 
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4 -5h. Gels were then overlaid with a sheet of filter paper, several sheets of blotting 
paper, a glass plate and pressed for 15min with a lkg weight before being washed in 
two changes of 0.01M sodium chloride and one wash of distilled water for 15min 
each and pressed as before. The flattened gels were dried with a hair -drier, stained 
for l Omin and then destained to visualise the antigen- antibody reaction. 
2.2.12 CROSSED IMMUNOELECTROPHORESIS (CIE) 
This procedure is a two- dimensional version of RIE and is described by Hancock & 
Poxton (1988). The solutions used are the same as described above for RIE. 
Preparation of the first -dimensional gel 
A 80mm square of GelbondTM was placed hydrophilic side up onto a glass plate and 
15ml of molten agarose poured onto the square. Once set, up to four circular wells, 
approximately 3mm in diameter were cut into the agarose, spaced 20mm apart and 
positioned 20mm from one edge. Wells were loaded with 20µl of sample and the gel 
placed in an electrophoresis tank with the edges of the gel connected to the buffer by 
Whatman No.1 presoaked filter paper. After applying a current of 100mA for 1h, 
50mm x 10mm agarose strips, incorporating the wells, were cut from the gel and 
placed on the edge of a 50mm square sheet of GelbondTM. Wells were positioned at 
the bottom right hand corner. 
Preparation of the second -dimensional gel 
The second -dimensional gel was prepared in a similar way to RIE. A 3m1 aliquot of 
molten agarose containing 0.5ml of polyclonal serum was cast against the first - 
dimension strip and allowed to set. Gels were placed in the electrophoresis tank with 
the first -dimensional strips nearer the cathode. The edge of the gels were connected 
to the buffer by means of pre- soaked filter paper. A current of 100mA was applied 
overnight at 40C. 
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Visualisation of antigen- antibody interactions in CIE gels 
Gels were pressed, washed, stained and destained as described above for RIE. 
2.2.13 CHEMICAL ANALYSIS OF LPS SAMPLES 
LPS preparations were used at a concentration of 5mg/ml. Optical densities were 
read against a reagent blank, (pyrogen -free water taken through the same procedure 
as the samples) in a SP -6 Pye- Unicam Spectrophotometer. All readings were 
performed in duplicate. 
Estimation of 3- deoxy -D- manno -2- octulosonic acid (Kdo) content. 
LPS preparations were assayed for Kdo by the standard thiobarbituric acid (TBA) 
method (Kharkanis et al, 1978). 
The following solutions were used: 
a) 25mmol periodic acid in 62.5mmol sulphuric acid 
b) 2 %(w /v) sodium arsenite in 0.5M hydrochloric acid 
c) 0.6 %(w /v) thiobarbituric acid (TBA) adjusted to pH 9 with sodium hydroxide 
A 10111 aliquot of a 1 mg/ml solution of Kdo was used as the standard. 
TBA method 
LPS samples (40111, 10011l, 400µ1, made up to 0.5ml with pyrogen -free water) were 
mixed with 0.5ml of 0.25M H2SO4 and heated at 1000C for 8min. Insoluble material 
was removed from turbid suspensions by centrifugation at 4000 g for 1Omin. 
Aliquots (0.5m1) of the acid hydrosylate were mixed with 0.25m1 of periodic acid 
reagent and incubated at 370C for 30min. Once cooled, 0.25m1 of sodium arsenite 
solution was added and the solution mixed until the brown colour disappeared, before 
addition of 0.25m1 of TBA solution. The solution was heated at 1000C for 7.5min 
and whilst still hot 1ml of dimethylsulphoxide added to preserve the colour. 
Adsorption was measured at 548nm. 
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Hydrofluoric acid Dephosphorylation 
This method is based on the procedure described by Beckmann et al (1989). 
Hydrofluoric acid dephosphorylation was used to remove any potential phosphate 
substituent from the Kdo moiety which would have prevented a detectable reaction in 
the standard TBA assay. 
LPS samples (1mg) were added to 0.3ml of aqueous 50% hydrofluoric acid and 
sealed in polypropylene tubes at 4°C for 48h. Volatile material was removed at room 
temperature by a stream of nitrogen gas and the residue dissolved in 0.3ml of 
pyrogen -free water. The sample was again dried by a stream of nitrogen gas and the 
residue resuspended in lml of pyrogen -free water and kept at -200C until required. 
The Kdo content of the samples was analysed by the TBA method described above. 
Estimation of phosphorus content. 
The phosphorus content was estimated by the method of Chen et al (1956). The 
following solutions were used: 
a) Digestion mixture comprised concentrated sulphuric acid and 60% perchloric acid 
mixed 3:2(v /v). 
b) Phosphate reagent comprised 10% 3M sulphuric acid, 0.25 %(w /v) ammonium 
molybdate and 1 %(w /v) ascorbic acid. 
A 100111 aliquot of a 1014/m1 sample of phosphorus (NaH2PO4) was used as a 
standard. 
LPS samples (20111 and 401.11) were reduced to dryness by heating on a rack, before 
0.1m1 of digestion mixture was added and the solutions heated to boiling point. 
Solutions were then refluxed for 20min or until a clear solution remained. After 
cooling, 8ml of freshly prepared phosphate reagent was added, mixed, and the 
solution incubated at 370C for 90min. Absorbance was read at 820nm. 
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Estimation of Carbohydrate content 
The presence of neutral sugars was estimated by the phenol -sulphuric acid method 
described by Dubois et al (1956). 
A 50µ1 aliquot of a 180.tg/ml glucose solution was used as a standard. 
LPS samples (20µ1 and 40µ1) were made up to 0.5ml with pyrogen -free water and 
mixed before addition of 0.5ml of 5 %(w /v) phenol. After mixing, 2.5ml of sulphuric 
acid was pipetted directly onto the samples by aid of a dispensette (Brand, West 
Germany). After cooling for 30min the absorbance was read at 490nm. 
Estimation of protein content 
The protein concentration was estimated for both LPS and OM preparations by the 
Folin assay of Lowry et al (1951). The following solutions were used: 
a) 12.5 %(w /v) sodium carbonate 
b) 0.1 %(w /v) copper sulphate 
A 2511l aliquot of a 2mg/m1 solution of bovine serum albumin was used as a standard. 
Samples (5µl and 25µ1) were made up to 0.4ml with pyrogen -free water and 1.2m1 of 
12.5% Na2CO3 and 0.2ml of 0.1% Cu.SO4.5H20 added. Solutions were mixed and 
left to stand for 1h. Folin reagent diluted 1:3 was added (0.2m1) and the mixtures left 
for 25min. The absorbance was read at 750nm. 
2.2.14 LIMULUS AMOEBOCYTE LYSATE (LAL) ASSAY 
LPS preparations (5mg/m1) were assessed for endotoxic activity by the 'kinetic 
method for the determination of endotoxin in water' by the Coatest© Endotoxin Kit 
(Chromogenix, Mölndal, Sweden). LPS samples were diluted in pyrogen -free water 
to a concentration of 5ng/m1- 0.05ng/ml and 5411 of each sample added to a flat - 
bottomed microtitre plate. The control endotoxin (E. coli 0111:B4) was serially 
diluted 1 in 5 in pyrogen -free water to provide a standard concentration range of 
24- 0.0384 endotoxic units (EU) /ml. The outer wells were omitted to avoid 
93 
temperature gradients that may have interfered with the result. Freshly prepared 
chromogenic LAL reagent (2O1.11) was added to the wells by means of a transfer plate 
to ensure that each well received the reagent at the same time. Plates were read 
kinetically every 19 seconds for 90 minutes in a Thermomax plate reader (Molecular 
Devices, London, UK) at 405nm. All samples were tested in duplicate. All material 
coming into contact with the sample was purchased as endotoxin -free (Rainin 
Instrument Co. Inc., CA, USA) or depyrogenated by heating to 250°C for 2.5h. 
2.2.15 PREPARATION OF CELLS FOR CYTOKINE ASSAYS 
Separation of mononuclear leucocytes (MNL) 
Human mononuclear leucocytes were separated from heparin treated human 
leukocyte concentrate (buffycoat; 30% monocytes; supplied by Blood Transfusion 
Service, Edinburgh) on lymphocyte separation medium (ICN Flow, CA, USA) 
following a two -fold dilution in RPMI 1640 (ICN Flow). Cells were harvested at 
1000 g for 30min with the MNL forming a white interface between the serum and 
separation medium. This layer was carefully transferred with a sterile pasteur pipette 
to a sterile tube and washed three times in RPMI 1640 at 4000 g for 15mins. At the 
last wash, cells were resuspended in pre -warmed RPMI 1640 supplemented with 10% 
Foetal Calf Serum (FCS; Sigma), 1mM L- glutamine (Greiner Labortechnik Ltd., 
Gloucestershire, UK) and penicillin + streptomycin (10014/m1; Gibco BRL Life 
Technologies, Paisley, UK) to a concentration of 8 x 106 cells /ml. Cells were 
counted in a haemocytometer. 
Separation of alveolar macrophages 
Human alveolar macrophages from broncheoalveolar lavage fluid were separated and 
kindly gifted by M. Imrie and Dr A. Greening, Western General Hospital, Edinburgh. 
Cells were suspended in RPMI 1640 supplemented with 10% FCS, 
L- glutamine, 
penicillin and streptomycin to a concentration of 1 x 106 cells /ml. 
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Separation of neutrophils 
Neutrophils were separated from heparinised blood from healthy volunteers by Dr J. 
Hughes, Department of Medical Microbiology, University of Edinburgh. Cells were 
resuspended in RPMI 1640 supplemented with 10 %FCS, L- glutamine, penicillin and 
streptomycin to a concentration of 2 x 106 cells /ml. 
Growth and maintenance of cell lines 
The cell lines used throughout this thesis are listed in Table 2.3. 
Table 2.3 Origin, source and cell type of cell lines used in this thesis 
Cell Line Origin Cell Type Source 
Dr D. Morrison, University 
THP -1 Human Blood Monocyte of Kansas Medical Centre, 
USA 
A549 Human Lung Epithelial ECCCa 
L929 Mouse Connective Tissue Fibroblastic ECCC 
a = European cell culture collection 
Growth of cell lines from liquid nitrogen 
Ampoules were removed from liquid nitrogen and rapidly thawed at 37°C. Contents 
were transferred to a sterile container with 1 ml of pre -warmed media added to the 
ampoule and the washings transferred to the container. Cells were harvested at 4000 
g for 10min, resuspended in approximately 25ml of media, transferred to a 50cm2 
tissue culture flask and incubated at 37°C in a 5% CO2 atmosphere. 
Maintenance of cell lines 
All cell lines were checked every two days for growth and divided approximately 
twice a week by one of the following methods; 
a) Attached cells. The fibroblastic cell lines A549 and L929 adhere to the plastic of 
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flask walls and had to be detached once a confluent monolayer was established. For 
maintenance purposes this was achieved by discarding approximately half the media 
and dislodging the cells by use of a cell scraper. Contents were split into two flasks 
and MEM media (Sigma) added to the same volume as before. To prepare the A549 
and L929 cells for the bioassays, media was discarded and cells dislodged by 0.05% 
trypsin/0.02 %EDTA (Gibco) digestion, added at a 20% volume of discarded media. 
Cell detachment was confirmed by viewing under an inverted microscope. Cells were 
transferred to a sterile container and media containing FCS added, to ensure the 
digestion of excess trypsin. Cells were centrifuged at 4000 g for 15min, washed twice 
and finally resuspended to the required concentration in MEM media containing 
10 %FCS, L- glutamine, penicillin and streptomycin. 
b) Suspension cells. ThP -1 cells are non adherent and were maintained by pouring 
half the contents of a flask into a new container and adding RPMI 1640 media to the 
new flask to the appropriate volume. For use in the bioassays, cells were harvested 
and washed twice at 4000 g for 15min and finally resuspended in fresh media to the 
required concentration. 
Enhancement for CD14 in ThP -1 cells 
ThP -1 cells were enhanced for expression of CD14, an LPS binding receptor, by 
addition of 0.11.1M of 1,25 -dihydroxyvitamin D3 (ICN Flow). Cells were grown in 
75cm2 tissue culture flasks for 72h and a half volume of vitamin D3- containing 
medium added and the flasks incubated for a further 24h. Cells were prepared as 
described previously. CD14 IgG MAb (SAPU) was used neat for inhibition assays. 
Freezing cell lines 
To establish a stock of cell lines, cells were frozen approximately every three months 
and viability checked accordingly. The following solution was required: 
Freezing medium comprised 10% DMSO, 5 %FCS in RPMI 1640 
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Cells were harvested in the same manner described above and resuspended in freezing 
medium to a concentration of between 8 x 106 -2 x 106 cells /ml. Aliquots (1ml) were 
transferred into cryogenic ampoules (NUNC) and frozen at -200C for 30min. 
Ampoules were then transferred to liquid nitrogen. 
2.2.16 STIMULATION OF CELLS FOR CYTOKINE ASSAYS 
Bacterial extracts, diluted in pyrogen -free water, were added to 96 -well round bottom 
plates or 24 -well plates for time -course experiments (Greiner), in a ratio of 1:10 of 
the cells to be stimulated. Plates were incubated at 370C in a 5 %CO2 atmosphere, 
with 100µl of supernate removed at appropriate intervals, frozen and stored at -20°C 
until required for the bioassay. 
2.2.17 TNF BIOASSAY 
The bioassay for TNF used a mouse fibroblastic cell line, L929, that is sensitive to the 
cytotoxic effects of TNF. Cells were harvested and resuspended to a concentration of 
3 x 105 cells /ml in MEM media containing 5 %FCS, L- glutamine, penicillin and 
streptomycin as described in 2.2.15. L929 cells (100µ1) were added to wells of a 96- 
well flat -bottom plate and incubated overnight at 370C in a 5 %CO2 atmosphere to 
form a confluent monolayer. 
Bioassay for TNF 
Growth medium from the plate was discarded and replaced with 100111 of fresh MEM 
containing Actinomycin D (2 tg/ml; Sigma) to inhibit further growth of the L929 cells. 
Supernates from the stimulation assays were diluted 1:5 in MEM and 100µl added to 
the wells, thus giving a final dilution of 1:10. A human rTNF -a standard (National 
Institute for Biological Standards and Control) at a stock concentration of 40,000 
International Units was serially diluted 1:5 in MEM and 10011l added to provide a 
standard concentration range of 1000 -0.0128 lU /ml. All samples and standards were 
tested in duplicate. Samples of pyrogen -free water and MEM media were also tested 
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as controls. Plates were incubated at 37°C in a 5 %CO2 atmosphere overnight. 
After incubation, the medium was discarded and 104t1 of filtered crystal violet 
solution (0.5 %w /v crystal violet in 20 %v /v methanol) added. Only living L929 cells 
take up the stain. After two minutes, plates were washed in running tap water until 
no further colour was removed. Plates were dried by use of a hairdryer, 100111 of 
20 %(v /v) acetic acid added to the wells and crystals lysed by shaking on a microtitre 
plate shaker. Plates were read at 585nm in a Vmax plate reader (Molecular Devices). 
Optical densities were converted to TNF equivalents using the TNF standard as a 
reference. 
2.2.18 SPECIFICITY OF TNF BIOASSAY 
A human anti -TNFa antibody (Genzyme, NBS Biologicals, Herts, UK) was serially 
diluted 1:10 in MEM down to a 1:10,000 dilution. Pooled supernates from 
stimulation assays were diluted 1:5 in MEM to which 14t1 of each dilution of anti - 
TNF antibody was added. After a 30min incubation at 37°C, 10011l of dilution was 
added to a plate of L929 cells and incubated for a further 24h. The plate was then 
washed, stained and read as before. Supernate alone and antibody alone were used as 
comparative controls. 
2.2.19 INDUCTION AND BIOASSAY FOR IL-8 
Stimulation of IL -8 from MNL or alveolar macrophages was carried out by the same 
method as described for TNF induction. 
The bioassay for IL -8 was a radioimmunoassay and was carried out by J. McCoIm, 
Department of Child Life and Health, University of Edinburgh. 
2.2.20 MEASUREMENT OF LPS MITOGENITY 
The following experiment was performed in conjunction with D. Delahooke, 
Department of Medical Microbiology, University of Edinburgh. 
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Spleen and lymph nodes from C3H/HeN mice (removed by M. Kerr, Department of 
Medical Microbiology) were placed in RPMI 1640 and homogenised into a single cell 
suspension. Filtered cells were harvested at 4000 g for 15min, washed twice in RPMI 
1640 and resuspended to a concentration of 2 x 106 cells /ml in RPMI 1640 
supplemented with 5 %FCS. Aliquots (l00111) of cell suspension were added to an 
equal volume of either PHA or LPS in a 96 -well plate and incubated for 48h at 37°C, 
5% CO2. Each sample was tested in triplicate. After incubation, lOp.Curies of 
3H- thymidine (Amersham International, Little Chalfont, Bucks., UK.) diluted in 20µ1 
of RPMI 1640 was added to each well and the plates incubated for a further 24h as 
before. Each well was washed ten times in distilled water with an Autowash 2000 
wash machine (Dynatech Laboratories Ltd., West Sussex, UK) and the washings 
deposited onto filter paper (Filter Paper for Cell Harvester, ICN Flow) which was left 
to dry overnight. The filter paper discs were removed and placed into polyvial 
polyethylene tubes to which lml of scintillation fluid was added. The tubes were 
sealed and beta -emissions registered in a Tricarb Liquid Scintillation Analyzer 1900 
CA (Packard Instrumentation BV, Berks, UK). 
2.2.21 STATISTICAL ANALYSIS 
The Wilcoxon rank sum test for nonparametric data was used for comparison of 
results in the LAL and TNF -a assays. Advice on statistical analysis of the data was 




ENVIRONMENTAL MODULATION OF CELL SURFACE 
VIRULENCE DETERMINANTS OF 
BURKHOLDERIA CEPACIA 
The influence of growth environment on both the phenotypic expression of cell 
surface components and the induction of virulence factors is well documented. The 
following experiments aimed to investigate potential virulence determinants of 
B. cepacia, focusing in particular on environmental modulation of cell surface factors. 
Throughout the present study the isolate referred to as the 'epidemic' strain is known 
to be highly transmissible between CF patients (Govan et al, 1993); isolates referred 
to as 'non -epidemic' do not appear, to date, to be highly transmissible. 
3.1 GROWTH AND SURVIVAL OF B. CEPACIA IN DIFFERENT 
ENVIRONMENTAL CONDITIONS 
The influence of nutrient -limitation ongrowth 
The influence of 12 different growth media on the colonial morphology of two strains 
of B. cepacia, C1359 (epidemic) and C1409 (non -epidemic), was investigated. 
Colonies of the epidemic strain normally appear as dry, rough and much smaller than 
the larger, smoother colonies of C1409. Four genetically- characterised strains of 
P. aeruginosa with defined environmentally -regulated alginate production were used 
as controls. Strains were inoculated onto various solid media, passaged once and 
growth marked at 24h, 48h, 72h and 96h (Table 3.1). All plates were incubated 
aerobically at 37 °C. 
From Table 3.1 it can be seen that certain nutrient conditions inhibit growth of 
B. cepacia. For example, both strains tested did not grow well on phosphate- limiting 
medium. However, no major change in colonial morphology, including the presence 
of a mucoid phenotype, was observed. In all culture conditions, with the exception of 
CEP media, growth of C1409 was faster compared to growth of C1359; colonies of 
C 13 59 reaching 'full size' only after 48h growth compared to 24h for C1409. The 
defined P. aeruginosa strains grew well in all conditions with the exception of the 
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carbon -limited medium, where growth was inhibited and much lower than for the 
B. cepacia strains. As expected, alginate biosynthesis was modulated in response to 
varying nutrient conditions. 
Table 3.1 The Influence of Growth Media on Colonial Morphology" 
Mediab C1359 C1409 J35 J36 J37 J38 
CEP / +++c -H-+ +++M M -M 
PIA 
MA ++ III +++M +++M III +++ 
MB ++ +++ +++M +++M +++M -H--i- 
MD ++ +++M ++( +) +++M +++ +++ 
MH - +( +) +++M ++ ++M ++( +) 
Mg -limit + ( +) + ++M ++M + 
Fe -limit + +( +) ++(+)M +++M M +++ 
P -limit +( +) +( +) +( +)M +( +)M + / -M +( +) 
ETOH + ++ +-I-FM M M +-H- 
Acetone +( +) ++( +) +++M MM +-1-+ 
Semi - 
solid 
++ M +++ ++-i- I I I _M +H.. 
Carbon- 
limited 
+/- ++( +) +/- - 
a = results tabulated are for 96h growth compared to CEP or PIA controls 
b = refer to section 2.1.3 for recipe 
c = growth scored from +++ (maximum) to - (no growth) 
M = mucoid phenotype characteristic of high EPS production 
The influence of atmosphere on growth 
The experiment above was repeated except that plates were incubated under 
microaerophilic and anaerobic conditions to investigate the influence of atmosphere 
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on growth and survival of B. cepacia. In microaerophilic conditions, no changes in 
colonial morphology were observed, although growth of C1359 was much slower; 
colonies required 72h to reach 'full size'. This observation suggests that a 
microaerophilic atmosphere inhibits growth of the epidemic strain. 
Neither B. cepacia strain grew on any medium incubated anaerobically. However, 
due to the exceptional versatility of this organism, (for example survival in pyrogen- 
free water), it was considered that B. cepacia might adopt a dormant form. To test 
this theory, C 13 59 and C1409 were inoculated onto MB plates, (which allow 
anaerobic growth of P. aeruginosa), and incubated in an anaerobic cabinet. Swabs of 
the anaerobic plate were taken at weekly intervals for four weeks and subsequently 
inoculated onto CEP media incubated aerobically. Although both strains of 
B. cepacia did not show any visible growth on the anaerobic plates, growth did occur 
on the CEP plates. Even the swab taken four weeks after initial inoculation produced 
growth, indicating that B. cepacia can survive anaerobic conditions. Strains were 
confirmed as B. cepacia by API 20NE. 
The influence of pH on growth 
pH may be an important factor for the growth of B. cepacia since this organism is 
pathogenic for onions, one of the few vegetables with a pronounced acidic 
composition (Geigy, 1962). The influence of pH on the growth of six strains of 
B. cepacia from clinical and environmental sources was investigated. Malka A 
medium was prepared with predetermined volumes of 1M HCI, to give a range of 
media with different initial pH levels. In addition, onion -agar medium 
was 
investigated as a growth substrate. Growth was marked at 24h, 48h and 72h relative 
to a CEP control (Table 3.2). With the exception of the epidemic strain which 
was 




pH measurements during growth were taken over time to determine any trend in 
growth metabolism. The pH of each medium was determined using a combination pH 
electrode specially constructed for agar plates. Initial pH measurements were taken 
before bacterial inoculation, then every 24h for eight days. Figure 3.1 shows the pH 
measurements taken with B. cepacia C 1409, representative of all strains examined. 
Uninoculated control plates did not exhibit any change, from the initial pH level, 
during the course of the experiment. Interestingly, the culture medium which 
supported the best growth of B. cepacia CEP, was metabolised to an alkaline pH. 
Furthermore, of the MA plates, only the MA(pH7) produced substantial growth. As 
all MA plates were identical with the exception of the initial pH levels, these results 
indicate that B. cepacia does not grow well in low pH conditions with neutral or 
alkaline levels preferred. 
Table 3.2 The Influence of pH on Growth of B. cepacia 
Media J3 666 J762c C1732' C 1744' C 13 59c C 1409c 
CEP +++ +++ IIY +++ +++ +++ 
OA +++ +++ ++( +) ++ ++( +) +++ 
MA(pH7) +++ ++ +++ +++ +++ +++ 
MA(pH6.3) ++( +) +++ ++( +) + +++ +++ 
MA(pH5.5) + + +( +) ++ ++ +/- ++ 
MA(pH5) +/- ++ + + + 
MA(pH4) +/- +/- +/- +/- +/- 
a = results shown are for 72h growth compared to a CEP control 
b = environmental strains 
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Figure 3.1 pH change during the growth of B. cepacia C1409 
* = initial pH level 
3.2 CHARACTERISTICS AND ENVIRONMENTAL REGULATION OF LPS 
The aim of this section was to characterise the lipopolysaccharide phenotype from 
strains of B. cepacia, using B. gladioli and P. aeruginosa isolates as comparative 
controls, and in addition, investigate whether growth in different environmental 
conditions altered the LPS structure. LPS was extracted by either the phenol water 
(PW), phenol -chloroform- petroleum spirit (PCP) or proteinase K method, separated 
by PAGE and visualised by silver- staining and immunoblotting. 
LPS Phenotype 
Five strains of B. cepacia; C1359 (epidemic CF strain), C1409 & C1504 (non - 
epidemic CF strains), ATCC 17762 (non -CF clinical strain) and J2540 (environmental 
isolate), and one strain of B. gladioli (ATCC 10248) were examined for LPS profile 
by silver- stained PAGE. Figure 3.2 shows the LPS profiles extracted by the PW 
method and confirms that strains of B. cepacia may possess rough or smooth LPS. 
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M.' 
Figure 3.2 Silver stained LPS profiles of PW extracts of B. cepacia and 
B. gladioli separated by SDS -PAGE (14% w/v acrylamide). Track 1, B. cepacia 
C1359; Track 2, B. cepacia C1409; Track 3, B. cepacia C1504; Track 4, B. cepacia 
ATCC 17762; Track 5, B. cepacia J2540, Track 6, B. gladioli ATCC 10248. 
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The influence of environmental growth conditions on LPS structure 
The same bacterial isolates used in the above experiment were grown in different 
culture media and their LPS profiles examined. All strains were grown in a nutrient 
rich medium NB +YE, a defined minimal medium MA and a physiological medium 
MA +S. In addition, LPS from two strains of B. cepacia, C1359 (epidemic) and 
C1409 (non -epidemic), were extracted from growth in high osmolarity medium MD, 
iron -limiting medium MA +E and carbon -limiting medium MAN (Figure 3.3 and 3.4). 
Differences in band staining intensity could be seen but no major structural changes 
were observed. 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
I Oa- 
lamp makalia0041111 
Figure 3.3 Silver stained LPS profiles of B. cepacia C1359 and 
C1409 extracted 
from different growth conditions. Tracks 1 -6, C1359 proteinase 
K digests from 
NB +YE, MA, MA +S, MD, MA +E and MAN; Tracks 7 -9, 
C1359 PW extracts from 
NB +YE, MA, MA +S; Tracks 10 -15 C1409 proteinase K 
digests and Tracks 16 -18 
C 1409 PW extracts from the same growth media. 
106 
a 1 2 3 4 5 6 7 8 9 
b 
Figure 3.4a -b. Silver stained LPS profiles of proteinase K whole cell digests of 
B. cepacia, B. gladioli and P. aeruginosa strains extracted from different growth 
environments. Figure 3.4a Tracks 1 -3, B. cepacia ATCC 17762; Tracks 4 -6, 
B. cepacia J2540; Tracks 7 -9 B. gladioli ATCC 10248; Figure 3.4b Tracks 1 -3, 
P. aeruginosa PAO1; Tracks 4 -6, P. aeruginosa C1250; all LPSs were extracted 
from NB +YE, MA and MA +S respectively. 
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Immunoblotting 
Immunoblotting was performed on the same strains as above using a variety of 
antisera obtained from both CF patients and rabbits. CF sera were categorised into 
four groups 1) CF patients colonised by B. cepacia epidemic strain, 2) CF patients 
colonised by B. cepacia non -epidemic strain, 3) CF patients colonised by 
P. aeruginosa, and 4) CF patients not colonised by either B. cepacia or 
P. aeruginosa. Rabbit sera was raised against heat -killed whole cells of either 
B. cepacia C1359 (epidemic), B. cepacia C1409 (non -epidemic) or B. cepacia J2395 
(hospital environment). 
Figure 3.5a -c shows immunoblots probed with CF sera from group 1, 2 and 3 
respectively and reveals a difference in immunogenic structure between the bacterial 
strains. CF sera from group 1 (patients colonised only with the epidemic strain) gave 
a positive reaction with the low molecular mass core LPS from this strain (Figure 
3.5a; Track 1) and one band from two other B. cepacia strains, C1504 & J2540, 
(Figure 3.5a; Track 3 & 5). The reaction to the CF sera from group 2 (patients 
colonised with a non -epidemic strain; C 1409) was markedly different. The high 
molecular weight moiety of the LPS from C1409 and surprisingly B. gladioli reacted 
strongly (Figure 3.5b; Track 2 & 6), with no reaction from the epidemic strain 
observed. P. aeruginosa LPS from strain C1250 did not exhibit cross -reactivity with 
any of the B. cepacia strains at the serum concentration used. Furthermore, using CF 
sera from group 3 (patients colonised with P. aeruginosa), only LPS samples from the 
two P. aeruginosa strains tested gave a reaction (Figure 3.5c; Track 2 & 4). No 
reaction was observed for any LPS sample probed with group 4 CF sera, (patients 
B. cepacia and P. aeruginosa negative). 
Figure 3.6a -c shows the immunoblots obtained using rabbit sera raised against C1359, 
C1409 and J2395 respectively. Immunoblots using C1359 and C1409 rabbit sera 
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(Figure 3.6a & 3.6b) were similar to the reactions observed with CF serum, except 
C1409 rabbit serum also reacted against a high molecular weight structure of C1504, 
ATCC 17762 and J2540 (Figure 3.6b; Tracks 3 -5). This greater cross -reactivity 
could be due to the higher level of antibody present in the rabbit sera. The reaction of 
the antisera from the rabbit inoculated with J2395 (an environmental isolate) showed, 
rather surprisingly, a similar response to that observed from CF sera group 1 (Figure 
3.5a). The strongest reaction was against the environmental isolate (Figure 3.6c; 
Track 5), with C1504 also giving a reaction (Track 3). 
These results suggest that there is marked intra- species variation between the LPS 
types of B. cepacia. Furthermore, two B. cepacia strains, C1504 and ATCC 17762, 
although observed to have R -LPS by silver -staining (Figure 3.2), showed high 
molecular weight bands upon immunoblotting (Figure 3.6b; Track 3 & 4) suggesting 
that cross -reactive antigenic epitopes were present. However, whether these bands 
are part of an LPS structure is not known. The lack of cross -reaction between 
P. aeruginosa LPS and B. cepacia sera highlights the difference between these two 
CF pathogens, whereas the positive reaction of B. gladioli confirms the close 
taxonomic relationship of these species within the new genus Burkholderia. 
All the bacterial LPS samples used in the above immunoblots were PW extracts 
from 
growth in NB +YE. Figure 3.7 shows the immunoblot reaction using PW 
-LPS 
samples from B. cepacia C1359 and C1409 grown in NB +YE, MA and 
MA +S. The 
sera used to probe the blots was the same rabbit sera as described 
above. No 
difference in LPS structure from the different culture media was observed 
and thus 













































































































































































































































































































































































































































































































































































































































































Figure 3.7a -b Immunoblots of PW -LPS antigens extracted from different 
growth environments and probed with rabbit sera raised against heat -killed 
whole cells of (a) B. cepacia C1359, and (b) B. cepacia C1409. Figure 3.7a 
Tracks 1 -3, B. cepacia C1359 LPS extracted from NB +YE, MA and MA +S. Figure 
3.7b Track 1 B. cepacia C1409 LPS extracted from NB +YE; Track 2, B. cepacia 
C1409 LPS extracted from MA; Track 3, Blank; Track 4, B. gladioli ATCC 10248; 
Track 5, Blank; Track 6, B. cepacia C1409 LPS from MA +S. 
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The influence of pH on B. cepacia LPS structure 
The three most acid -tolerant B. cepacia strains, as determined by the pH growth 
experiment described in section 3.1, were selected, J762, C1744 and C1409, and their 
LPS extracted from growth in MA media with an initial pH level of 7.0, 6.3, 5.5 and 
5.0. LPS from growth in NB +YE and OA was also extracted. Analysis of the 
proteinase K LPS profiles (Figure 3.8) showed LPS extracted from OA to comprise 
more core -LPS compared to the MA samples. In addition certain bands stained more 
intensely suggesting increased production of 0- antigen of this chain length. However, 
no major structural differences were observed with regards to the different MA media. 
1 r ii;8 9 10 71 1213 14 15 16 E-r_ s_ dau..r...i.r ... 
Figure 3.8 Silver- stained LPS profiles of proteinase K whole cell digests of 
B. cepacia strains grown under a range of pH conditions. Tracks 1 -6, B. cepacia 
C1744 (environmental isolate); Tracks 7 -11, B. cepacia J762 (non -CF clinical isolate) 
and Tracks 12 -16 B. cepacia C1409 (CF isolate), all LPSs extracted from 
NB +YE(pH6.8), MA(pH7), MA(pH6.3), MA(pH5.5), MA(pH5; for C1744 only) and 
OA(pH6.3). 
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The influence of different extraction methods on LPS structure 
It has been reported that the endotoxicity of a bacterial strain is dependent on the 
extraction method employed (Delahooke et al, 1995a). Therefore, as well as the 
actual growth environment, the LPS extraction method will be important in affecting 
LPS profile. To determine whether LPS extraction method influenced LPS profile, 
LPS from B. cepacia C 13 59 and C1409 were obtained by both the PW and PCP 
method and compared to the proteinase K profile from Figure 3.3. 
A silver -stained gel and immunoblot of the LPS of B. cepacia C 1409 extracted by the 
PW and PCP methods are shown in Figure 3.9a and 3.9b respectively. Using the PW 
method the LPS of C1409 appears mainly as high molecular weight material with 
some core antigen visible by silver -staining. No difference in LPS profile compared to 
a proteinase K sample was observed. However, using the PCP method, although the 
LPS again appeared the same by silver staining (Figure 3.9a; Track 2), immunoblots 
revealed two very dense bands (Figure 3.9b; Track 2), lower in molecular weight than 
normally observed with either the or K 
The LPS profile of C1359 obtained by PW extraction was the same as a proteinase K 
sample, low molecular weight core LPS, as observed by silver -staining and 
immunoblotting (Figure 3.9c; Track 1 & Figure 3.9d; Track 1 respectively). 
However, LPS obtained by the PCP method differed in several respects. Firstly, the 
LPS extract was extremely hydrophobic and is best described as a piece of 
rubber/hard chewing gum! The extract would not form an aqueous solution easily 
even when heated, sonicated and repeatedly freeze -thawed but did dissolve rapidly 
in 
90 %(w /v) phenol. Secondly, when the sample was examined by silver -stain the track 
appeared blank (Figure 3.9c; Track 2). Thirdly, and quite surprisingly, 
immunoblotting of the PCP sample probed with rabbit sera raised against C1359 did 
show a reaction. However, in contrast to the normal low molecular weight core 
LPS, 
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three high molecular weight dark bands and two very faint bands were observed 
(Figure 3.9d; Track 2). These bands are unlikely to be part of an LPS ladder pattern 
as they were not regularly spaced and unlikely to be an artifact of the PCP procedure 
as they reacted with specific antisera but not upon silver -staining. Whether these 
bands are present in vivo and are involved in pathogenicity requires further studies. 
In the PW extraction method, LPS is normally obtained from the upper aqueous layer 
and the bottom phenol layer is discarded. Due to the extreme hydrophobic nature of 
the C1359 PCP extract and its ability to dissolve easily in phenol, further experiments 
examined the LPS from both the aqueous phase and the phenol phase of a PW 
extract. This process was performed to determine whether any LPS was present in 
the phenol layer and if so, whether it differed from that obtained from the aqueous 
layer. B. cepacia C1409 and P. aeruginosa C1250 were also re- examined as a 
comparison. In addition, both phases extracted from C 1409 were ultracentrifuged 
and the pellet and supernate retained to compare both the LPS from the pellet and 
supernate and from the ultracentrifuged and uncentrifuged samples. 
Figure 3.10a shows the immunoblot of LPS from C1359 obtained from the aqueous 
and phenol layer of a PW extraction. The sample obtained from the phenol layer was 
not observed on silver -staining but was observed by blotting. Samples from the two 
layers reacted differently; the aqueous layer appeared as a low molecular weight core 
(Figure 3.10a; Track 1), but the phenol layer in contrast, showed a large high 
molecular weight moiety not observed previously (Figure 3.10a; Track 2). Similarly, 
the samples of P. aeruginosa C1250 obtained from the two PW phases also varied. 
The phenol phase extract was not observed on silver -staining even though there was a 
reaction by blotting (Figure 3.10b; Track 2); indeed, more reactive bands were 
observed in the phenol extract compared to the aqueous sample. 
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Figure 3.11a and 3.11b show the results obtained with C1409 LPS by silver- staining 
and immunoblotting. Firstly, there was no visual difference between LPS obtained 
from the ultracentrifuged pellet, the supernate or the crude extract (pellet + supernate) 
that is normally used (Figure 3.11a; Tracks 1, 2 & 4). However, there was a variation 
between the samples obtained from the aqueous and phenol layers, with the phenol 
layer LPS being of a lower molecular weight. Furthermore, the supernate from the 
ultracentrifuged phenol layer gave a different reaction to the other samples upon both 
silver -staining and immunoblotting. As all three organisms show variations in LPS 
structure between the PW phases this may be important in terms of LPS expression in 
vivo and hence pathogenicity. 
In order to establish the purity of the LPS extracts, proteinase K (401.1g/mg LPS 
sample) and 0.1M sodium periodate (2000mg LPS sample) were added to the PW 
extracts from C1359. As the sample did not show any reaction after treatment with 
periodate (Figure 3.12; Track 3) it may be concluded that the majority of the extract 
is periodate- labile LPS. However, upon treatment with proteinase K, some of the 
core LPS mass is also lost (Figure 3.12; Track 2) indicating that a small amount of 
protein may be present. 
B. cepacia strains exhibit a variety of LPS profiles ranging from the rough -LPS core 
structure to the characteristic ladder pattern of smooth LPS. Minor variations in LPS 
profile were observed from samples extracted from different growth environments 
although the variations were mainly differences in band intensity. However, 
extraction method appears to have a considerable influence on LPS structure with 
PCP extracts and the aqueous and phenol phase PW extracts exhibiting different 
structures when probed with specific sera. Unfortunately B. cepacia isolates, in 
general, do not resolve well on SDS -PAGE which makes observing structural changes 
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difficult. It is possible that LPS changes may be occurring but cannot be detected due 
to the limited resolution of the techniques employed. 
a b c d 
1 2 1 2. 
Figure 3.9 Profile of LPS samples from different extraction methods. (a & b) 
B. cepacia C1409 LPS samples and (c & d) B. cepacia C1359 LPS samples as 
observed by (a &c) Silver -stained LPS PAGE and (b & d) Immunoblot probed with 
rabbit sera raised against the homologous strain. Track 1, PW method; Track 2, PCP 
method. 
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Figure 3.10 Immunoblots of LPS samples obtained from different phases of a 
PW extract. (a) B. cepacia C1359 LPS samples and (b) P. aeruginosa C1250 LPS 
samples as observed by immunoblots probed with (a) rabbit serum raised against 
C1359 and (b) serum from a P. aeruginosa colonised CF patient. Track 1, Aqueous 
layer from a PW extract; Track 2, Phenol layer from a PW extract. 
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Figure 3.11a -b. Profile of LPS samples from B. cepacia C1409 obtained from 
different phases of a PW extract as observed by (a) silver -stained LPS PAGE 
and (b) immunoblot probed with rabbit serum raised against the homologous 
strain. Figure 3.11a Track 1, uncentrifuged aqueous layer extract; Track 2, 
ultracentrifuged aqueous layer pellet; Track 3, ultracentrifuged phenol layer pellet; 
Track 4, ultracentrifuged aqueous layer supernate; Track 5, ultracentrifuged phenol 
layer supernate. Figure 3.11b Track 1, uncentrifuged aqueous layer extract; Track 2, 
ultracentrifuged aqueous layer pellet; Track 3, ultracentrifuged aqueous layer 
supernate; Track 4, ultracentrifuged phenol layer supernate. 
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1 2 3 
Figure 3.12. PW -LPS samples of B. cepacia C1359 after 
proteinase K and periodate as observed by silver -stained LPS PAGE. Track 1, 
C1359 PW -LPS sample; Track 2, after treatment with proteinase K; Track 3, after 
treatment with periodate. 
Chemical analysis of LPS 
Simple chemical analysis was carried out on the LPS samples to characterise further 
the LPS structure and to investigate whether the chemical composition was altered 
due to environmental growth conditions. 
Table 3.3 shows the yield of lyophilised cells and PW -LPS extracts obtained from 
strains of B. cepacia, B. gladioli and P. aeruginosa grown in NB +YE, and in addition 
B. cepacia C 13 59 and C 1409 grown in MA and MA +S. The yield of cells extracted 
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from the different bacterial species did not correlate with the final amount of 
lyophilised PW extract. Interestingly, growth in minimal media produced the lowest 
yield of cells although the lowest yield of LPS was obtained from growth in serum 
supplemented media. This discrepancy may be due to the varying hydrophobicity of 
the LPS extracts as the PW method selects preferentially for hydrophilic material (see 
results in section 3.5). 
Table 3.3 Yield of cells and PW -LPS extracts obtained from different bacterial 
isolates and growth media. 
Strain Growth media Yield of lyophilised 
cells (WI) 
PW extract (% 
of cell dry wt.) 
B. cepacia C1359 NB+YE 0.658 5.6 
B. cepacia C1359 MA 0.446 6.7 
B. cepacia C1359 MA+S 0.564 2.3 
B. cepacia C1409 NB+YE 0.667 12.0 
B. cepacia C 1409 MA 0.525 16.8 
B. cepacia C 1409 MA+S 0.533 3.7 
B. cepacia C 1504 NB+YE 0.320 1.9 
B. cepacia ATCC 17762 NB+YE 0.890 7.5 
B. cepacia J2540 NB+YE 0.470 14.6 
B. gladioli ATCC 10248 NB+YE 0.958 7.1 
P. aeruginosa PAO1 NB+YE 0.900 8.1 
P. aeruginosa C1250 NB+YE 0.270 0.4 
Chemical analysis of the PW -LPS preparations is summarised in Table 3.4 and 
provides several interesting observations. The Kdo content of the various PW -LPS 
samples differed slightly when assayed by the standard TBA method or after prior 
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dephosphorylation with hydrogen fluoride; the latter method generally selecting for 
less Kdo content. This finding would imply that the dephosphorylation process for 
B. cepacia actually destroys the reactive components rather than releasing more, 
unlike the findings described for other Gram- negative organisms (Beckmann et al, 
1989). Furthermore, the amount of Kdo differed dramatically between the 
B. cepacia /B. gladioli preparations and those from P. aeruginosa with the latter 
samples containing on average five -fold more Kdo. The average Kdo content of the 
B. cepacia extracts is 0.4% which agrees with previous reports (Cox & Wilkinson, 
1991) and reinforces the theory that B. cepacia contains only one Kdo unit. Very 
little protein was detected in the samples, the largest proportion amounting to only 
0.37 %, confirming the observations made by silver -stained PAGE in Figure 3.12. The 
carbohydrate content of the PW -LPS samples is greater than the other chemical 
components as may be expected, although, it must be remembered that the assay used 
in the present study measures only neutral sugars and therefore more unreactive 
carbohydrate may be present. The phosphorus content of the B. cepacia samples is 
higher than previously reported but is unlikely to be due to phosphorus in the reagents 
as the assay was repeated four times with different PW extracts and freshly prepared 
reagents each time. 
There was no obvious distinction between the chemical composition of samples from 
clinical and environmental B. cepacia isolates, or between B. cepacia and B. gladioli 
samples and no correlation to LPS phenotype was detected. Furthermore, there was 
no difference between epidemic and non -epidemic B. cepacia isolates, with the 
exception of the epidemic strain (C 1359) possessing less carbohydrate. 
Chemical variations were also observed between PW -LPS samples extracted from 
different growth environments. MA +S extracts possessed more Kdo but less 
carbohydrate compared to the other samples. In addition, both MA and MA +S 
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extracts possessed a greater amount of protein contamination compared to the 
nutrient rich media NB +YE. 
Table 3.4 Chemical analysis of PW -LPS preparations 
Strain Growth 
media 
Kdod Prt CHO P 
TBA HF 
C 1359a NB+YE 3.4±0.3e 3.3±0.2 1.9±0.1 210±18 40.7±3.5 
C1359 MA 2.0±0.2 1.8±0.1 3.0±0.2 200±10 38.1±2.4 
C1359 MA+S 5.6±0.4 5.3±0.3 2.8±0.1 180±9 40.2±2.4 
C1409a NB+YE 2.5±0.2 2.7±0.2 1.9+0.1 344±12 25.0±2.2 
C1409 MA 2.6+0.2 1.9+0.2 3.0+0.2 3 70± 15 27.9+2.1 
C1409 MA+S 2.6±0.2 4.0±0.3 2.9±0.2 259±15 45.7±2.5 
C1504a NB+YE 3.4+0.4 NT 2.1+0.1 288+9 30.1+0.6 
ATCC 17762a NB+YE 4.9+0.4 2.9+0.2 3.7+0.2 282+15 49.2+2.1 
J2540a NB+YE 6.5+0.2 NT 2.1+0.1 290+27 31.5+2.0 
ATCC10248b NB+YE 3.6+0.2 2.8±0.4 1.1±0.1 243±24 24.6±2.3 
PAOIc NB+YE 23.4+1.5 17.5+1.3 2.9±0.2 239±11 57.3±4.2 
C 1250c NB +YE 19.9 ±0.5 NT 3.7 ±0.1 203 ±16 37.0 ±0.9 
a = B. cepacia isolates; b = B. gladioli isolates; c = P. aeruginosa isolates 
d = Kdo measured by the standard thiobarbituric acid method (TBA) or after prior 
dephosphorylation with hydrogen fluoride (HF) 
e = All results are shown as p.g/mg dry weight sample 
All results are given as the mean ± standard error from at least three experiments 
prt = protein; CHO = carbohydrate; P = phosphorus; NT = not tested 
The chemical composition and yield of lyophilised LPS obtained by different 
extraction methods is shown in Table 3.5. For B. cepacia C1359 and C1409, the 
yield of sample obtained from the phenol layer of a PW extract was less than the 
amount obtained from the aqueous layer. In contrast, the yield of sample obtained for 
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P. aeruginosa C1250 from the two PW layers was the same. This finding correlates 
with a previous report in which only 25% of LPS from a rough P. aeruginosa isolate 
was recovered from the aqueous phase (McGroarty & Rivera, 1990). The PW 
aqueous layer gave the highest yield of LPS for C1409 whereas the PCP method gave 
the highest yield for C1359. This may have been expected as the PCP method 
preferentially selects for rough LPS. However, whether C1359 expresses rough LPS 
in vivo is debatable considering the immunoblot results in Figure 3.9 and 3.10. 
Table 3.5 Chemical analysis and yield of LPS from different extraction methods 
Strain Sample Yield of lyophilised 
sample (% of cell dry wt.) 
Kdoc prt CHO P 
C1359a PW -aq 4.8 3.2 1.9 226 56.4 
C1359 PW -ph 1.1 1.4 587 144 12.6 
C 13 59 PCP 10.0 1.0 92 102 0.5 
C 1409a PW- aq(plt) 2.5 3.2 1.1 292 23.4 
C1409 PW- aq(sn) 11.5 2.5 1.3 360 19.9 
C1409 PW- ph(plt) 0.7 0.6 4.4 160 9.66 
C1409 PW- ph(sn) 1.0 0.8 665 154 5.3 
C1409 PCP 3.6 2.0 55 239 9.2 
C 1250b PW -aq 1.1 20.1 3.5 196 40.0 
C1250 PW -ph 1.1 11.4 754 117 6.4 
a = B. cepacia isolates; b = P. aeruginosa isolate 
c = results are pg/mg dry weight sample 
prt = protein CHO = carbohydrate P = phosphorus 
PW -aq = aqueous layer of a phenol water extract; PW -ph = phenol layer of a phenol 
water extract; plt = pellet from an ultracentrifuged PW extract; sn = supernate from 
an ultracentrifuged PW extract; PCP = phenol chloroform petroleum extract. 
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Different LPS extraction methods select for samples of varying chemical composition; 
reflecting the varying structures observed in Figures 3.9 -3.11. As expected for a PW 
extract, LPS samples obtained from the aqueous layer possessed the highest levels of 
Kdo and phosphorus, whereas samples from the phenol layer, in particular the 
supernate, possessed a high level of protein. Similarly, the PCP extracts also 
contained more protein contamination compared to the PW aqueous extracts. 
Carbohydrate content was more uniform between the samples, although levels were, 
in general, higher for the aqueous PW extracts. The variation in chemical 
composition between the samples once again lends speculation to the LPS structure 
expressed in the host. 
3.3 CHARACTERISTICS AND ENVIRONMENTAL REGULATION OF 
OMP 
Outer membrane profile 
Outer membranes were extracted from eight strains of B. cepacia, two strains of 
P. aeruginosa and one strain of B. gladioli. For two of the B. cepacia strains, 
isolates C 13 59 (epidemic) and C1409 (non -epidemic), outer membranes were 
extracted from growth in five different media; NB +YE, MA, MD, MA +E and MAN. 
Samples were stained by the Coomassie blue method. In addition, immunoblots of the 
OMP antigens were performed using both human and rabbit sera as described for the 
LPS samples. 
On analysis of the OMP Coomassie blue stained gel (Figure 3.13), it is immediately 
obvious that no two strains share the same profile. However, several bands 
are 
common to all the B. cepacia strains studied, including a major band at approximately 
30kD, recently proposed as a potential immunotherapeutic fret on account of its 
conserved nature (Burnie et al, 1995). All the B. cepacia strains 
expressed high 
molecular weight bands with the exception of the non -epidemic CF isolate 
C1409 and 
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the environmental isolate J366. 
1 2 I 4 5 6 7 8 9 10 11 
Figure 3.13 Coomassie blue stained outer membrane profiles of B. cepacia, 
B. gladioli and P. aeruginosa separated by SDS -PAGE (10% w/v acrylamide). 
Track 1, P. aeruginosa C1250; Track 2, P. aeruginosa PAO1; Track 3, B. gladioli 
ATCC 10248; Track 4, B. cepacia J2395; Track 5, B. cepacia J366; Track 6, 
B. cepacia J2540; Track 7, B. cepacia ATCC 29424; Track 8, B. cepacia ATCC 
17762; Track 9, B. cepacia C1504; Track 10, B. cepacia C1409; Track 11, 
B. cepacia C1359. Molecular weights of protein standards are indicated. 
The influence of growth environment on OM profile 
Figure 3.14 shows the OMP profile of B. cepacia C1409 and C 13 59 grown under 
different environmental conditions and again highlights the dissimilar profiles between 
these two isolates. As with other Gram- negative bacteria, B. cepacia strains change 
their protein composition in response to growth environment. This adaptation will 
affect the overall permeability of the outer membrane and allow the organism to 
survive in unfavourable conditions. C1409 grown in NB +YE (Figure 3.13; Track 10) 
expresses fewer high molecular weight bands compared to the other growth 
conditions studied which may be expected in a nutrient -rich environment. OMP 
profiles from C1409 grown in MA, MA +E and MAN (Tracks 2, 4 & 5) show two 
new high molecular weight bands at approximately 65kD and 78kD respectively, the 
OMP extracted from MI) (Track 3) shows a unique band at 44kD and from MAN an 
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extra intense band at just under 30kD. The function of these induced bands is 
unknown. OM preparations from C1359 grown in MA and MD (Tracks 7 & 8) 
produce the largest number of bands, although a major protein over 78kD, 
approximately 110kD, is not expressed when grown in conditions of high osmolarity 
(MD). Again the purpose of the proteins that are induced or repressed remains to be 
determined. Band intensity also varied between the growth conditions, (for example 
the 12kD band common to all the samples), and highlights the influence of the 
environment on levels of protein expression. It is interesting to note, that when 
grown under the same condition the two strains did not induce or repress proteins of 
the same molecular weight, implying that different B. cepacia isolates adapt to 
stressful environments in a variable manner. 











Figure 3.14 Coomassie blue stained outer membrane profiles of B. cepacia 
C1409 and C1359 extracted from different growth environments. Tracks 1 -5 
C1409 OM samples extracted from NB +YE, MA, MD, MA +E and MAN; Tracks 
6 -10 C1359 OM samples extracted from the same growth media. Molecular weights 
of protein standards are indicated. 
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Immunoblot analysis of the OM profile 
Immunoblot analysis of the OM samples revealed differences in antigenic structure 
between the strains. Figure 3.15a and 13.15b show the immunoblots of OM 
preparations probed with sera from a CF patient colonised with an epidemic and non - 
epidemic B. cepacia strain respectively. All the OM preparations gave reaction with 
serum from an epidemic -colonised CF patient, except the environmental B. cepacia 
isolate J366 (Figure 3.15a; Track 10). The strongest reaction was against C1359 
grown in NB +YE (Figure 3.15a; Track 1), although B. cepacia ATCC 17762, J2395 
and B. gladioli ATCC 10248 also reacted well (Figure 3.15a; Track 7, 8 & 9). With 
regards to the antigenicity of the OMs extracted from different growth environments, 
C1359 grown in MD gave reaction with only two bands compared to the numerous 
bands reacting from the MA and NB +YE samples. Similarly, the OM sample from 
C 1409 grown in MD also showed fewer bands reacting. 
Serum from a CF patient colonised with an non -epidemic strain (C1583) gave a very 
different response to that observed in Figure 3.15a described above. The 
P. aeruginosa OM sample and the high molecular weight bands of B. cepacia ATCC 
17762 gave the strongest reaction (Figure 3.15b; Track 1 & 9). However, all other 
OM preparations gave a poor response. Thus, the two CF sera used in the present 
study gave a very different reaction to the OM samples with regards to strength of 
response and cross -reaction. 
The response of the OM samples to rabbit sera raised against C1359 (epidemic 
strain), C 1409 (non- epidemic strain) and J2395 (environmental strain) are shown in 
Figure 3.16a -c respectively. The reaction observed using rabbit sera against C1359 
(Figure 3.16a) differs from that seen using serum from a CF patient colonised with the 
homologous strain (Figure 3.16a); less reactive bands are observed with the rabbit 
serum, for example there is no reaction with the P. aeruginosa sample. It seems 
unlikely that the greater reaction against the CF serum is due to cross reaction with 
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other bacteria as the CF patient was colonised only by the epidemic strain of 
B. cepacia and no other Burkholderia or Pseudomonas isolate. 
The immunoblot using rabbit sera raised against C1409 (Figure 3.16b) cannot be 
compared with the blot shown in Figure 3.15b as the CF patient, from whom the 
serum was obtained, was not colonised with the same non -epidemic B. cepacia isolate 
as used to inoculate the rabbit. The immunoblot in Figure 3.16b does however show 
several interesting results. Firstly, P. aeruginosa was the only OM sample not to 
show any reaction. Secondly, for C1359, NB +YE (Figure 3.16b, Track 3) gave the 
strongest reaction of all growth conditions although two bands from the OM 
extracted from MA +E (Track 6) also reacted well. Thirdly, although all OM samples 
from C 1409 reacted strongly there was obvious differences between the preparations 
from different growth conditions. For example, growth in MA and MA +E (Tracks 9 
& 11) produced four highly reactive bands above the common 30kD band, compared 
to only three from growth in MD (Track 10) and two from growth in NB +YE and 
MAN (Track 8 & 12). 
Rabbit sera raised against J2395 showed a different and weaker reaction against the 
OM preparations. All the samples reacted but only the homologous strain and 
B. cepacia ATCC 29424 showed a strong response. The 30kD band was highly 
reactive, as was observed using other sera, confirming the antigenicity and conserved 
nature of this protein. 
Unlike the LPS samples, the OMs of B. cepacia and P. aeruginosa cross -reacted, 
although this depended highly on the source of serum. Furthermore, the influence of 
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Figure 3.15 Immunoblots of outer membrane antigens of B. cepacia, B. gladioli 
and P. aeruginosa probed with sera from a CF patient colonised with (a) the 
epidemic strain and (b) a non -epidemic strain. Figure 3.15a Track 1, B. cepacia 
C1359 from NB +YE; Track 2, MA; Track 3, MD; Track 4, B. cepacia C1409 from 
NB +YE; Track 5, MA; Track 6, MD; Track 7, B. cepacia ATCC 17762; Track 8, 
B. cepacia J2395; Track 9, B. gladioli ATCC 10248; Track 10, B. cepacia J366; 
Track 11, P. aeruginosa PAO1. Figure 3.15b Track 1, P. aeruginosa PAO1; Track 
2, B. cepacia C1359 from NB +YE; Track 3, MA; Track 4, MD; Track 5, B. cepacia 
C 1409 from NB +YE; Track 6, MA; Track 7, MD; Track 8, B. gladioli ATCC 10248; 
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Figure 3.16 Immunoblots of outer membrane antigens of B. cepacia, B. gladioli 
and P. aeruginosa probed with rabbit sera raised against (a) B. cepacia C1359, 
(b) B. cepacia C1409 and (c) B. cepacia J2395. Figure 3.16a Track 1, 
P. aeruginosa PAO1; Track 2, B. gladioli ATCC 10248; Track 3, B. cepacia C1359 
from NB +YE; Track 4, NB +YE; Track 5, MA; Track 6, MD; Track 7, MA +E; Track 
8, MAN; Track 9, B. cepacia C1409 from NB +YE; Track 10, MA; Track 11, MD; 
Track 12, B. cepacia ATCC 17762; Track 13, B. cepacia J2395; Track 14, 
B. cepacia ATCC 29424; Track 15, B. cepacia J366. Figure 3.16b Track 1, 
P. aeruginosa PAO 1; Track 2, B. gladioli ATCC 10248; Track 3, B. cepacia C1359 
from NB +YE; Track 4, MA; Track 5, MD; Track 6, MA +E; Track 7, MAN; Track 8, 
B. cepacia C1409 from NB +YE; Track 9, MA; Track 10, MD; Track 11, MA +E; 
Track 12, MAN; Track 13, B. cepacia ATCC 17762; Track 14, B. cepacia J2395; 
Track 15, B. cepacia ATCC 29424, Track 16, B. cepacia J366. 
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Figure 3.16c Track 1, P. aeruginosa PAO1; Track 2, B. gladioli ATCC 10248; 
Track 3, B. cepacia ATCC 17762; Track 4, B. cepacia J2395; Track 5, B. cepacia 
J366; Track 6, B. cepacia ATCC 29424; Track 7, B. cepacia C1359 from NB +YE; 
Track 8, B. cepacia C1409 from NB +YE; Track 9, MA; Track 10, MD; Track 11, 
MA +E; Track 12, MAN; Track 13, C 13 59 from NB +YE; Track 14, C1409 from 
NB +YE. 
3.4 CHARACTERISTICS AND ENVIRONMENTAL REGULATION OF EPS 
EPS profile 
The B. cepacia strains used in this study do not produce high levels of 
exopolysaccharide as observed by simple colonial morphology. However, to 
investigate further the possibility of EPS production Percoll discontinuous density 
centrifugation was carried out on 11 strains of B. cepacia, one strain of B. gladioli 
and two strains of P. aeruginosa with results shown in Figure 3.17. (Refer to Figure 
6.7 for a photograph of Percoll profiles). 
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Figure 3.17 Percoll profiles of B. cepacia, B. gladioli and P. aeruginosa strains 
grown in NB +YE. The main areas of bacterial concentration are marked by the dark 
bands. 
The Percoll profiles show that the majority of strains centrifuged to the 60 -80% 
interface indicating that strains of B. cepacia produce little EPS. Investigation of the 
Percoll populations using an India ink stain confirmed the lack of capsular material. 
However, B. cepacia ATCC 17762 and J2395 gave some precipitation at the 40 -60% 
interface, although again no EPS could be observed by India ink staining. In contrast, 
P. aeruginosa C1250 produced a mucoid phenotype that was easily identified on agar 
plates and precipitated to the 0 -20% interface. All Percoll centrifugations were 
carried out on 24h old cultures, although no difference in profiles was observed after 
48h growth. 
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The influence of growth environment on EPS profile 
Percoll profiles of the bacterial strains grown in different environments were also 
carried out to investigate the influence of culture conditions on EPS production. As 
seen from the results in Figure 3.18, the Percoll profile was not greatly influenced by 
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Figure 3.18 The influence of growth environment on the Percoll profile of 
B. cepacia, R gladioli and P. aeruginosa strains. The main areas of bacterial 
concentration are marked by the dark bands. 
No difference in Percoll profile was seen for C1359, C 1504, ATCC 17762 and PAU 1. 
Changes were observed in C1409 grown in MAN which produced an additional small 
band at the 20 -40% interface, in J2540 which precipitated to the 40 -60% interface in 
MA and MA +S, and in B. gladioli which centrifuged to the 40 -60% layer in MA +S, 
indicating increased production of EPS in those growth conditions. Surprisingly, the 
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mucoid P. aeruginosa strain C1250 grown in MA sedimented out to both the 40 -60% 
and the 20 -40% interface, suggesting that less alginate is produced in minimal 
medium. Furthermore growth in MA +S also produced two bands, present at the 
0 -20% and 20 -40% interfaces. Thus, the majority of strains appeared as 
homogeneous populations with respect to EPS production. In other words, the 
bacterial sample centrifuged to only one interface. However, this was not observed 
with B. cepacia C1409 in MAN, ATCC 17762 and P. aeruginosa C1250 in MA and 
MA +S, which suggests these three strains form heterogeneous populations in terms of 
EPS production. This could not be detected however by India ink staining. 
EPS extraction and analysis 
The alginate polysaccharide of P. aeruginosa C1250 was extracted and visualised on 
silver -stained 12% and 10% SDS -PAGE gels and by immunoblotting using human 
serum from a CF patient colonised with a mucoid P. aeruginosa as a probe. 
The alginate did not separate out well on the SDS -PAGE gel which is what would be 
expected for such a high molecular weight material and, more importantly, no other 
polysaccharide material was observed indicating the absence of any LPS material. In 
addition no reaction was observed by immunoblotting. 
3.5 CELL SURFACE HYDROPHOBICITY 
The cell surface hydrophobicity of five B. cepacia isolates, two P. aeruginosa isolates 
and one B. gladioli strain was determined by HIC. Specific hydrophobic interactions 
were measured by octyl Sepharose CL -4B with Sepharose CL -4B used as a control 
for non -specific absorption. Results (Figure 3.19) are expressed as the percentage of 
cells retained by the octyl Sepharose relative to retention by Sepharose. In addition, 
the hydrophobicity of B. cepacia C 13 59 (epidemic CF strain), C1409 (non- epidemic 
CF strain) and J2540 (environmental strain) grown in different culture media was 
measured (Figure 3.20). 
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Figure 3.19 Cell Surface Hydrophobicity of B. cepacia, B. gladioli and 
P. aeruginosa strains. 
The cell surface hydrophobicity of B. cepacia averaged at 25 %, the same as for 
B. gladioli, but slightly less than the average for P. aeruginosa, measured at 32 %. 
However, no correlation could be determined between cell surface hydrophobicity and 
bacterial source or LPS phenotype. 
For the three B. cepacia strains tested, C1359, C1409 and 32540, growth in MA +S 
increased hydrophobic interactions (Figure 3.20). This increase was particularly 
pronounced in the epidemic strain, with relative hydrophobicity reaching levels of 
70 %. For the two CF strains, growth in MA produced bacteria of low 
hydrophobicity, whereas for the environmental strain 32540, NB +YE gave the least 
hydrophobic interactions. However, the difference in cell surface hydrophobicity 
between the growth conditions varied for each strain tested. 
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Figure 3.20 The Cell Surface Hydrophobicity of B. cepacia C1359, C1409 and 
J2540 grown in NB +YE, MA and MA +S. 
3.6 ANTIGEN DETECTION BY RIE 
Further investigations of the surface antigenic structures were performed with both 
rocket (RIE) and crossed immunoelectrophoresis (CIE). Samples of LPS extracted 
by different methods and from various growth conditions and OMs from different 
growth environments were loaded onto agarose gels containing either human or rabbit 
antisera. 
Figure 3.21a-f shows the RIE gels of several LPS and OM samples, with some 
interesting results emerging. Firstly, and most surprisingly, no sample gave reaction 
with any of the rabbit sera. Secondly, only one major reaction was ever observed 
using the CF sera; between the PW -LPS sample of the epidemic strain and serum 
from a patient colonised by the homologous strain (Figure 3.21a). Furthermore, this 
unique reaction of the epidemic strain was observed using PW -LPS extracts from 
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different growth environments (Figure 3.21b). Thus, the reactions observed by RIE 
were not the same as observed by immunoblotting, even though the same samples and 
sera were used in both methods. The antigen that was detected with the CF serum 
was confirmed as LPS as little reaction was obtained with a periodate- treated sample 
and on addition of proteinase K or autoclaving a precipitin line remained (Figure 
3.21c). Two -dimensional CIE was used to observe the precipitin further, although as 
can be seen from Figure 3.21d, only a single peak could be detected. 
The discrepancies in results between the RIE and immunoblotting experiments must 
be due to the techniques per se; nevertheless the RIE results demonstrate that out of 
all the reactions studied, the interaction between the epidemic strain and CF patients is 
the strongest. Furthermore as there was a difference between human and rabbit sera, 
this leads to speculation that the core -LPS antigens were somehow masked on the 
whole cells used to raise the rabbit antisera. Masking would most likely be due to 
EPS, although none could be detected for the epidemic strain. Therefore, why the 
rabbit serum gave no reaction against the PW -LPS sample of C1359 is not clearly 
understood, although the presence and, hence, masking effect of a high molecular 
weight compound in the epidemic strain should not be discounted. 
OM samples also reacted against the CF serum, although a 'streak' rather than a 
precipitin arc was produced (Figure 3.21e). It is possible that these streaks are 
actually salt present in the samples precipitating out. Interestingly, using serum from 
a CF patient colonised by both C1359 (epidemic) and C 1409 (non- epidemic), OM 
samples from both strains gave a reaction (Figure 3.21f), although only C1359 LP S 
precipitated out. However, whether this reaction is again due to salt precipitate 




Figure 3.21a. Rocket immunoelectrophoresis of LPS samples from R cepacia, 
B. gladioli and P. aeruginosa strains. Track 1, P. aeruginosa PAO1 PW -LPS; 
Track 2, B. cepacia C1359 PW -LPS; Track 3, B. cepacia C1409 PW -LPS; Track 4, 
B. cepacia ATCC 17762 PW -LPS; Track 5, B. gladioli ATCC 10248 PW -LPS. 
Figure 3.21b RIE of R cepacia PW -LPS samples from different growth 
environments. Track 1, B. cepacia C1359 PW -LPS from NB +YE; Track 2, PW- 
LPS from MA; Track 3, PW -LPS from MA +S; Track 4, B. cepacia C1409 PW -LPS 
from NB +YE, Track 5, B. cepacia C1359 PW -LPS from MA +S; Track 6, C1359 
PW -LPS from MA. Serum used in both a and b was obtained from a CF patient 




Figure 3.21c RIE of B. cepacia C1359 PW -LPS samples after treatment with 
proteinase K and periodate. Track 1, PW -LPS; Track 2, PW -LPS after periodate 
treatment; Track 3, PW -LPS after proteinase K treatment; Track 4, PW -LPS after 
autoclaving. Figure 3.21d Crossed immunoelectrophoresis of B. cepacia C1359 
PW -LPS extract. Serum used in both c and d was obtained from a CF patient 





Figure 3.21e RIE of OM samples from B. cepacia, B. gladioli and P. aeruginosa 
strains. Track 1, B. gladioli ATCC 10248 OM from NB +YE; Track 2, B. cepacia 
C1409 OM from MA; Track 3, B. cepacia C1409 OM from NB +YE; Track 4 
B. cepacia ATCC 17762 OM from NB +YE; Track 5, B. cepacia C1359 OM from 
NB +YE; Track 6, B. cepacia C1359 OM from MA; Track 7, P. aeruginosa PAO1 
OM from NB +YE. Figure 3.21f RIE of LPS and OM samples from B. cepacia 
strains. Track 1, C1409 PW -LPS; Track 2, C1409 OM sample from NB +YE; Track 
3, C1409 PCP; Track 4, C1359 PCP; Track 5, C1359 OM sample from NB +YE; 
Track 6, C1359 PW -LPS; Track 7, C1359 OM sample from MA. Serum used for 
3.21e was from a CF patient colonised by the epidemic strain, serum used for 3.21f 
was from a CF patient colonised by both the epidemic strain, C1359, and a non - 




BIOLOGICAL ACTIVITY OF THE CELL SURFACE 
COMPONENTS OF BURKHOLDERIA CEPACIA 
The interaction between the bacterial cell surface and the host immune system plays a 
major part in pathogenesis. Experiments described in this section aimed to determine 
the biological activity, and in particular the inflammatory potential, of two bacterial 
cell surface components, LPS and OM, focusing on their endotoxicity and capacity to 
induce TNF -a and IL -8, two major proinflammatory cytokines involved in CF. 
Throughout the following experiments the same eight bacterial strains were used, 
B. cepacia C 13 59 (CF, epidemic), C1409 (CF, non -epidemic), C1504 (CF, non - 
epidemic), ATCC 17762 (non -CF), J2540 (environmental), B. gladioli ATCC 10248 
(environmental, type strain) and P. aeruginosa C1250 (CF, mucoid) and PAO1 
(genetic type strain). 
4.1 THE ENDOTOXICITY OF LPS SAMPLES 
PW -LPS samples from the bacterial strains described above were assayed for their 
endotoxic potential in vitro using the Limulus Amoebocyte Lysate (LAL) assay. 
Dose response 
To determine the optimal concentration of LPS extract to use in the LAL assay, PW- 
LPS samples were serially diluted ten fold in pyrogen -free water to provide a 
concentration range from 5ng/m1- 0.05pg/ml. Figure 4.1 shows the dose response 
curve for three representative strains. An LPS concentration lying between 5ng/ml- 
0.5ng/ml was chosen as the optimal concentration of PW sample to use in the LAL 
assay, as the optical density values produced from this concentration range 
corresponded to the middle of the standard curve and would, therefore, provide more 
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Figure 4.1 Dose response curve of three LPS samples as measured by the LAL 
assay. Results shown are the mean of duplicates. 
The endotoxicity of PW -LPS samples from different bacterial strains 
PW -LPS samples from B. cepacia, B. gladioli and P. aeruginosa, at a concentration 
of 1 ng/ml, were assayed for their endotoxic potential (Figure 4.2). In the LAL assay, 
B. cepacia LPS was significantly more endotoxic (P <0.01) than LPS preparations 
from P. aeruginosa. No correlation was observed between LPS phenotype and LAL 
activity although, interestingly, the LPS from the epidemic strain gave the lowest 
endotoxic readings from all B. cepacia strains tested. Further experiments carried out 
using LPS samples of 5ng/m1 and 0.5ng/ml confirmed the difference between 
B. cepacia and P. aeruginosa, indicating the trend observed was not dependent on 
LPS concentration. 
The influence of growth environment on LPS endotoxicity 
The PW -LPS extracts of B. cepacia C1359 and C1409 grown in NB +YE, MA and 
MA +S were assayed to determine whether growth environment influenced the 
endotoxicity of the LPS samples (Figure 4.3). 
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Figure 4.2 The endotoxic activity of PW -LPS preparations as measured by the 
LAL assay. LPS samples were used at a concentration of ing/ml. The results shown 
represent the mean of three experiments. The endotoxic activity of B. cepacia was 
significantly different from P. aeruginosa (P <0.01) which is highlighted by the ** 
symbol 
For both strains, LPS preparations extracted from growth in MA gave the highest 
endotoxin values. For the epidemic strain, no difference in endotoxicity between LPS 
extracted from growth in NB +YE and MA +S could be detected, whereas for C 1409, 
the LPS sample extracted from NB +YE gave a markedly higher endotoxic response 
compared to the sample from MA +S. Furthermore, for all three growth conditions, 
LPS preparations from C 1409 had a greater endotoxic potential than C1359. 
Thus, although no structural difference between the LPS samples from different 
growth media could be detected by silver -stained PAGE and immunoblotting, 
endotoxicity does appear to be dependent on environmental conditions. Interestingly, 
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there seems to be an inverse relationship between Kdo levels (Table 3.4) and LAL 
activity; the LPS preparations from C1359 had more Kdo compared to C1409 and 
samples extracted from growth in MA had less Kdo in comparison to NB +YE and 
MA +S. 
C1359 C1409 
Figure 4.3 The influence of growth environment on the endotoxicity of PW -LPS 
samples. LPS was used at a concentration of ing/ml. Each value represents the 
mean of two experiments. 
4.2 INFLAMMATORY POTENTIAL OF LPS 
Increasing levels of TNF -a have been reported to be associated with pulmonary 
deterioration in CF patients (for example Wilson et al, 1993). LPS is well- established 
as a potent stimulator of TNF -a, therefore, the following experiments were performed 
to investigate the potential of B. cepacia LPS to induce TNF -a, using both 
B. gladioli and P. aeruginosa LPS extracts for comparison. 
TNF -a levels were measured in a two -stage bioassay. LPS samples were used to 
stimulate cells, and hence induce cytokine production, and the supernate collected. 
Subsequently, diluted supernates were added to L929 cells, which are sensitive to the 
cytotoxic effects of TNF -a, and the levels of L929 cell killing used to calculate the 
amount of TNF -a present. 
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Specificity of TNF -a bioassay. 
To ensure that the L929 bioassay was measuring TNF -a specifically, an anti -TNF -a 
MAb was mixed with supernate from a stimulation experiment and added to the L929 
cells. In addition, to ensure that the PW -LPS samples themselves had no direct effect 
on the L929 cells a lmg/ml LPS sample was added directly to the L929 cells. Results 
are shown in Figure 4.4. 
i.íïï`í//r/' % 
Figure 4.4 Specificity of TNF -a Bioassay. Supernate was collected at 4h. Results 
shown are the mean of duplicates. MAb = monoclonal antibody; sn = supernate. 
Figure 4.4 shows that the anti -TNF -a MAb neutralises TNF-a in the supernate up to 
a dilution of 1:10,000. In addition, the PW -LPS samples alone had no effect on the 
L929 cells. Thus, it can be concluded that the bioassay used in the present study 
measures only TNF -a in the culture supernate and it is solely responsible for lysis of 
the L929 cells. 
PW -LPS samples were also treated with either periodate, proteinase K or both, to 
confirm that TNF -a activity was indeed being induced by the LPS molecule (Figure 
4.5). It is interesting to note, however, that there is a small reduction in TNiF -a levels 
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on addition of proteinase K. This observation implies that either the protein present in 
the sample is inducing a small cytokine response per se or the protein, in combination 
with the LPS molecule, presents a more active form of compound compared to pure 
LPS. Alternatively, the proteinase K may have been contaminated with an enzyme 
which degraded some of the LPS sample. Proteinase K and periodate alone did not 








Figure 4.5 The influence of periodate and proteinase K treated PW -LPS 
samples on induction of TNF -a. Results are the mean of four wells. Supernate was 
collected at 4h. Per = periodate; Prtnase K = Proteinase K. 
Further controls in each experiment consisted of assaying the supernate from wells 
containing medium only, MNL cells only and water used to dilute the LPS samples. 
Assays in which TNF -a levels could not be detected above the background ODs 
(determined as the OD produced from a well containing L929 cells only) were 
rejected. Fresh samples were diluted every time from 5mg/m1 stock solutions kept at 
-200C, with fresh stock solutions prepared approximately every two months. 
147 
4.3 TNF -a INDUCTION FROM MONONUCLEAR LEUCOCYTES 
Mononuclear leucocytes (MNL) were separated from healthy blood donors and used 
as a source of immune cells. As with the LAL assay, the optimal parameters of the 
TNF assay were assessed in order to obtain the most accurate and reliable results for 
future experiments. 
Dose response 
Figure 4.6 shows the TNF -a levels induced by PW -LPS samples of B. cepacia C1359 
and C 1409 at different concentrations. At a concentration equal or greater than 
1000ng/ml the levels of TNF -a induced were so great that no value could be 
assigned. The optimal LPS concentration was chosen so that the OD values 
corresponded to the linear section of the sigmoid standard curve. In this study, the 








----- B. cepacia C1359 f B. cepacia C1409 
E 
to 














Figure 4.6 Dose response of PW -LPS samples from MNL cells. Supernate was 
collected at 3.5h Results are the mean of four readings. 
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MNL cell concentration 
In the present study, MNL cells were used at a concentration of 8 x 106 cells/ml; 
chosen as the optimum cell number by preliminary experiments in another study. 
However, as shown in Figure 4.7, MNL cell concentrations ranging from 
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Figure 4.7 The influence of MNL cell concentration on TNF -a levels induced by 
B. cepacia C1409 PW -LPS samples. LPS samples were used at a concentration of 
1 ng/ml. Supernate was collected at 3.5h. Results are the mean of duplicates. 
Time course 
The MNL used in the TNF -a bioassay were living cells and as such required a period 
of time to respond to LPS stimulation. To ensure that the peak cytokine response 
was assessed, experiments were performed to measure TNF -a induction over time. 
TNF -a measurements were made at 30min intervals from 0 -9h (Figure 4.8) and at 
24h intervals over a 6 -day period (Figure 4.9). For clarity, results from three 
representative strains only are shown. 
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Figure 4.8 Time -course of TNF -a induction by PW -LPS preparations from 0 -9 







Oh 3.5h 5.5h 24h 48h 72h 96h 120h 1441 
---f--- B. cepacia C1359 
-AL- B. gladioli ATCC 10248 




Figure 4.9 Time Course of TNF -a induction by PW -LPS preparations over a 
six -day period. LPS samples were used at a concentration of ing/ml. Results shown 
are the mean of duplicates. 
For all PW -LPS preparations the peak TNF -a response was observed between 
approximately 2.5h -4.5h (Figure 4.8). Furthermore, after 24 hours negligible TNF -a 
was detected. For all future experiments LPS preparations at ing/ml were used and 
supernatant collected at 3.5h. 
It must be stressed that MNL cells from different blood donors vary slightly, and as a 
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result, the levels of TNF -a induced in each assay will differ. Consequently, the graphs 
shown in the following pages are representative results. Each experiment was 
repeated a minimum of three times to ensure that the trend observed was accurate and 
reproducible. 
TNF -a induction from MNL 
Figure 4.10 shows a representative study of TNF -a stimulation by PW -LPS 
preparations of B. cepacia, B. gladioli and P. aeruginosa. Both B. cepacia and 
B. gladioli samples induced at least a nine -fold higher activity compared to either of 
the P. aeruginosa preparations and as a population, B. cepacia was significantly 





Figure 4.10 TNF -a levels produced from MNL in response to PW -LPS 
preparations of B. cepacia, B. gladioli and P. aeruginosa. LPS samples were used 
at a concentration of 1 ng/ml. Supernate was collected at 3.5h. Results are the mean 
of duplicates. The levels of TNF -a induced by B. cepacia were significantly different 
from P. aeruginosa (P <0.01) which is highlighted by the ** symbol. 
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In contrast to the LAL assay results, in which the epidemic strain had the lowest 
endotoxicity of the B. cepacia strains tested, the epidemic strain produced one of the 
highest levels of TNF -a. Furthermore, there was a significant difference in TNF -a 
levels induced from B. cepacia clinical and environmental strains (P <0.05) which 
would apparently confirm the view that a sub -group of B. cepacia may be 'safe' for 
environmental release as a biocontrol agent or decontaminant of soil. However, it 
must be stressed that all the B. cepacia samples tested possessed a greater biological 
activity compared to the P. aeruginosa extracts. 
E. coli is considered to have one of the most potent LPS structures, therefore, to 
define more clearly the activity of B. cepacia LPS, samples of both species, plus a 
P. aeruginosa control, were compared by LAL assay and TNF -a induction. The 
E. coli sample (O18K; S -LPS) was prepared by D. Delahooke, Department of 
Medical Microbiology, Edinburgh. 
Table 4.1 Comparison of LAL and TNF -a values between B. cepacia, E. coli 
and P. aeruginosa PW -LPS samples. 
PW -LPS sample LAL (EU /ml) TNF -a (IU /ml) 
B. cepacia C1359 60.99 97.23 
B. cepacia C 1409 94.40 106.80 
E. coli O18K 17.44 68.38 
P. aeruginosa C1250 2.32 2.36 
Results shown are the mean of duplicates. 
LPS samples were used at a concentration of ing/ml. 
Samples for the TNF -a assay were taken at 3.5h. 
As expected, both B. cepacia and E. coli samples were more active than the 
P. aeruginosa sample. Unexpectedly however, B. cepacia PW -LPS samples gave a 
greater response compared to the E. coli PW -LPS sample in both the LAL and 
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TNF -a assays. Therefore, it appears that B. cepacia produces an LPS with extremely 
high inflammatory potential, which may be a major factor in B. cepacia pathogenesis. 
The influence of growth environment on TNF -a induction 
The PW -LPS samples from B. cepacia C1359 and C1409 grown in NB +YE, MA and 
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Figure 4.11 The influence of growth environment on TNF -a induction from 
MNL by PW -LPS samples. LPS samples were used at a concentration of 1 ng/ml. 
Supernate was collected at 3.5h. Each value represents the mean of duplicates. 
For both strains tested, PW -LPS preparations extracted from growth in MA +S were 
more stimulatory than samples extracted from NB +YE, which in turn produced more 
TNF -a than the MA preparations. However, although this was a trend observed in 
four different assays, there was no significant difference between growth conditions. 
Furthermore, these results do not correlate with the LAL assay, where LPS 
preparations from MA were the most endotoxic. 
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The influence of LPS extraction method on TNF -a induction. 
Results in chapter three showed that the LPS extraction method affected LPS profile, 
antigenicity and chemical composition. To determine the influence of LPS extraction 
method on TNF -a induction, LPS samples extracted by the PCP method and 
preparations from both the aqueous and phenol layer of a PW extract of B. cepacia 











Figure 4.12 The influence of LPS extraction method on TNF -a induction. LPS 
samples were used at a concentration of ing/ml. Supernate was collected at 3.5h 
Results are the mean of four readings. PW = phenol water extract; AQ = aqueous 
layer; PH = phenol layer; PCP = phenol -chloroform- petroleum spirit extract; sn = 
supernate. 
The aqueous layer and phenol layer extracts of B. cepacia C 1409 showed no major 
difference in induction of TNF -a. In contrast, the biological activity of the phenol 
layer extract of C1359 was markedly reduced compared to the aqueous sample. 
Furthermore, the PCP samples of both B. cepacia strains tested, induced very little 
detectable TNF -a activity. Thus, it can be concluded that LPS extraction method not 
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only alters LPS structure but also biological activity, a factor which should be 
remembered when relating results to bacterial pathogenic potential. PW -LPS samples 
were used in all future LPS experiments due to the higher biological potential. In 
addition, the ultracentrifuged pure LPS pellet, supernate and the uncentrifuged 
preparation from C1409 did not differ significantly, showing that the uncentrifuged 
LPS samples used in these experiments are good representatives of the pure LPS. 
Although a standard cell type for immunoassays, MNL separated from blood may not 
be considered relevant to CF pathogens; therefore, the following two sections 
investigated the TNF -a response from lung cells. 
4.4 TNF -a INDUCTION FROM LUNG EPITHELIAL CELLS 
Dose response and time course 
Preliminary experiments were performed to measure TNF -a levels over time and with 
a concentration range of PW -LPS samples to obtain the optimal time of induction and 
concentration of sample to use. Figure 4.13a and 4.13b show the dose response and 
time course graphs using the A549 lung epithelial cell line. 
-f- B. cepacia C1359 
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Figure 4.13a Dose response of PW -LPS samples from A549 lung epithelial cells. 
Results are the mean of duplicates. Supernate was collected at 4h. 
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From the concentration range tested, the optimum TNF -a response was obtained with 
the LPS sample of lmg/ml. The peak time of TNF -a production from the A549 cells 
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Figure 4.13b Time -course of TNF -a induction by PW -LPS preparations from 
A549 cells. LPS samples were used at a concentration of lmg/ml. Results are the 
mean of duplicates. 








Figure 4.14 TNF -a levels produced from A549 cells in response to PW -LPS 
preparations of B. cepacia, B. gladioli and P. aeruginosa. LPS samples were used 
at a concentration of lmg/ml. Supernate was collected at 4h. Results are the mean of 
duplicates. The levels of TNF -a induced by B. cepacia were significantly different 
from P. aeruginosa (P <0.01) which is highlighted by the ** symbol. 
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The B. cepacia PW -LPS samples induced a significantly higher level of TNF-a 
(P <0.01) compared to the P. aeruginosa samples, suggesting once more that 
B. cepacia plays a vital role in the immune -mediated damage observed in the CF lung. 
However, the A549 cells did not produce large quantities of TNF-a in response to the 
LPS samples tested. This low cytokine production may have been because the 
fibroblastic A549 cells were not allowed to adhere before addition of the LPS 
samples. 
To test whether adherence of the A549 cells influenced production of TNF-a, the 
A549 cells were seeded at 3 x 105 cells /ml (the same as used for the fibroblastic L929 
cells) and left for 24h to form a confluent monolayer. LPS samples were subsequently 
added and supernate collected at 4h (Figure 4.15). 
I. B. cepacia C1359 
B. cepacia C1409 
B. cepacia J2540 
P. aeruginosa C1250 
LPS added before adherence LPS added after adherence 
Figure 4.15 The influence of adherence on TNF -a production from A549 cells. 
LPS samples were used at a concentration of lmg/ml. Results are the mean of 
duplicates. Supernate was collected at 4h. 
No difference in TNF -a levels was observed between adhered and non -adhered A549 
cells with very little TNF -a induced overall (Figure 4.14). Thus, although B. cepacia 
LPS samples stimulated more TNF -a with respect to P. aeruginosa LPS, the levels 
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induced are very small compared to the levels from MNL cells, implying that lung 
epithelial cells do not contribute substantially to the clinically relevant TNF -a levels 
observed in CF patients. 
4.5 TNF -a INDUCTION FROM ALVEOLAR MACROPHAGES 
Alveolar macrophages are the major inflammatory cells of the lung, releasing large 
quantities of immune mediators. Therefore, it was essential not only to investigate the 
cytokine response from these important lung cells but also to determine if the trend 
observed previously with blood -derived monocytes (Figure 4.10) was representative 
of alveolar macrophages. Samples of purified human alveolar macrophages, prepared 
from broncheoalveolar lavage fluid, were gifted by Dr. A. Greening and M. Imrie, 
Western General Hospital, Edinburgh. 
Dose response and time course 
Preliminary experiments were again performed to estimate the optimal LPS 
concentration and time of TNF -a production (Figure 4.16a and 4.16b). 
Unfortunately, due to the relative scarcity of samples, only a small dose response and 
time course experiment could be set up, based primarily on results obtained with the 
MNL cells. In addition, the alveolar macrophages could only be used at a cell 
concentration of 1 x 106 cells /ml, again due to the low number of cell samples 
available. 
All three concentrations of PW -LPS sample tested, 1000ng/ml, 1ng/ml and 1pg/ml, 
produced a good TNF -a response with optimal OD values, thus an LPS 
concentration of 1 ng/ml was chosen to conform with the samples used in the MNL 
assays. 
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Figure 4.16a Dose response of PW -LPS samples from alveolar macrophages. 
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Figure 4.16b Time course of TNF -a induction from alveolar macrophages in 
response to PW -LPS samples. LPS samples were used at a concentration of 
1 ng/ml. Results are the mean of duplicates. 
The time -course in Figure 4.16b shows the levels of TNF -a produced from alveolar 
macrophages over a 24h period. The TNF -a levels rise dramatically after 2h, reach a 
peak at 4.5h, before decreasing at 6h and reaching negligible levels after 24h. 
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Therefore, the peak TNF -a response was observed between a broad time range of 
approximately 2.5 -5h. However, the peak time of cytokine production from alveolar 
macrophages was slightly later at 4.5h, compared to the MNL cells at 3.5h. Whether 
this time variation was due to differences in cell concentration or initial activation 
state requires further investigation. 
TNF -a induction from alveolar macrophages 
Figure 4.17 TNF -a levels produced from alveolar macrophages in response to 
PW -LPS preparations of B. cepacia, B. gladioli and P. aeruginosa. LPS samples 
were used at a concentration of ing/ml. Supernate was collected at 4.5h Results are 
the mean of duplicates. The levels of TNF -a induced by B. cepacia was significantly 
different from P. aeruginosa (P <0.01) which is highlighted by the ** symbol. 
Figure 4.17 shows TNF -a production from alveolar macrophages in response to PW- 
LPS preparations at a concentration of ing/ml and from supernate collected at 4.5h. 
Most importantly, the general trend in TNF -a production from alveolar macrophages 
was similar to that observed with MNL. The levels of TNF -a produced from 
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B. cepacia PW -LPS preparations were at least five times greater than either of the 
two P. aeruginosa samples and as a population B. cepacia produced a significantly 
different TNF -a response compared to P. aeruginosa (P <0.01). Similarly, there was 
a difference in TNF -a levels between B. cepacia clinical isolates and the 
environmental strain J2540 and B. gladioli. Therefore, from the similarity in 
responses it can be concluded that MNL cells act as a suitable model for alveolar 
macrophages. 
4.6 TNF -a INDUCTION FROM NEUTROPHILS 
One characteristic of CF is the large neutophil influx into the lung, thus it was 
essential to investigate TNF -a production from these cells. Neutrophil preparations 
were separated from blood donors by Dr. J. Hughes, Department of Medical 
Microbiology, University of Edinburgh. 
Dose response and time course 
Figure 4.18a and 4.18b show a typical dose response and time course from 
neutrophils in response to PW -LPS samples. 
B. cepacia C1359 
B. cepacia C1409 0 P. aeruginosa C1250 
0.01mg /m1 100ng/m1 
LPS concentration 
ing/ml 
Figure 4.18a Dose response of neutrophils in response to PW -LPS preparations. 
Supernate was collected at 3.5h. Results are the mean of duplicates. 
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Two B. cepacia strains and one P. aeruginosa strain were used for the dose response 
measurements, with three concentrations of LPS used: 0.01mg/ml, 100ng/m1 and 
1 ng/ml. All three PW -LPS concentrations tested induced detectable TNF -a which 
corresponded with optimal OD values, thus, to conform with previous experiments it 
was decided to use a PW -LPS concentration of ing/ml. 
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Figure 4.18b Time course of TNF -a induction from neutrophils in response to 
PW -LPS preparations. Results are the mean of duplicates. 
The peak of TNF -a production by the neutrophil cells was observed at 3.5h, similar 
to other cell types investigated. However, there was a rapid decline in TNF -a levels 
at 4h and beyond which had not been seen previously. This may be due to the shorter 
lifespan of neutrophils compared to macrophage cells. 
TNF -a induction from neutrophils 
Using a PW -LPS concentration of ing/ml and collecting the supernate at 3.5h, Figure 
4.19 shows the TNF -a induced from all eight PW -LPS preparations. The TNF -a 
response observed from neutrophils was different from the reaction seen with 
monocytes, macrophages and epithelial cells; the inflammatory capacity of the 
B. cepacia samples did not differ significantly from the P. aeruginosa PW -LPS 
preparations. Similarly, there was no distinct variation between B. cepacia clinical 
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and environmental strains. However, the B. cepacia extracts still induced an equal, if 
not greater, amount of TNF -a compared to the P. aeruginosa samples, reiterating the 
importance and huge inflammatory potential of B. cepacia. 
Figure 4.19 TNF -a levels produced from neutrophils in response to PW -LPS 
preparations. LPS samples were used at a concentration of ing/ml. Supernate was 
collected at 3.5h. Results are the mean of duplicates. 
4.7 TNF -a INDUCTION FROM DIFFERENT CELL TYPES 
Table 4.2 shows the levels of TNF -a induced, per cell, from the different cell types 
tested in this study in response to B. cepacia C1359 LPS. 
Results from Table 4.2 show that alveolar macrophages produce the highest level of 
TNF -a per cell. This observation supports the major role of alveolar macrophages in 
contributing to the immune -mediated damage observed in the CF lung. 
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Table 4.2 Levels of TNF -a produced per cell in response to B. cepacia C1359 
LPS. 
Cell type TNF -a (IU /mi x10-6) 
MNL 9.18 
Lung epithelial cell 0.03 
Alveolar macrophage 41.77 
Neutrophil 1.79 
Calculations were made from results using a ing/ml LPS sample. 
4.8 TNF -a INDUCTION FROM THP -1 CELLS 
The findings of the present study have shown the considerable difference in TNF -a 
induction between B. cepacia and P. aeruginosa, suggesting a potentially important 
role for immune -mediated damage in B. cepacia pathogenesis. However, one reason 
for the observed difference between the two species may be that B. cepacia and 
P. aeruginosa LPS signal through different pathways. If indeed this were the case 
then one pathway may be more or less efficient and hence produce more or less TNF - 
a. To test this theory a monocyte /macrophage cell line ThP -1 was used, which can be 
enhanced for the expression of CD14, the best characterised LPS receptor. It was 
postulated that if CD14 was required for B. cepacia or P. aeruginosa LPS signalling 
then levels of TNF -a should be increased when CD14 expression is enhanced, as has 
been observed for E. coli (Delahooke et al, 1995a). 
Dose response and time course 
Figure 4.20a and 4.20b show the dose response and time course for the ThP -1 cell 
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Figure 4.20a Dose response of ThP -1 cells in response to PW -LPS extracts. 
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Figure 4.20b Time course of TNF -a induction from ThP -1 cells by PW -LPS 
samples. LPS samples were used at a concentration of ing/ml. Results are the mean 
of duplicates. 
The levels of TNF -a induced from ThP -1 cells decreased in a dose -dependent manner 
as expected. TNF -a levels induced by LPS at a concentration of 1mg/m1 and 
0.01 mg/ml were calculable, but outwith the linear range of the TNF standard curve. 
Thus, as with the MNL, alveolar macrophages and neutrophil cells, an LPS 
concentration of 1 ng/ml was chosen as the optimum concenti ation to produce OD 
values corresponding to the linear section of the standard curve and providing the 
most accurate measurements of TNF -a. The time course experiment using ThP -1 
cells, shows a familiar trend which correlates with the response observed with the 
other monocytes and macrophage cells tested. Increasing TNF -a levels were 
detected in a broad time frame between approximately 2h and 7h, longer than 
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observed previously, before decreasing to negligible levels at 24h. For future 
experiments the supernate was collected at 4h in order to measure the maximum 
cytokine response. 
LPS signalling - The dependence on CD14 receptor expression 
Figure 4.21 shows TNF -a levels induced from ThP -1 cells both with and without 
enhancement for CD14 in response to PW -LPS extracts from B. cepacia, B. gladioli 
and P. aeruginosa. Results show that for some PW -LPS samples a non -significant 
increase in TNF -a levels is observed in response to enhanced CD14 expression. 
However, of more importance is the significant difference in TNF -a levels between 
B. cepacia and P. aeruginosa both with and without enhancement for CD14 
expression. Thus, the available evidence suggests that both B. cepacia and 
P. aeruginosa LPS signal through a CD14- independent pathway. Interestingly, using 
this cell line the variation between clinical and environmental strains of B. cepacia is 
not observed. Furthermore, B. gladioli gives a comparable reaction to the 
P. aeruginosa samples. 
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171 B. cepacia C1409 
EZI B. cepacia C1504 
B. cepacia ATCC17762 
B. cepacia J2540 
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Figure 4.21 TNF -a stimulation from ThP -1 cells with and without enhancement 
for CD14 in response to PW -LPS samples from B. cepacia, B. gladioli and 
P. aeruginosa. LPS samples were used at a concentration of lng/ml. Supernate was 
collected at 4h. Results are the mean of four readings. 
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To confirm the redundancy of the CD14 receptor in B. cepacia and P. aeruginosa 
LPS signalling, a further experiment was performed. A CD14 MAb was incubated 
with ThP -1 cells 30min prior to addition of the PW -LPS extracts. It was speculated 
that if B. cepacia or P. aeruginosa LPS operated through a CD 14- dependent pathway 
then the MAb would block LPS binding and TNF -a levels should fall. 
No significant decrease in TNF -a levels occurred on addition of an anti -CD 14 MAb. 
Some PW -LPS samples do show a fall in TNF -a induction levels, although in 
contrast, other samples show a rise in TNF -a, reiterating the redundancy of CD14 in 
B. cepacia and P. aeruginosa LPS signalling. Furthermore, there is no correlation 
between rising or falling TNF -a levels and the enhanced expression of CD14. 
IN B. cepacia C1359 
B. cepacia C1409 
B. cepacia J2540 
B. gladioli ATCC10248 
P. aeruginosa C1250 
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sn only sn +MAb 
with enhancement for CD14 
Figure 4.22 The influence of an anti -CD14 MAb on TNF -a induction from 
ThP -1 cells with and without enhancement for CD14. LPS samples were used at 
a concentration of 1 ng/ml. Supernate was collected at 4h. Results are the mean of 
duplicates. 
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4.9 THE INFLUENCE OF CO- STIMULATION BY B. CEPACIA AND 
P. AERUGINOSA LPS ON TNF -a INDUCTION. 
Evidence from the ThP -1 experiments suggests that both B. cepacia and 
P. aeruginosa initiate LPS signalling through a pathway independent of CD14. This 
poses the question that if both LPS types signal through the same pathway, what 
would happen when both LPSs are presented together, as is often the case in the CF 
lung? The following experiments were set up to try to answer this question and to 
investigate whether there was a synergistic or competitive effect on co- stimulation. 
B. cepacia C 1409 and P. aeruginosa C1250 were used to stimulate MNL both alone 
and together (Figure 4.23). In each case the MNL cell concentration remained the 
same as did the levels of B. cepacia LPS for the co- stimulations, the only variable was 
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Figure 4.23 TNF -a levels produced in response to co- stimulation with 
B. cepacia C1409 and P. aeruginosa C1250 PW -LPS together. The numbers 
indicate the ratio of B. cepacia to P. aeruginosa LPS. Supernate was collected at 
3.5h. Results are the mean of duplicates. 
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The results of the co- stimulation assay gave several interesting findings. Firstly, as 
expected, the levels of TNF -a induced in response to B. cepacia LPS alone were 
markedly higher compared to P. aeruginosa LPS alone. Secondly, when equal 
amounts of B. cepacia and P. aeruginosa LPS were added together the TNF -a levels 
decrease. Thirdly, as P. aeruginosa LPS becomes more in excess of B. cepacia, so 
the levels of TNF -a drop in a dose -dependent manner. These results are extremely 
important as it implies colonisation by B. cepacia alone may cause more immune - 
mediated damage than co- colonisation with both organisms. Fourthly, even when 
P. aeruginosa LPS is in a twenty -fold excess of B. cepacia LPS the levels of TNF -a 
are still greater than P. aeruginosa LPS alone. This latter finding re- emphasises the 
importance of B. cepacia as an opportunistic pathogen in its own right and highlights 
the major inflammatory potential of this organism in CF pathogenesis. Therefore, this 
study suggests that both organisms are competing for the same LPS receptors and 
surprisingly, that P. aeruginosa can modulate the inflammatory response of 
B. cepacia. 
In order to determine whether the inhibitory effect observed in Figure 4.23 in 
response to co- stimulation was observed with other B. cepacia and P. aeruginosa 
strains, the experiment was repeated with B. cepacia C1409 and P. aeruginosa 
PAO1, B. cepacia C1359 and P. aeruginosa PAO1 and B. cepacia C1359 and 
P. aeruginosa C1250. Results shown in Figure 4.24 confirm the trend observed 
previously, namely excess P. aeruginosa LPS in the presence of B. cepacia LPS, 
dampens the TNF -a response in a dose -dependent manner. 
169 




4 0 - 
E -1 
2 0 - 
1 : 2 1:4 






PA01 1:1 1:2 1:10 
C1359 C1250 1:1 1:2 1:10 
Figure 4.24 TNF -a levels produced in response to co- stimulation with 
B. cepacia and P. aeruginosa PW -LPS together. The numbers indicate the ratio of 
B. cepacia to P. aeruginosa LPS. Supernate was collected at 3.5h. Results shown 
are the mean of duplicates. (a) Co- stimulation with B. cepacia C1409 and 
P. aeruginosa PAO 1; (b) Co- stimulation with B. cepacia C 13 59 and P. aeruginosa 
PA01 and; (c) Co- stimulation with B. cepacia C1359 and P. aeruginosa C1250. 
P. aeruginosa LPS was in excess in each experiment. 
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The next stage was to determine whether the inhibitory effect could also be observed 
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Figure 4.25 TNF -a levels produced in response to co- stimulation with two 
B. cepacia PW -LPS samples or two P. aeruginosa PW -LPS samples. The 
numbers indicate the ratio of B. cepacia to P. aeruginosa LPS. Supernate was 
collected at 3.5h. Results shown are the mean of duplicates. (a) Co- stimulation with 
B. cepacia 0359 59 and 0409; (b) Co- stimulation with P. aeruginosa PAO 1 and 
C1250. C 1409 and C1250 were randomly chosen as the LPS samples to be in excess. 
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The results of co- stimulation by two B. cepacia strains or two P. aeruginosa strains 
differed from the results observed upon co- stimulation with both species together. As 
observed previously, TNF -a levels drop when equal amounts of the two LPS samples 
were added together. The biological activity of LPS is thought to be dependent on its 
solubility, hence, it was speculated that the observed decrease in TNF -a levels may be 
due to LPS forming a micellar structure, less active in the bioassay. However 
although this theory cannot be discounted, it seems unlikely as the assays using an 
excess of LPS, that is co- stimulation in a 1:2 or 1:10 ratio, showed an equal or greater 
level of TNF -a compared to the LPS sample alone. Thus, the TNF -a reduction 
observed when both B. cepacia and P. aeruginosa LPS were added together must 
reflect competitive inhibition for LPS receptors. 
4.10 THE MITOGENIC POTENTIAL OF B. CEPACIA AND P. AERUGINOSA 
LPS. 
LPS is well -known as a potent mitogen, interacting with T- or B- lymphocytes to 
initiate proliferation and stimulate cell- mediated immunity. To determine the 
mitogenic potential of B. cepacia LPS, samples from B. cepacia C1359 were used to 
stimulate lymphocytes from both spleen and lymph nodes and the DNA proliferation 
compared to P. aeruginosa C1250 LPS samples (Figure 4.26). 
B. cepacia LPS has a greater proliferative effect on lymphocytes compared to 
P. aeruginosa LPS, emphasised particularly with the spleen cell suspension. PHA is a 
known mitogen and produced count levels similar to the P. aeruginosa sample and 
also the B. cepacia sample acting on the lymph node suspension. Both organisms 
produced greater levels than the control as expected. The difference in count results 
between the spleen and lymph node samples may be due to the greater number of 
lymphocytes obtained from the spleen suspension. These results indicate that 
B. cepacia may stimulate a greater cell- mediated response than P. aeruginosa. 
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However, further work is required to investigate if the proliferative response was 
mainly T -or B- lymphocyte- dependent, as that finding would have implications for 
antibody production. 
spleen 
!: lymph nodes 
Bc C1359 Pa C1250 control 
sample 
PHA 
Figure 4.26 The mitogenic potential of B. cepacia and P. aeruginosa PW -LPS 
samples on lymphocytes from spleen and lymph nodes. PW -LPS samples were 
used at a concentration of 25p.g/ml, results are the mean of triplicates. 
control = no stimulant; PHA = phytohaemagglutanin 
4.11 THE BIOLOGICAL ACTIVITY OF OM SAMPLES 
The next section assessed the biological activity of B. cepacia, B. gladioli and 
P. aeruginosa OM samples, as in the host LPS would be unlikely to be found pure but 
rather complexed to protein or other components of the bacterial cell surface. Thus, 
these experiments aimed to determine the influence of the outer membrane on LPS 
endotoxicity and inflammatory potential. 
4.11.1 THE ENDOTOXICITY OF OM SAMPLES 
To confirm the presence of LPS in the OM samples, the OM preparations were tested 
in the LAL assay (Figure 4.27). 
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B. cepacia B. gladioli P. aeruginosa 
Figure 4.27 The endotoxic activity of B. cepacia, B. gladioli and P. aeruginosa 
OM samples as measured by the LAL assay. OM samples were used at a protein 
concentration of 1 ng/ml. Results are the mean of four readings. 
All three OM samples tested produced a detectable endotoxic response. The 
B. gladioli OM sample exhibited the greatest endotoxicity followed by B. cepacia 
C1359 and P. aeruginosa C1250, similar to the observation made with the PW -LPS 
samples (Figure 4.2). 
4.11.2 THE INFLAMMATORY POTENTIAL OF OM SAMPLES. 
The OM samples were tested in the TNF -a assay to determine their inflammatory 
potential. OM preparations of B. cepacia, B. gladioli and P. aeruginosa were diluted 
in pyrogen -free water to provide a protein concentration range from 1.61.ig/ml- 
0.16pg/ml and were used to induce TNF -a from MNL cells (Figure 4.28). 
Surprisingly, the TNF -a levels did not follow a dose -dependent response. The most 
concentrated OM sample at 1.614/ml, produced lower levels of TNF -a compared to 
less concentrated OM preparations. However, this may be partly explained by the 
high viscosity of the OM samples at this concentration, particularly those of 
B. gladioli and P. aeruginosa. Thus, the optimal OM protein concentration to obtain 
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optical densities corresponding to the linear part of the standard curve was 16ng/ml. 
Supernates were collected at 3.5h, the same as for the PW -LPS samples. 
B. cepacia C1359 
-A- B. cepacia C1409 
0 B. cepacia ATCC17762 
- B. gladioli ATCC10248 
° P. aeruginosa C1250 
Figure 4.28 Dose response of OM samples from MNL cells. The OM 
concentration corresponds to the concentration of protein present in the sample. 
Supernate was collected at 3.5h. Results are the mean of duplicates. 
Figure 4.29 shows the TNF -a levels produced from MNL in response to OM samples 
prepared from the same eight bacterial strains used to obtain the PW -LPS samples. 
The trend in TNF -a induction observed in response to the OM samples was different 
from the response observed by the PW -LPS samples. There were two major 
variations. Firstly, although all the B. cepacia OM samples induced more TNF -a than 
the P. aeruginosa preparations, there was no significant difference between the two 
bacterial populations. Thus, it may be concluded that for the outer membrane there is 
a comparable TNF -a response between B. cepacia and P. aeruginosa. Secondly, the 
OM sample inducing the greatest response was J2540, the environmental strain. 
Using PW -LPS samples, this strain induced less TNF -a compared to the clinical 
isolates. This finding suggests that all B. cepacia strains regardless of origin exhibit a 
degree of inflammatory potential. However, it is unclear whether these variations 
between LPS and OM results are due to protein present in the OM samples, the 
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influence of the outer membrane on the presentation of LPS or whether the varying 
levels of LPS within the OM samples are solely responsible. 
Figure 4.29 TNF -a levels produced from MNL in response to B. cepacia, 
B. gladioli and P. aeruginosa OM samples. OM samples were used at a protein 
concentration of 16ng/ml. Supernate was collected at 3.5h. Results are the mean of 
duplicates. 
The influence of growth environment on TNF -a induction by OM samples 
OM preparations from B. cepacia C 1409 grown in NB +YE, MA and MA +S were 
used to assess the influence of growth environment on the stimulation of TNF -a. As 
seen in Figure 4.30, growth environment affects the induction of TNF -a in response 
to stimulation by OM extracts. The OM preparation extracted from NB +YE 
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produced the greatest amount of TNF -a followed by MA +S and finally MA. 
Although these results are from only one strain they do correspond to the trend 
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Figure 4.30 TNF -a levels produced from MNL in response C1409 
OM samples extracted from different growth environments. OM samples were 
used at a protein concentration of 16ng/ml. Supernate was collected at 3.5h. Results 
shown are the mean of duplicates. 
4.12 THE BIOLOGICAL ACTIVITY OF EPS SAMPLES 
Previous reports investigating the inflammatory potential of EPS found a high 
biological activity for alginate (Ottlerlei et al, 1993). Therefore, although the LPS 
from the mucoid P. aeruginosa strain C1250 has been shown to be of low activity, it 
was thought prudent to investigate the inflammatory potential of its EPS, as this may 
partly account for the discrepancy observed between the two species. 
Alginate samples at 1 ng/ml dry weight were initially tested in the LAL assay for the 
presence of LPS. No endotoxicity was detected and indeed the onset time for the 
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start of the LAL reaction was beyond the standard range, confirming both the absence 
of LPS and the purity of the alginate sample. Alginate samples were also used to 
stimulate TNF -a from a variety of cells (Table 4.3). 
Table 4.3 TNF -a levels produced from a variety of cell types in response to 
alginate and PW -LPS samples. 
Sample TNF -a (IU /ml) produced by 
MNL 
alveolar 
epithelial cells macrophages neutrophils 
alginate 1.65a 1.621 3.07 1.96 
PW -LPS (Pa)b 1.18 2.34 1.81 6.82 
PW -LPS (Bey 49.04 9.02 41.77 10.27 
samples were used at ing/ml dry weight of sample. 
a = Results are the mean of duplicates. 
b = Both the alginate and the P. aeruginosa PW -LPS sample were from strain C1250 
c = The PW -LPS B. cepacia sample was from strain C1359. 
As shown in table 4.3, alginate produced a detectable TNF -a response but only at 
levels comparable to the PW -LPS extracts. Indeed, even if both the alginate and 
P. aeruginosa PW -LPS response were taken together, the levels of TNF -a induced 
would still be below the levels observed for B. cepacia. Thus, the presence of 
alginate does not appear to increase substantially the biological activity of the 
P. aeruginosa strain tested in this study. 
4.13 IL-8 INDUCTION BY PW -LPS SAMPLES 
Interleukin -8 (IL -8) levels are substantially increased in CF patients and thought to be 
largely responsible for the observed neutrophil influx. Assays were performed to 
determine the induction of IL -8 by PW -LPS samples. The stimulation was performed 
by myself although the assay to measure IL -8 concentration was performed by J. 
McColm, Department of Child Life and Health, Edinburgh. 
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Using the PW -LPS samples from B. cepacia C1359 and P. aeruginosa C1250 at the 
same concentration used for the TNF -a assays, I ng/rril, a time course was initially 
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Figure 4.31 Time course of IL-8 induction from MNL in response to PW -LPS 
preparations. LPS samples were used at a concentration of ing/ml. Results are the 
mean of duplicates. 
A broad peak of IL -8 production was observed between approximately 3h -7h, longer 
lasting than for the TNF -a response. Although any sampling would be satisfactory in 
that broad time frame an optimal sampling time of 5h was chosen for future 
experiments. 
Induction of IL -8 from MNL in response to PW -LPS samples 
Figure 4.32 shows IL -8 stimulation from MNL in response to PW -LPS preparations 
of B. cepacia, B. gladioli and P. aeruginosa. Similar to the findings of the TNF -a 
assays, B. cepacia strains induce more IL -8 compared to the P. aeruginosa strains. If 
B. cepacia and P. aeruginosa are treated as two distinct populations, there is a 
significant difference in IL -8 levels (P< 0.05). However, the statistical analysis must 
be treated with some caution due to the smaller number of IL -8 assays performed 
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Further experiments examining IL -8 production from more PW -LPS samples would 
be required before any satisfactory conclusion could be reached. 
Figure 4.32 IL-8 levels produced from MNL in response to B. cepacia, 
B. gladioli and P. aeruginosa PW -LPS extracts. LPS samples were used at a 
concentration of 1 ng/ml. Supernate was collected at 5h. Results shown are the mean 
of duplicates. The levels of IL -8 induced by B. cepacia was significantly different 
from P. aeruginosa (P <0.05) which is highlighted by the ** symbol 
The influence of rowth environment on IL -8 roduction 
PW -LPS samples of B. cepacia C1359 and C1409 extracted from growth in NB +YE, 
MA and MA +S, were used to investigate the influence of growth environment on 
IL -8 production (Figure 4.33). 
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For B. cepacia C1359 the influence of culture condition on IL -8 production follows 
the same pattern as for TNF -a, namely NB +YE produces most IL -8, followed by 
MA +S then MA. However, as there was no variation in IL -8 production with PW- 
LPS samples from strain C1409, more strains and samples would have to be tested 
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Figure 4.33 The influence of growth environment on IL-8 induction from MNL 
in response to PW -LPS samples. LPS samples were used at a concentration of 
lng/ml. Supernate was collected at 5h. Each value represents the mean of duplicates. 
IL -8 induction from alveolar macrophages 
IL -8 induction from alveolar macrophages in response to PW -LPS samples is shown 
in Figure 4.34. The B. cepacia samples again induced a greater response compared to 
the P. aeruginosa samples. In addition, less variation between B. cepacia isolates 
was noted compared to the IL -8 -MNL assay (Figure 4.32). However, due to the 
scarcity of the alveolar macrophage extracts, this assay was only able to be performed 










Figure 4.34 IL-8 levels produced from alveolar macrophages in response to PW- 
LPS samples. LPS samples were used at a concentration of ing/ml. Supernate was 
collected at 5h. Results shown are the mean of duplicates. 
4.14 IL-8 INDUCTION FROM OM SAMPLES 
Five OM samples from B. cepacia C1359, C1409, ATCC 17762, B. gladioli ATCC 
10248 and P. aeruginosa PAO1 were tested for IL -8 production from MNL cells 
(Figure 4.35). IL -8 production in response to the OM samples varied from the 
response to the PW -LPS samples. For the OM preparations, it is concluded that only 






Figure 4.35 IL-8 levels produced from MNL in response to OM samples. OM 
samples were used at a protein concentration of 16ng/ml. Supernate was collected at 
5h. Results shown are the mean of duplicates. 
4.15 IL-8 INDUCTION BY EPS SAMPLES 
Alginate samples were tested for their capacity to stimulate IL -8 from both MNL and 
alveolar macrophages. 
Alginate samples induced comparable levels of IL -8 to the PW -LPS extract of the 
homologous strain C1250, and in addition, the levels of IL -8 produced were only 
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Figure 4.36 IL-8 levels produced from MNL and alveolar macrophages in 
response to alginate and PW -LPS samples. Alginate samples and LPS samples 
were used at a concentration of ing/ml. Supernate was collected at 5h. Results 
shown are the mean of duplicates. 
Overall, the results of the present study highlight the significant inflammatory capacity 
of B. cepacia, confirming the pathogenic potential of this species and challenging the 
hypothesis that B. cepacia acts merely as a marker of existing lung disease. A 
significant difference in TNF -a levels between B. cepacia and P. aeruginosa PW -LPS 
samples was observed from MNL, alveolar macrophages and lung epithelial cells. 
Most importantly, however, LPS co- stimulation experiments demonstrated that 
P. aeruginosa can modulate the inflammatory response of B. cepacia. It seems 
reasonable to conclude that immune- mediated damage is an important factor in 





Burkholderia (formerly Pseudomonas) cepacia was first described in 1950 as a 
causative agent of bacterial rot in onion bulbs, but has in the last decade, emerged as a 
serious human pathogen, most notably in patients with cystic fibrosis (CF), the most 
common, fatal inherited disease affecting Caucasian populations. The clinical impact 
of B. cepacia is based on its inherent multiresistance to antibiotics, direct 
transmissibility between CF patients and the occurrence of 'cepacia syndrome', a 
rapidly fatal necrotising pneumonia, observed in 20% of colonised patients and rarely 
associated with other CF pathogens. These three factors have had devastating 
consequences for the CF population leading, ultimately, to the introduction of a 
world -wide segregation policy separating B. cepacia colonised from non -colonised 
CF patients in an attempt to reduce cross -infection. 
The impact of B. cepacia on the CF community, and the recent reports of serious 
community- acquired B. cepacia infection in non -CF patients (Hobson et al, 1995), 
has prompted urgent clarification on the pathogenic potential of this organism. 
Considerable progress has been made in elucidating the transmission and 
epidemiology of B. cepacia (Goldstein et al, 1995; Govan et al, 1993); in contrast 
virulence determinants and pathogenic mechanisms remain poorly understood. Part of 
this problem is highlighted by suggestions that B. cepacia isolates vary considerably in 
virulence; some strains are highly virulent whilst others are essentially avirulent 
(Gilligan, 1991). This leads to the question of whether the highly- transmissible 
'epidemic' strains, or indeed CF isolates as a whole, represent a distinct, virulent 
subpopulation of B. cepacia; a question which requires resolving for two important 
reasons. Firstly, the health hazards associated with the release of B. cepacia into the 
environment as a biocontrol agent or soil decontaminant must be addressed; is there a 
group of B. cepacia strains which are 'safe' to use? Secondly, and more importantly, 
there are calls for the abolition of the controversial segregation policy in areas where a 
B. cepacia problem has not yet arisen. However, before any relaxation of the 
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segregation policy is introduced, it is essential that the virulence factors of B. cepacia 
are identified so that virulent strains can be distinguished from avirulent isolates. 
Therefore, the aims of this thesis were to identify putative virulence factors, identify 
possible pathogenic mechanisms in vivo and to distinguish any variation in virulence 
between B. cepacia isolates from a variety of sources. 
5.1 ENVIRONMENTAL MODULATION OF CELL SURFACE VIRULENCE 
DETERMINANTS OF B. CEPACIA 
Progress into the understanding of B. cepacia pathogenesis has been hampered by the 
finding that this organism produces few recognised virulence factors such as exotoxin 
A or alginate; associated with P. aeruginosa infection in CF (McKevitt & Woods, 
1984). The surface components of Gram- negative bacteria are well -established as 
classic virulence factors. Furthermore, these surface structures can be heavily 
influenced by environmental conditions. Indeed, in many cases of infection, growth 
environment induces the expression of a more virulent form of cell surface structure, 
for example the production of alginate in the CF lung (section 1.2). Thus, the first 
section of this study characterised the expression and antigenicity of cell surface 
factors from a variety of B. cepacia strains. The influence of the environment on 
these components, and on growth and survival mechanisms, was also investigated. 
Growth and survival 
Preliminary studies investigated changes in growth and colonial morphology in several 
different nutrient -limiting media, mimicking conditions thought to be encountered in 
situ or previously reported to induce cell surface alterations. No obvious change in 
morphology was observed on any of the media, although certain culture conditions, 
for example phosphate- limiting medium, did restrict growth. 
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In addition, low pH minimal medium was found to be highly inhibitory to all 
B. cepacia strains tested, with growth decreasing in a pH- dependent manner. This 
observation is in contrast to a previous report in which one B. cepacia strain grew 
well at pH 4.5 and 7 but was inhibited at pH 9.5 (Dejsirilert et al, 1991). 
Interestingly, however, in the study of Dejsirilert et al, the complex media used (heart 
infusion broth), was rapidly metabolised to produce an alkaline pH, regardless of 
initial pH level; indeed, the media supporting the best growth of B. cepacia in this 
study, the commercially prepared laboratory medium CEP, although initially prepared 
to pH 6.2, was also rapidly metabolised to produce an alkaline pH. Therefore, the 
discrepancy between these two studies is likely to be due to the different metabolic 
by- products and buffering capacity of the various media rather than a true pH 
response. Taken together, however, the results from the two studies show that 
growth of B. cepacia can be restricted in an environment maintained at a low or high 
pH. 
It must be stressed, however, that in this study, all the B. cepacia strains grew to 
some extent at low pH levels, with the exception of the epidemic strain. This 
observation is slightly surprising, as previous studies have opted to use a low growth 
pH in selective media for B. cepacia environmental isolates ( Hagedorn et al, 1987). 
In contrast, media used to isolate clinical B. cepacia strains is generally prepared 
around pH 6.7 (Wu & Thompson, 1984; Gilligan et al, 1985; Welch et al, 1987), 
implying that clinical and environmental isolates vary in their pH tolerance. In the 
present study however, no difference in pH tolerance was observed between clinical 
and environmental isolates. 
It was initially speculated that the ability to grow at a low pH would be an important 
property of B. cepacia, not only because onions, a natural host, are highly acidic 
(Geigy, 1962) but also because phagocytes kill ingested bacteria in an acidic 
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phagolysosome (Janeway & Travers, 1994). Indeed, the prevalence of B. cepacia in 
patients with CGD and the theory that B. cepacia may survive intracellularly in CF 
patients would suggest that B. cepacia must tolerate low pH conditions. However, 
many Gram -negative organisms, including P. aeruginosa, are killed in phagocytic 
cells by cationic proteins, active during a transient increase in pH before acidification 
of the phagolysosome (Roitt et al, 1989). Thus, to survive inside phagocytes an 
organism must be able to tolerate both high and low pH conditions. 
Oxygen tension is an important environmental factor, as any bacterium growing as 
part of a colony, or close to a surface, will experience a gradual decrease in oxygen 
levels as the bacterial colony becomes larger or the organism is surrounded by debris. 
Indeed, alginate biosynthesis in P. aeruginosa has been reported to be dependent on 
oxygen levels (Leitáo & Sá- Correia, 1993). The ability of B. cepacia to exist in soil 
depths where oxygen tension is low would suggest that tolerance of low oxygen levels 
may play a role in survival and virulence. In this project, both B. cepacia strains 
tested grew in conditions of reduced oxygen levels, but, neither strain grew (to an 
observable level) under anaerobic conditions. Interestingly, however, both strains 
survived, at least four weeks in the oxygen -free atmosphere, despite the fact that 
B. cepacia does not possess the metabolic machinery required for anaerobic growth 
(Zannoni, 1989). This implies that B. cepacia has the ability for dormancy, an 
important biological property which could contribute to the success of an 
opportunistic pathogen; allowing an organism to remain viable in otherwise lethal 
situations. For example, to survive intracellularly a pathogen must be able to tolerate 
low oxygen levels. Indeed, in anaerobic conditions, Shigella species increase their 
invasiveness (Kanai & Kondo, 1994). Thus, the ability of B. cepacia to survive in 
conditions of low and high pH, nutrient limitation and oxygen -free conditions lends 
further credence to the proposal that intracellular survival may be a factor in 
B. cepacia pathogenesis. 
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Of all the B. cepacia strains tested in this study, the epidemic strain was the slowest 
growing and the most susceptible to adverse conditions, as has been observed by 
laboratory colleagues (Butler, 1994). However, as the anaerobic studies demonstrate 
this observation may only be a reflection of growth and not an indicator of survival. 
Cell surface factors - Lipopolysaccharide 
Lipopolysaccharide is widely regarded as the most potent of all bacterial cell surface 
factors, with a diverse range of biological properties important in the infection process 
(section 1.1). Characterisation of the LPS from several B. cepacia strains, originating 
from different sources and clonally distinct (based on observations made by PFGE, 
C. Doherty personal communication), confirmed previous reports that B. cepacia 
strains may possess rough or smooth LPS (McKevitt & Woods, 1984; Simpson et al, 
1994). Surprisingly, however, two of the strains previously reported to possess 
R -LPS exhibited reactive high molecular weight bands on immunoblot analysis. A 
distinct ladder pattern was observed using serum raised against a smooth LPS CF 
isolate. The reason why these reactive bands are only observed with immunoblotting 
is not understood. However, the positive reaction of the high molecular weight 
structures suggests that these components are expressed in vivo, and leads to 
speculation on the morphological heterogeneity of B. cepacia; a single strain varying 
in amount and structure of LPS. 
Results from the immunoblots revealed a lack of homology between LPS of different 
B. cepacia strains and other species including B. gladioli and P. aeruginosa. Serum 
raised against the epidemic strain reacted only with the core LPS of the homologous 
strain and a high molecular weight band of two other isolates. Conversely, serum 
raised against a S -LPS non -epidemic B. cepacia strain reacted very strongly against 
the homologous strain and with B. gladioli, and to a lesser degree with three other 
B. cepacia strains. A similar response was obtained using sera from CF patients. No 
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cross reaction with any of the P. aeruginosa isolates was observed, confirming the 
difference between these two species. The findings of the present study agree with 
previous reports (Nelson et al, 1993; Burnie et al, 1995), showing both LPS 
heterogeneity between B. cepacia isolates and the specificity of LPS antigens. LPS 
preparations were also extracted from different growth media and examined by SDS- 
PAGE and immunoblotting but no major variation in LPS structure was observed. 
The results of the LPS studies emphasise the distinct nature of the epidemic strain, not 
only by the lack of cross -reactivity to other B. cepacia isolates but also because it is 
the only B. cepacia strain consistently expressing R -LPS. Indeed, R -LPS has even 
been considered as one of the physiological markers in distinguishing these highly - 
transmissible strains (Simpson et al, 1994). 
Using different LPS extraction methods, however, it was shown that the epidemic 
strain may not always possess R -LPS. Two very important results were noted. 
Firstly, LPS extracted by the PCP method, produced a highly hydrophobic compound, 
which was not revealed by silver -staining but showed five high molecular weight 
bands on immunoblotting. The positive antigenic reaction suggests these bands are 
expressed in vivo although the role of the corresponding structure in pathogenesis can 
only be speculated. The irregularity of the band spacing implies the structure may not 
be smooth -type LPS but another amphipathic molecule, perhaps similar to the 
enterobacterial common antigen, or protein, which may account for the lack of 
reaction on silver -staining. Further work is required to determine whether the 
structure and function of these high molecular weight bands are similar to the bands 
cross -reactive with the epidemic strain serum as discussed previously. 
Secondly, the extreme hydrophobic nature of the PCP extract led to investigations of 
the phenol hydrophobic phase of a PW -LPS preparation. Very little LPS sample was 
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obtained in the phenol layer, compared to the normally used aqueous layer and no 
observation of the phenol sample was made by silver -staining. However, again, a 
large high molecular weight moiety reacted upon immunoblotting with a similar result 
obtained using another B. cepacia strain. 
It is well -established that different extraction procedures select for LPS of different 
structures and composition. However, the PW method usually selects for high 
molecular weight material, whilst the PCP selects for low molecular weight material; 
the opposite of the results found for the epidemic strain. Furthermore, the fact that 
the LPS from the epidemic strain can vary depending on the extraction procedure 
casts doubt on the possession of R -LPS by the epidemic strain in vivo and emphasises 
the importance of extraction procedures in studying bacterial components. 
A mystery therefore exists about the nature of the LPS of the epidemic strain, with 
several questions remaining unanswered; for example what LPS structure is expressed 
in vivo R -LPS, S -LPS or a mixture of both? Furthermore, if the LPS of the epidemic 
strain is indeed rough and highly hydrophobic why does the majority dissolve into the 
aqueous layer of a PW preparation? To answer these questions experiments were 
carried out to determine the cell surface hydrophobicity of whole cells. High 
hydrophobicity may play an important role in B. cepacia pathogenesis as it would 
allow bacteria to bind more efficiently to cells. This property may also render the 
bacteria more susceptible to phagocytic uptake, although this could be construed as 
an advantage for intracellular growth. Unfortunately, the epidemic strain did not 
show any major difference in cell surface hydrophobicity compared to other 
B. cepacia isolates. Interestingly, however, the hydrophobicity of the epidemic strain 
increased to approximately 70% when grown in minimal media supplemented with 
50% serum, far greater than any other strain or growth condition. Although no 
difference in LPS structure was seen with this growth condition, further extraction 
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procedures from serum supplemented media may elucidate the nature of the LPS of 
the epidemic strain. 
The distinctive nature of the epidemic strain is further highlighted by the observations 
made by rocket immunoelectrophoresis (RIE). Initially, RIE was performed as an 
additional method to investigate the antigenicity of cell surface factors. Although all 
the samples and sera used were the same as in the immunoblot experiments, only one 
positive reaction was ever observed; between the PW -LPS sample from C1359 
(epidemic) and serum from a CF patient colonised by this strain. No other sera or 
LPS sample gave a positive response. The discrepancies between the RIE and 
immunoblot assays can only be explained by an intrinsic difference in the two 
techniques (Shand et al, 1988). The results do however suggest that the epidemic 
strain is far more immunogenic than any other B. cepacia strain studied in this project. 
OM samples showed a different response; a streak was observed rather than a 
precipitin arc. Whether this streak is a true antigen- antibody reaction or an artifact 
produced by salt precipitation, moving by force of the electric current, is not clear. 
Chemical analysis was also performed on LPS samples from different strains, growth 
conditions and extraction procedures. The only major difference observed between 
the strains was the levels of Kdo in B. cepacia and P. aeruginosa LPS, with the latter 
species possessing over five fold more Kdo. Straus et al (1989) found a correlation 
between lethality in a mouse model and the presence of Kdo in an extracellular toxic 
complex of B. cepacia isolates. However, the toxicity observed in that study is more 
likely to be attributed to the overall composition of the complex rather than the 
presence of Kdo alone. The average Kdo content of the B. cepacia extracts used in 
the present study is 0.4% which agrees with other reports (Cox & Wilkinson, 1991). 
This level of Kdo is generally considered to be low and may account for the previous 
debate on the apparent absence of this compound. However, it is now known that 
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B. cepacia also possesses D- glycero- a- D- talo -2- octulosonic acid (Ko), an unusual 
hydroxylated form of Kdo. Ko is also found in the LPS of B. pseudomallei, and some 
Legionella species (Wilkinson & Pitt, 1995), both intracellular bacteria, which adds 
further support to the hypothesis that B. cepacia strains are able to invade cells and 
survive intracellularly as part of their pathogenic strategy. 
Cell surface factors - Outer membrane 
All the B. cepacia strains studied possessed a distinct OM profile, highlighting the 
heterogeneity between isolates. Immunoblot analysis however, revealed that OMs 
from all the B. cepacia strains tested, regardless of origin, cross -reacted, suggesting 
that although the outer membrane profiles from different strains appear distinct, the 
strains express common epitopes in vivo. 
P. aeruginosa and B. cepacia OMs also cross -reacted, albeit to varying degrees 
depending on the sera used. Previous studies have concluded that some B. cepacia 
OM components may be antigenically related to P. aeruginosa (Aronoff, 1988; 
Nelson et al, 1993). In contrast, a recent report (Lacy et al, 1995) found that despite 
extensive preabsorption with P. aeruginosa whole cells, the IgG antibody response 
against the OMs of B. cepacia was not reduced, implying that the OM antigens were 
B. cepacia- specific and not cross -reactive with P. aeruginosa. In the present study, 
the cross -reactivity between B. cepacia and P. aeruginosa depended largely on the 
serum used. Rabbit sera raised against whole cells of three different B. cepacia 
strains showed no response against a P. aeruginosa OM sample. In contrast, sera 
from CF patients colonised with B. cepacia but not P. aeruginosa exhibited a positive 
reaction against the P. aeruginosa sample. In all of the previous reports only sera 
from a CF patient was used. 
The rabbit sera used came from animals kept in relatively sterile conditions with a low 
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risk of exposure to bacteria; in contrast, CF patients stand a high risk of exposure to 
the ubiquitous P. aeruginosa. Thus, the results of the immunoblots using rabbit sera 
suggest that anti -B. cepacia OM antibodies recognise distinct epitopes and do not 
cross -react with P. aeruginosa OMs. Therefore, the immunoblot reactions using sera 
from P. aeruginosa negative CF patients suggest prior exposure to P. aeruginosa, 
rather than a true cross reaction between B. cepacia and P. aeruginosa OM antigens. 
However, the rabbit sera used was raised against heat -killed whole cells and the cross 
reactive OM antigens may simply have been denatured or masked by other cell 
components, thereby preventing the production of antibodies against these epitopes. 
Variation in OM profile within a single strain was observed when isolates were grown 
in different conditions. Growth in the nutrient -rich media produced fewer proteins 
compared to conditions of environmental stress. This observation may correlate with 
nutrient requirements, as bacteria growing in nutrient -depleted environments would 
possess larger, more numerous porins to allow entry of sufficient nutrient supplies. 
Proteins induced in the nutritionally depleted environments may be important in the 
transfer of these limited nutrients across the cell membrane although, surprisingly, no 
growth condition induced specifically the same protein in both B. cepacia strains 
tested. Variation in OM profile either between growth environments or between 
strains may be correlated not only to nutrient requirements but also to survival, 
including increased resistance to antimicrobial agents (Parr et al, 1987) and serum 
killing (Butler et al, 1995). Indeed, resistance to ß- lactams, tetracycline, quinolones 
and chloramphenicol have all been related to a decrease in porin number or porin size 
(Burns, 1995; Aronoff, 1988; Moore & Hancock, 1986; Burns et al, 1989). 
Immunoblot analysis of the OM samples from different growth conditions revealed 
some changes in antigenicity, although a number of proteins were conserved both 
between strains and between growth conditions. It is interesting to note that one of 
194 
these conserved epitopes, a major protein of approximately 30kD, described 
previously as the porin D antigen of B. cepacia, has recently been suggested as a 
potential immunotherapeutic agent (Burnie et al, 1995). However, Aronoff et al 
(1991), showed that anti -porin D antibody did not protect CF patients against 
B. cepacia colonisation. Therefore, the prospective use of this therapy would be 
limited. 
The B. cepacia strains tested in this study possessed varied OM profiles that could be 
influenced by growth condition. The function of many of these proteins, and their 
potential role in B. cepacia pathogenesis remains to be defined. 
Cell surface factors - Exopolysaccharide 
In the present study, the relative absence of EPS production by B. cepacia, as 
compared to a mucoid P. aeruginosa control, was confirmed by Percoll profiles of 
washed whole cells from a number of isolates. Only two of the B. cepacia strains 
tested, one clinical and one environmental isolate, exhibited a profile consistent with 
moderate EPS production. More importantly, the epidemic strain was unique in 
possessing a Percoll profile characteristic of no exopolysaccharide production. This 
observed absence or low level EPS production from a number of B. cepacia strains 
would suggest that, in contrast to P. aeruginosa infection, EPS does not play a major 
role in B. cepacia pathogeneis. Indeed, Sage et al (1990) found no correlation 
between production of EPS by B. cepacia and the ability to colonise the respiratory 
tract. However, B. cepacia strains used in the study of Sage et al, and in more recent 
investigations (Allison & Goldsborough, 1994), have been found to produce copious 
amounts of EPS in the presence of high osmolarity and excess glucose. Further 
experiments to study the influence of such growth parameters on EPS production 
induced alterations in Percoll profiles for three of the strains tested, although the 
majority of isolates did not vary. Thus, for the B. cepacia strains tested in this study, 
EPS does not appear to be a major virulence factor in pathogenesis. 
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The studies in this section examined the cell surface components of representative 
B. cepacia strains, not only to investigate the expression of such components per se 
but also to characterise the extracts which were to be used in the future studies of 
inflammatory potential, detailed in the next section. Intra- and inter -species OM cross 
reaction was observed, depending on the source of sera used. As expected, OM 
profiles were adaptable to changing environmental conditions. LPS samples, in 
general, were more heterogeneous. Of importance was the loss of the characteristic 
R -LPS phenotype of the epidemic strain when different LPS extraction methods were 
employed. This finding leads to new speculation on virulence factor expression in 
vivo and the loss of important cell surface factors when grown in vitro. For example 
can the epidemic strain produce both smooth and rough LPS? Although no S- to 
R -LPS transition has been observed in this present study, previous reports have 
suggested this mechanism on the basis of experimental findings (Lacy et al, 1995). 
The adaptation of the outer membrane to changing surroundings is an important 
intrinsic survival mechanism. In addition, this study has shown the ability of 
B. cepacia to survive in adverse conditions such as low pH, high pH, oxygen 
limitation and nutrient limitation which is an important property for the success of an 
opportunistic pathogen. No major virulence determinant was specifically induced, 
although the OM and LPS samples were shown to be adaptable and both surface 
components have been reported as important factors in bacterial infection. Thus the 
role of the OM and LPS in B. cepacia pathogenesis was investigated further in the 
next section. 
5.2 BIOLOGICAL ACTIVITY OF CELL SURFACE COMPONENTS OF 
B. CEPACIA 
CF patients colonised by exactly the same strain of B. cepacia, as distinguished by 
genetic typing methods, present variable clinical outcomes. This observation, plus the 
knowledge that B. cepacia produces few possible virulence determinants, leads to the 
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suggestion that the host, and in particular the immune response, plays the major role 
in B. cepacia pathogenesis. Unfortunately, studies have shown anti -B. cepacia 
antibodies to be neither protective nor prognostic for CF patients (Nelson et al, 1993; 
Butler, 1994). 
Cytokine production is an essential component of the host defence system, required 
for development and maintenance of the immune response. However, excess cytokine 
production is now widely accepted as a primary cause of several diseases (section 
1.3). Furthermore, previous reports have found a correlation between increasing 
cytokine levels and pulmonary deterioration in CF patients. Wilson et al, (1993) 
reported a strong association between increasing plasma and mRNA levels of TNF -a 
and IL -1ß and pulmonary and nutritional decline in P. aeruginosa- colonised CF 
patients. Similarly, Greally et al (1993) and Norman et al (1989) suggested that the 
observed cytokine response to P. aeruginosa infection in CF patients was contributing 
significantly to the airway inflammation and airflow obstruction associated with acute 
lung injury. 
To date, no specific study on cytokine induction by B. cepacia has been performed. 
Thus, the induction of two major proinflammatory cytokines were studied and their 
potential role in B. cepacia pathogenesis in the CF lung assessed. TNF -a is one of 
the first cytokines produced during infection and is a key factor in inducing the 
cytokine cascade observed during inflammation. IL -8 is a chemotactic cytokine 
responsible for attracting neutrophils to the site of infection, a major characteristic of 
CF lung disease. Both cytokines play an important role in the immune- mediated 
damage observed in CF patients. The next section therefore focused on the 
inflammatory capacity of B. cepacia cell surface factors compared to the activity of 
B. gladioli and P. aeruginosa controls. 
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Endotoxicity 
LPS, or endotoxin, has long been recognised as possessing many biological properties 
harmful to a host and remains one of the most potent inducers of cytokines. One of 
the methods to determine the toxic potential of LPS is the LAL assay, often used to 
detect LPS in products such as blood, saline and dialysate materials. Initial 
investigations determined the endotoxicity of LPS samples from a variety of strains 
and growth conditions. Surprisingly, and very unexpectedly, LPS samples from 
B. cepacia were found to possess significantly higher endotoxic potential compared to 
P. aeruginosa LPS. Furthermore, growth condition influenced the endotoxicity of the 
samples, implying that although no structural changes could be observed by SDS- 
PAGE or immunoblotting, the LPS composition is somehow varied and virulence 
altered correspondingly. 
Induction of TNF -a by LPS 
Initial experiments determined the capacity of several PW -LPS samples to induce 
TNF -a from human mononuclear leucocytes (MNL). Cytokine levels induced by 
B. cepacia LPS were significantly higher compared to P. aeruginosa PW -LPS 
samples. This important result indicates that B. cepacia has a greater potential to 
cause immune -mediated damage in the CF lung compared to P. aeruginosa and may 
be a vital pathogenic mechanism of B. cepacia in vivo. 
MNL are generally used as the standard leucocyte cell source for in vitro cytokine 
studies (for example Fomsgaard et al, 1990) and are obtained from healthy blood 
donors. To confirm the relevance of the above results to CF lung disease, 
experiments were performed with lung epithelial cells, alveolar macrophages and 
neutrophils. Lung epithelial cells play a vital role in the initial stages of bacterial 
adherence and colonisation and are extensively damaged during periods of 
exacerbation (Stadnyk, 1994). Alveolar macrophages are the pivotal effector cell 
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against invading bacteria in CF, able to secrete a variety of proteases, complement 
components and cytokines (Buret & Cripps, 1993). Neutrophils are the predominant 
cells of the alveolar space in CF patients, representing a substantial systemic 
circulatory component, and producing products such as elastase and superoxide which 
can also cause extensive tissue injury (Elborn & Shale, 1990). Therefore, all three cell 
types play a fundamental role in the host -pathogen interaction of cystic fibrosis. 
As with the MNL experiments, results obtained with the alveolar macrophages and 
lung epithelial cells showed that B. cepacia possessed a significantly higher 
inflammatory potential than P. aeruginosa. However, the same trend was not 
observed with the neutrophil preparations; B. cepacia producing only comparable 
levels of TNF -a to P. aeruginosa. It must be emphasised however, that 
P. aeruginosa LPS can cause extensive damage. Indeed, previous studies have found 
P. aeruginosa LPS to be highly active in both the LAL and the TNF assay 
(Fomsgaard, 1990) and clinical studies, focusing on P. aeruginosa -colonised CF 
patients, have detected clinically relevant levels of cytokine both locally in sputum and 
systemically in serum (Norman et al, 1989; Greally et al, 1993). Thus, although the 
result of the neutrophil stimulation was different from the other cell types studied, it 
still signifies that B. cepacia has the potential to cause serious tissue damage and 
inflammation and is not merely a marker of pulmonary disease. This conclusion is 
further substantiated by comparison of B. cepacia LPS to an E. coli control. 
Although only tested with MNL cells, the B. cepacia LPS was more active in both the 
LAL and TNF assay. 
LPS samples from different growth conditions were also tested, and showed some 
variation in their capacity to induce TNF. Although the difference was not significant 
this observation shows that the components of LPS required for receptor binding and 
cytokine induction can be sensitive to environmental change. 
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The above cytokine results are highly important in terms of understanding further the 
mechanisms of B. cepacia pathogenesis in the CF lung. A positive correlation has 
been found previously between increasing cytokine levels and pulmonary decline in 
CF patients. This study has shown B. cepacia to possess the capacity to stimulate a 
massive cytokine release that could lead to an uncontrollable response, causing rapid 
acceleration of pulmonary inflammation, damage and deterioration. Furthermore, 
these results firmly resolve the controversy; B. cepacia is not simply a marker of pre- 
existing lung disease but an organism with a high degree of pathogenic potential. 
The influence of LPS extraction method on TNF -a induction. 
For both B. cepacia strains tested, the LPS samples extracted by the PCP method 
induced very little detectable TNF -a compared to a PW control. The higher 
biological activity of PW -LPS samples compared to PCP -LPS has been described 
previously for other species of bacteria (Delahooke et al, 1995) and may be a general 
distinguishing property of the two procedures. PCP extraction produces a more 
hydrophobic material (as was observed), suggesting that the LPS could bind with 
greater efficiency to leucocytes. As this does not appear to occur, the epitopes 
required for efficient LPS receptor- binding (and correspondingly cytokine induction) 
must be either extensively different compared to PW -LPS samples, or masked in the 
high molecular weight moiety obtained by the PCP method. Which LPS structure 
and, hence, biological activity reflects that produced in vivo remains to be defined. 
For the epidemic strain, the phenol -layer extract of a PW -LPS preparation was also 
found to be a poor cytokine inducer, in comparison to the aqueous -layer sample. 
However, for C 1409 (non- epidemic) both phenol and aqueous layers have a 
comparable TNF response. These variations in biological activity between the 
samples must be due to the structural differences observed by immunoblotting. 
Further investigation of the different structures may lead to important new 
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information on the LPS binding regions of B. cepacia. 
Induction of TNF -a by OM 
LPS is unlikely to be present in a pure form in vivo, but rather attached to parts of the 
outer membrane. Investigations were therefore performed to establish the 
inflammatory potential of the outer membrane samples, which were shown in this 
study to contain levels of endotoxin as detected by the LAL assay. TNF -a was 
induced by all the outer membrane samples, although there was no significant 
difference between the levels stimulated by the B. cepacia OM extracts and the 
P. aeruginosa OM extracts. Furthermore, the influence of growth environment was 
found to exert an effect on OM inflammatory potential. These results indicate that 
TNF -a induction is dependent on the presentation, composition and surrounding 
environment of the LPS and confirm the conclusions made with the PW and PCP 
extracts. However, the contribution of the protein present in the OM samples is 
unknown and cannot be dismissed, as a proteinase K treated LPS sample showed a 
reduction in TNF -a levels compared to a crude extract. 
Induction of TNF -a by EPS 
The results in this section have established that the biological activity of B. cepacia 
LPS is equal to, if not greater than, P. aeruginosa LPS. A major characteristic of 
P. aeruginosa infection in CF is the production of alginate, which may effectively 
shield the LPS from leucocytes in vivo. Otterlei et al (1993), reported that alginate 
blocks possessed a high biological activity and were able to stimulate a greater level 
of cytokine compared to P. aeruginosa LPS. This finding may account for the 
variation in inflammatory capacities between B. cepacia and P. aeruginosa. To test 
this theory, alginate was extracted from the P. aeruginosa mucoid strain used 
throughout this study C1250, and assayed for TNF -a induction. However, alginate 
samples induced only a similar level of cytokine as the P. aeruginosa LPS samples; 
201 
thus alginate production cannot account for the discrepancy between the two species. 
Induction of IL -8 
One characteristic of CF lung disease is the migration of neutrophils into the airway 
lumen, where neutrophil proteases, elastase and other products are important 
mediators of local tissue destruction. IL -8 is a major neutrophil chemoattractant and 
CF patients have been found to exhibit increased IL -8 levels compared to non -CF 
controls (Richman -Eisenstat et al, 1993; Dean et al, 1993). Therefore, this study 
investigated the ability of B. cepacia cell surface factors to produce IL -8. 
IL -8 assays were performed with MNL and alveolar macrophages using the same 
PW -LPS preparations as before. Results of the studies showed that B. cepacia LPS 
produced a higher level of IL -8 compared to P. aeruginosa samples, confirming once 
more the inflammatory potential of B. cepacia. However, the difference between the 
two species was not so great as observed with the TNF assays. In addition, there was 
a good correlation between high TNF- inducing strains and high IL -8- inducing strains 
(from alveolar macrophages) which would support the suggestion that TNF -a derived 
from alveolar macrophages is a major stimulator of IL -8 in the lung (Standiford et al, 
1990). Both OM and EPS preparations were assayed for IL -8 production, but as with 
the TNF -a results, no significant difference between any of the samples was found. 
Intraspecies variation - are distinct subgroups of B. cepacia evident? 
With the exception of the epidemic strain, which has been shown to possess a distinct 
biological character, no major difference between the B. cepacia clinical strains was 
observed. However, an important result emerging from this study was the finding that 
B. cepacia clinical isolates induced a far greater level of TNF -a from MNL and 
alveolar macrophages than the environmental strain of both B. cepacia and 
B. gladioli. This observation confirms previous reports that B. cepacia strains vary in 
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virulence and a sub -group of avirulent B. cepacia may be safe for environmental 
release (Bevivino et al, 1994). Results from chapter three have demonstrated the 
structural heterogeneity among B. cepacia isolates and recent taxonomic studies 
(Vandamme, 1995) have shown that three or more new species may emerge on 
taxonomic properties alone. Furthermore, studies continuing in our laboratory 
suggest that there may indeed be certain clones of B. cepacia with a predilection for 
colonisation of the lungs of CF patients. However, as a word of caution, the 
environmental strains tested in the present study still induced equal, if not greater 
TNF -a and IL -8 levels compared to P. aeruginosa samples. This shows that 
environmental strains themselves possess considerable inflammatory potential, and 
until more is understood about how this potential may function in vivo, release of any 
strain seems premature. For example, we do not know whether a subgroup of 
environmental isolates can cause infections in humans de novo or whether all 
B. cepacia isolates can adapt in vivo, although results from this study would suggest 
the former. Future studies continuing in our laboratory and involving the CF mouse 
may help to determine the virulence of environmental strains in an in vivo situation. 
Interspecies variation - B. cepacia and B. gladioli 
The similarity between B. cepacia and B. gladioli throughout this study supports the 
taxonomic regrouping of the Pseudomonas rRNA homology group II. Information 
on B. gladioli remains scarce although it is known to act primarily as a plant 
pathogen. Due to the similarities of the two species, B. gladioli was considered more 
of a hindrance to the unequivocal identification of B. cepacia, rather than a human 
pathogen in its own right. Indeed, one of the very few reports on the pathogenic 
potential of B. gladioli found no harmful consequences of pulmonary colonisation in 
CF patients (Christenson et al 1989). However, the findings of Simpson et al (1994) 
showed that some clinical isolates of B. cepacia exhibited characteristics of both 
species, leading to the theory that a bacterial hybrid may have emerged with a 
203 
composite of virulence determinants required for life as a successful human pathogen. 
The results in the present study would certainly support the cautionary comments of 
Simpson et al as the B. gladioli LPS sample used in these investigations possessed 
comparable levels of biological activity to P. aeruginosa and B. cepacia LPS. 
Interestingly, another member of the same taxonomic group, B. pseudomallei, has 
been shown to possess the same level of endotoxicity as B. cepacia, and an equal 
level of TNF -a induction to Salmonella abortus (Kanai & Kondo,1994). As these 
three members all show a similar degree of endotoxicity and, more importantly, as 
B. cepacia strains appear to possess characteristics of both B. gladioli and 
B. pseudomallei, further taxonomic and phylogenetic studies are urgently required to 
assess the possibility and pathogenic potential of 'hybrid' organisms. 
B. cepacia and P. aeruginosa - LPS signalling pathway and co- stimulation 
This study has highlighted the differences between B. cepacia and P. aeruginosa. 
The structure and composition of the LPSs are very different, as established by the 
chemical analysis and lack of homology in the immunoblot experiments (section 3.2). 
These variations are one explanation for the observed difference in biological activity 
between the two species. However, the different antigenic epitopes may mean that 
the LPSs bind to different receptors, which may signal a higher or lower level of 
cytokine production. 
To test this theory LPS samples from both species were assayed in a 
monocyte /macrophage cell line able to be enhanced for expression of CD 14, the best 
characterised LPS receptor to date. In the presence of both enhanced CD14 
production and a CD 14 monoclonal antibody, used to inhibit receptor binding, no 
difference in cytokine production was detected, indicating, as far as possible, that both 
LPS types signalled in a similar manner. This is confirmed further by the observation 
that both LPS types induce only a single peak of TNF -a, whereas the CD14- 
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dependent E. coli induces multiple peaks (Delahooke et al, 1995). It is suggested that 
the periodic response of E. coli may be related to the requirement for CD14. In 
addition, a recent report by Merten et al (1995), showed CD14 was not involved in 
the LPS- induced increase in IL -6 production by a P. aeruginosa CF isolate. 
CD14 has been shown to be unessential for the induction of cytokines by bacterial 
LPS (Lynn et al, 1993). In their report, Lynn et al suggested that a CD14- 
independent pathway may be of more importance in sites of local infection, where 
LPS concentration is high. This would be the scenario in the CF lung where high 
levels of LPS would be situated. If both B. cepacia and P. aeruginosa LPS function 
in a similar manner then this suggests there may be competition for LPS receptors 
when both types are present, as is often the case in the CF lung. Both LPS types 
presenting together may produce a more exaggerated response or an inhibitory effect. 
Studies to investigate this possibility found that when P. aeruginosa was present in 
increasing amounts compared to B. cepacia, TNF -a levels fell correspondingly. 
Furthermore, even when P. aeruginosa was in a twenty -fold excess of B. cepacia 
more TNF -a was still secreted compared to P. aeruginosa alone, reiterating the major 
inflammatory potential of B. cepacia. The inhibitory effect of co- stimulation was 
repeatable with different B. cepacia and P. aeruginosa strains but was not observed 
with two different B. cepacia strains together or two P. aeruginosa strains together. 
This observation leads to the important suggestion that the inhibitory effect of co- 
stimulation is not merely a solubility phenomenon, due to the presence of a critical 
LPS concentration, but rather that P. aeruginosa LPS actually modulates the 
inflammatory response of B. cepacia. If reflected in vivo, this exciting finding could 
open up numerous opportunities for new therapies, for example antibodies directed 
against the LPS receptor. 
205 
Preliminary experiments with the PW -LPS samples showed B. cepacia LPS to be 
more matogenic than P. aeruginosa LPS. Ko, a component of B. cepacia LPS, has 
been proposed as a strong mitogen which may account for the observed difference 
(Wilkinson & Pitt, 1995). Further work is required to establish the independent T -cell 
and B -cell response and thus the impact of B. cepacia on antibody production and cell 
mediated immunity compared to P. aeruginosa. 
In summary, this study has established that B. cepacia does not produce a 
predominant virulence determinant, even when grown under conditions of 
environmental stress. Furthermore, B. cepacia strains have been shown to share 
similar properties with both B. gladioli and B. pseudomallei, re- emphasising the 
desperate need for a re- evaluation of the Burkholderia genus. Crude groupings of 
B. cepacia strains can be achieved, as determined by LPS homology on 
immunoblotting or capacity to induce TNF -a, although the distinct character of the 
'epidemic' strain was clearly seen. The recent recognition of transmissibility factors 
will be a useful tool for the rapid identification of these highly transmissible strains and 
may lead to new prospects of vaccine development against colonisation. However, 
due to the variation within the B. cepacia species, the antigen to which a vaccine 
would be directed would have to be chosen carefully. A vaccine directed against a 
cable pilus would stop only some highly transmissible strains and would be no use 
against 'non- epidemic' strains, some of which have been found to cause a rapid clinical 
deterioration. Therefore, work must continue in discovering the pathogenic 
mechanisms of B. cepacia in the hope of developing novel therapeutic strategies 
against all B. cepacia and B. cepacia -like organisms. 
To this end this study has provided some very important clues. This study firmly 
established that B. cepacia possessed a significantly higher inflammatory potential 
than P. aeruginosa, and may explain the ability of B. cepacia to cause severe immune- 
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mediated damage in the CF lung. It is speculated that the potentially huge level of 
cytokine induction by B. cepacia may contribute not only to a destructive local 
inflammation of the airways, but also a systemic inflammatory response, manifested by 
increased cytokine levels in the plasma and, in certain patients, contributing to rapidly 
fatal decline. Indeed, this hypothesis is confirmed by recent clinical data in which 
levels of the immune markers, C- reactive protein and neutrophil elastase (shown to be 
directly correlated to circulating TNF), were increased during periods of B. cepacia - 
associated exacerbations compared to P. aeruginosa- associated exacerbations (Elborn 
et al, 1994). Interestingly, the present study also showed that the B. cepacia 
inflammatory response may be modulated in the presence of P. aeruginosa, giving an 
important clue to why there are variable clinical outcomes in B. cepacia colonised CF 
patients. The clinical course of infection may be related not only to pre -existing lung 
disease, activated leucocytes or cytokine production per se, but also to co- 
colonisation with other organisms, such as P. aeruginosa. Of course, administration 
of P. aeruginosa or P. aeruginosa cell surface components to CF patients is not being 
suggested as any form of treatment. However, antibodies directed against the shared 
LPS receptor may be one possible therapy. In addition, recent unpublished clinical 
evidence indicates that patients who do not respond well to antibiotics but continue to 
exhibit rapid pulmonary decline, respond to treatment with commercial preparations 
of immunoglobulins (Dr J. Govan personal communication). B. cepacia antibodies 
are unlikely to be present in these preparations in significant numbers and, as the work 
of Nelson et al (1993) and Butler (1994) show, many CF patients already mount an 
enormous anti -B. cepacia response. Thus, the benefit of additional specific 
B. cepacia antibodies is doubtful. However, pooled immunoglobulin preparations 
may act as anti -inflammatory agents, perhaps containing anti -cytokine antibodies or 
anti -cytokine receptors. 
If indeed commercial immunoglobulin preparations are acting in an anti -inflammatory 
capacity then this may lead to the much needed development of a positive therapeutic 
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strategy. However, better understanding of B. cepacia pathogenesis in CF is still 
urgently required, as only then will B. cepacia infection truly be brought under control 





ENVIRONMENTAL MODULATION OF CELL SURFACE 
VIRULENCE DETERMINANTS OF BACTERDIDES 
FRAGILIS 
The cell surface components of Bacteroides fragilis are considered to be the major 
virulence factors. However, the expression and role of these structures in B. fragilis 
pathogenesis is still debated. The following experiments aimed to characterise the 
expression and antigenicity of potential virulence determinants of B. fragilis NCTC 
9343 and B. fragilis MPRL 1504 and of the related strains; B. vulgatus MPRL 1651, 
B. thetaiotaomicron NCTC 10582 and B. uniformes MPRL 1721. 
6.1 CHARACTERISTICS AND ENVIRONMENTAL REGULATION OF LPS 
Controversy still remains as to the exact phenotype of B. fragilis LPS and its potential 
role in disease. Part of this problem is due to the particularly close association of the 
Bacteroides cell surface components and the influence of culture conditions; factors 
not taken into account by previous workers. 
The influence of growth environment on LPS phenotype 
The LPS from the above five Bacteroides strains were extracted by proteinase K 
digestion from growth in a nutrient -rich proteose peptone -yeast extract medium PPY; 
a chemically defined minimal medium VT &W; and a physiological medium VT &S. In 
addition, the LPS of B. fragilis NCTC 9343 and MPRL 1504 was extracted from 
growth in 2 %(w /v) bile salts, 0.5 %(w /v) bile salts, 0.5 %(w /v) cysteine hydrochloride 
and low pH medium (pH5.5). 
From results obtained by SDS -PAGE and silver -staining, the following observations 
were made about the different Bacteroides species; the two B. fragilis strains 
possessed a typical core LPS structure, a series of closely spaced bands running 
approximately half -way down the gel area and particularly in strain NCTC 9343, a 
darkly staining high molecular mass antigen (speculated to be capsular polysaccharide; 
Figure 6.1a). B. vulgatus was the only Bacteroides strain to show a ladder pattern 
characteristic of smooth LPS (Figure 6.1d), with both B. thetaiotaomicron and 
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B. uniformis exhibiting core LPS and a single dark staining band but no obvious high 
molecular weight moiety (Figure 6.1e-0. 
Due to problems of poor separation and resolution, the LPS phenotype of B. fragilis 
has, in the past, been proposed as rough, semi -rough with common antigen or 
smooth. For the B. fragilis strains tested, the observed LPS phenotype was similar to 
that reported by Poxton & Brown (1986), although the distinctive common antigen, 
defined by these authors was not clearly seen in the LPS samples. 
Growth environment appears to influence B. fragilis LPS structure. LPS preparations 
of B. fragilis extracted from bile supplemented media showed the loss of the high 
molecular weight moiety, (Figure 6.1b -c; Track 3 & 4). For B. fragilis NCTC 9343, 
a decrease in production of core LPS was also observed and for MPRL 1504 
production of two extra high molecular weight bands was noted. As the gut contains 
bile salts and B. fragilis is noted for its bile -tolerance, these observed structural 
changes may be significant to the virulence of this organism. In addition, LPS 
samples of B. fragilis and B. vulgatus extracted from growth in PPY showed 
variation in banding pattern and core production compared to LPS profiles from 
VT &W and VT &S, with B. vulgatus exhibiting a pronounced decrease in 0- antigen 
chain length. No structural changes were observed with B. thetaiotaomicron or 
B. uniformis. 
Immunoblotting 
To investigate the structures contributing to LPS antigenicity, immunoblots of the five 
Bacteroides strains were performed. Rabbit sera raised against the homologous 
strains were used as probes, except for B. fragilis NCTC 9343, where serum raised 
against the similar strain B. fragilis NCTC 9344 was used (Figure 6.2a -c). For the 
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Figure 6.1d LPS profile of B. vulgatus MPRL 1651 extracted from growth in PPY, 
VT &W and VT &S; Figure 6.1e LPS profile of B. thetaiotaomicron NCTC 10582 






Figure 6.2a -c Immunoblots of proteinase K LPS digests of B. fragilis, 
and B. vulgatus extracted from different growth conditions. Figure 6.2a 
B. fragilis NCTC 9343 LPS extracted from growth in; Track 1, PPY; Track 2, 
VT &W; Track 3, VT &S; Figure 6.2b B. fragilis MPRL 1504 LPS; and Figure 6.2c 
B. vulgatus MPRL 1651 LPS extracted from the same growth conditions. 
Immunoblots were probed with rabbit sera raised against NCTC 9344, MPRL 1504 
and MPRL 1651 respectively. 
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although the number and spacing of the bands varied between the two isolates. 
B. fragilis NCTC 9343 also exhibited a reactive high molecular weight moiety above 
the bands, again suggestive of capsular polysaccharide. 
In contrast, the immunoblot of B. vulgatus (Figure 6.2c) showed a positive reaction 
against the core LPS and the ladder pattern but, the response was much weaker. The 
differences in antigenicity between the Bacteroides species may be important for the 
increased virulence of B. fragilis. No reaction was seen with B. thetaiotaomicron or 
B. uniformis despite repeated attempts. Furthermore, no change in antigenicity was 
observed with LPS samples extracted from different growth conditions. 
The influence of antibiotics on LPS structure. 
Growth in the presence of antibiotics has been reported to influence cell surface 
structure. As an inhabitant of the intestinal tract, it is probable that B. fragilis will 
encounter oral antibiotics which may influence LPS structure and hence virulence 
potential. To test this theory, B. fragilis NCTC 9343 and MPRL 1504 were grown in 
the presence of two antibiotics, metronidazole and chloramphenicol, with the MIC 
level determined by the standard discontinuous tube dilution assay (Table 6.1). 
Table 6.1 MIC levels of B. fragilis NCTC 9343 and MPRL 1504 grown in the 
resence of metronidazole and chloram henicol. 
Strain MIC (mg/1) 
Metronidazole Chloramphenicol 
B. fragilis NCTC 9343 






B. fragilis NCTC 9343 and MPRL 1504 were grown in minimal medium 
supplemented with ' /2, 1/4 and Ins -MIC level of metronidazole and chloramphenicol. 




Figure 6.3a -c LPS profile of B. fragilis NCTC 9343 and MPRL 1504 grown in 
sub -MIC conditions. Figure 6.3a Silver -stained SDS -PAGE, Tracks 1 -8 NCTC 
9343 LPS extracted from growth in PPY; VT &W; 118 -MIC metronidazole; 1/4 -MIC 
metronidazole; 1/2 -MIC metronidazole; 1/8-MIC chloramphenicol; 
1/4 -MIC 
chloramphenicol; 1/2 -MIC chloramphenicol; Tracks 9 -16 MPRL 1504 LPS extracted 
from the same growth conditions. 
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Figure 6.3b Immunoblot of NCTC 9343 LPS extracted from growth in; Track 1, 
VT &W; Track 2, 118 -MIC metronidazole; Track 3, 118 -MIC metronidazole; Track 4, 
114 -MIC metronidazole; Track 5, 1/4 -MIC metronidazole; Track 6, 1/2 -MIC 
metronidazole; Track 7, 1/8-MIC chloramphenicol; Track 8, 114 -MIC 
chloramphenicol; Track 9, 1/2 -MIC chloramphenicol; and Figure 6.3c Immunoblot of 
MPRL 1504 LPS extracted from growth in; Track 1, VT &W; Track 2, 1/8-MIC 
metronidazole; Track 3, 114 -MIC metronidazole; Track 4, 112 -MIC metronidazole; 
Track 5, 1/8 -MIC chloramphenicol; Track 6, 1/4 -MIC chloramphenicol; Track 7; 1/2- 
MIC chloramphenicol. Immunoblots were probed with rabbit sera raised against 
NCTC 9344 and MPRL 1504 respectively. 
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Figures 6.3a -c show the silver- stained PAGE and immunoblots of LPS preparations 
from NCTC 9343 and MPRL 1504 grown in sub -MIC conditions. For the silver - 
stained PAGE (Figure 6.3a), the characteristic core LPS, closely spaced bands and 
high molecular weight antigen is seen; with no obvious structural differences observed 
between growth in the sub -MIC antibiotic medium compared to the control medium. 
Immunoblots probed with rabbit antiserum did, however, show slight changes in 
antigenicity (Figure 6.3b -c). For B. fragilis NCTC 9343 (Figure 6.3b) the rabbit sera 
reacted with the core LPS and the banding pattern but not with the high molecular 
weight moiety, unlike the immunoblot in Figure 6.2a. In addition, LPS samples 
extracted from sub -MIC antibiotic media exhibited a reduction in band production, 
compared to LPS from minimal medium alone. For both B. fragilis isolates, LPS 
from the sub -MIC media showed an increase in core antigen production compared to 
the control, with the exception of MPRL 1504 LPS samples extracted from ' -MIC 
media which reacted very weakly and gave little reaction with core antigen (Figure 
6.3c; Tracks 4 & 7). Thus, growth in antibiotic -supplemented medium induces slight 
antigenic changes which highlights the plasticity of the cell surface of B. fragilis. 
6.2 CHARACTERISTICS AND ENVIRONMENTAL REGULATION OF OM 
OM phenotype 
Outer membranes were extracted from B. fragilis NCTC 9343 and MPRL 1504, 
grown in PPY. OM samples of B. vulgatus MPRL 1651 and B. thetaiotaomicron 
NCTC 10582 were gifted by E. Allan, Department of Medical Microbiology, 
Edinburgh. Samples separated by SDS -PAGE were stained with Coomassie blue 
(Figure 6.4) and as expected each Bacteroides species showed a distinct OM profile. 
The influence of growth environment on OM structure 
Outer membranes from two B. fragilis strains were extracted from growth 
in VT &W, 
VT &S, iron -limiting medium VT &E and bile -containing medium 
VT &B. As 
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observed with other Gram- negative bacteria, B. fragilis was responsive to different 
growth conditions with outer membrane protein production increasing or decreasing 
to change overall permeability and aid survival (Figure 6.5). Production of a major 
band of 41 kD is induced for B. fragilis NCTC 9343 when grown in PPY (Track 1). 
Similarly, growth in VT &W appears to increase production of a 5810 OMP (Track 
2). OM preparations from VT &B and VT &E gave a weaker response. For 
B. fragilis MPRL 1504, only the OM samples extracted from PPY, VT &S and VT &E 
gave a reaction; VT &W and VT &B samples did not react due to the low protein 
concentration in these extracts. However, differences in OMP profile between growth 
conditions were still observed, for example a 1210 band was seen only in the sample 
from VT &S (Track 8). Variation between the two B. fragilis samples was also 
highlighted, for example the band at 41 kD was present in NCTC 9343 grown in PPY 
(Track 3) but not in MPRL 1504 (Track 6). 
Immunoblotting 
The outer membranes from B. fragilis NCTC 9343 and MPRL 1504 were extracted 
from growth in PPY, VT &W and VT &S and probed using rabbit sera raised against 
NCTC 9344 and MPRL 1504 (Figure 6.6a -b). A large number of bands gave a strong 
reaction, particularly the 4110 band from NCTC 9343 grown in PPY (Figure 6.6a, 
Track 3). Interestingly, there was a large cross -reaction between the OM samples 
of 
the two B. fragilis strains tested, implying that OM antigenic epitopes are conserved 
within the B. fragilis species. 
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Figure 6.4 Coomassie blue stained outer membrane profiles of B. fragilis, 
B. vulgatus and B. thetaiotaomicron separated by SDS -PAGE (10% w/v 
acrylamide). Track 1 B. fragilis NCTC 9343; Track 2, B. fragilis MPRL 1504; 
Track 3, B. vulgatus MPRL 1651 and Track 4, B. thetaiotaomicron NCTC 10582. 
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Figure 6.5 Outer membrane profiles of B. fragilis NCTC 9343 and MPRL 1504 
extracted from different growth conditions and stained with Coomassie blue. 
Tracks 1 -5 B. fragilis NCTC 9343 OM extracted from growth in PPY, VT &W, 
VT &S, VT &B, VT &E; Tracks 6 -10 B. fragilis MPRL 1504 OM extracted from the 
same growth conditions. 
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Figure 6.6a -b Immunoblots of outer membrane antigens of B. fragilis extracted 
from different growth conditions and probed with rabbit sera raised against (a) 
NCTC 9344 and (b) MPRL 1504. Figure 6.6a Tracks 1 -3, NCTC 9343 OM 
samples from growth in PPY, VT &W, VT &S; Tracks 4 -6 MPRL 1504 OM samples 
extracted from the same growth conditions. Figure 6.6b Tracks 1 -2, NCTC 9343 
OM samples from growth in PPY, VT &W; Tracks 3 -7, MPRL 1504 OM samples 
from growth in VT &E, PPY, VT &W, VT &S and VT &B. 
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6.3 CHARACTERISTICS AND ENVIRONMENTAL REGULATION OF EPS 
The influence of growth condition on EPS profile. 
The capsular polysaccharide of B. fragilis is regarded as a major virulence 
determinant. However, the close association of the capsule with LPS and the 
recognition that capsules from a wild -type population of B. fragilis are 
heterogeneous, with respect to structure and antigenicity, has led to further confusion 
about the role of this structure in pathogenesis. To determine the influence of growth 
environment on EPS production, the Percoll profile of two B. fragilis strains, one 
B. vulgatus strain, one B. uniformis strain and one B. thetaiotaomicron strain grown 
in PPY, VT &W and VT &S, were investigated. In addition, the profile of the 
B. fragilis isolates grown in bile - supplemented medium VT &B, and iron -limited 
medium VT &E, was also examined. 
EPS production from Bacteroides strains was found to be highly sensitive to 
environmental conditions. For example, B. fragilis MPRL 1504 grown in PPY 
produced mainly small capsules, growth in VT &W mainly large capsules and for 
growth in VT &S no capsular production was observed (Figure 6.7a). This result 
implies B. fragilis increases EPS production in conditions of nutrient limitation. 
However, the Percoll profile of other Bacteroides strains differed from MPRL 1504 
(Figure 6.7b) and therefore no overall correlation between culture conditions and EPS 
production could be reached. Thus, although capsule production was shown to be 
dependent on environmental conditions, the pathological basis of these changes 
requires further investigation. 
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Figure 6.7a The influence of growth environment on the Percoll profile of 






B. fragilis NCTC 9343 B. fragilis MPRL 1504 
PPY VT&W VT&S VT&B VT&E VT&B VT&E 
B. vulgatus MPRL 1651 
PPY Vr&W vr&s 
B thetaiotaomicron NCTC 10582 B. unifomvs MPRL 1721 
PPY Vr&W Vr&S PPY Vr&W VT&S 
Figure 6.7b The influence of growth environment on the Percoll profile of 
B. fragilis, B. vulgatus, B. thetaiotaomicron and B. uniformis strains. The main 
areas of precipitation are marked with dark bands. 
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6.4 CELL SURFACE HYDROPHOBICITY 
The cell surface hydrophobicity of four Bacteroides strains grown in PPY, VT &W 
and VT &S was determined by HIC. Specific hydrophobic interaction was measured 
using octyl Sepharose CL -4B with Sepharose CL -4B used as a control for non- 
specific absorption. Results shown in Figure 6.8, from growth in PPY, are expressed 
as the percentage of cells retained by octyl -Sepharose CL -4B relative to retention 







Figure 6.8 Cell surface hydrophobicity of B. fragilis, B. vulgatus and 
B. thetaiotaomicron grown in PPY. 
Differences in cell surface hydrophobicity between the Bacteroides species are 
apparent; B. fragilis NCTC 9343 possessed the highest degree of hydrophobicity 
whereas B. vulgatus MPRL 1651 was found to be the least hydrophobic. The greater 
hydrophobicity of the B. fragilis isolates, and thus in theory the greater adherence, 
suggests a close association of B. fragilis with mucosal surfaces, confirming previous 
clinical observations. Unfortunately, due to the oxygen sensitivity of the bacteria 
225 
grown in VT &W and VT &S, no measurement of cell surface hydrophobicity could be 
determined for these culture conditions and thus the influence of growth environment 
could not be assessed. 
In summary, members of the Bacteroides genus produce distinct LPS, OM and EPS 
profiles which vary with environmental growth conditions. This plasticity is a vital 
biological property, allowing organisms to adapt and survive in otherwise lethal 
situations. Furthermore, varying the production of cell surface components may be 
important to the pathogenic potential of B. fragilis by allowing this organism to 
induce a more virulent form of structure only when required. A possible pathogenic 




BIOLOGICAL ACTIVITY OF THE CELL SURFACE 
COMPONENTS OF BACTEROIDES FRAGILIS 
Experiments in this chapter were designed to investigate the potential role of 
B. fragilis cell surface components in SIRS, examining in particular biological 
endotoxicity and capacity to induce TNF -a. The influence of growth environment on 
these pathogenic properties was also determined. 
PW -LPS samples were used throughout this chapter. Bacteroides extracts were 
prepared by E. Allan and the E. coli sample (018K) by D. Delahooke, both of the 
Department of Medical Microbiology, Edinburgh. 
7.1 THE ENDOTOXICITY OF B. FRAGILIS LPS SAMPLES 
Dose response of LPS for LAL assay. 
The LPS stock solution of B. fragilis NCTC 9343 was diluted in pyrogen -free water 
to a concentration of 1Ong/ml, ing/ml and O.ing/ml to determine the optimum LPS 
concentration to use in the LAL assay. 
Figure 7.1 shows the results obtained and as expected endotoxin values correlated 
with LPS concentration. The 1Ong/ml sample gave the highest endotoxin reading but, 
unfortunately, produced optical density values outwith the normal standard range. 
The 1 ng/ml sample, although lower in endotoxicity, produced OD values 
corresponding to the middle of the standard range and was thus chosen as the optimal 
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Figure 7.1 Dose response curve of B. fragilis NCTC 9343 LPS as measured by 
the LAL assay. Results shown are the mean of duplicates. 
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Comparison of LPS endotoxicity between B. fragilis and E. coli 
The endotoxicity of LPS from B. fragilis NCTC 9343 and MPRL 1504 was 
compared to E. coli 018K (Figure 7.2). 
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Figure 7.2 The endotoxic activity of B. fragilis and E. coli LPS preparations as 
measured by the LAL assay. LPS samples were used at a concentration of ing/ml. 
Results are the mean of duplicates. 
The E. coli LPS sample possessed a greater endotoxic potential compared to the 
B. fragilis preparations, confirming previous reports. Surprisingly, however, the 
endotoxicity levels for the B. fragilis LPS samples were only five- to nine -fold less 
than the levels for the E. coli preparation. Considering the huge predominance of 
Bacteroides in the gut, outnumbering facultative anaerobes by 100 -1000 fold, this 
results implies that as a population, B. fragilis LPS may possess as much, if not more, 
biological potential than E. coli LPS. 
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7.2 INFLAMMATORY POTENTIAL OF B. FRAGILIS LPS 
A primary characteristic of SIRS is excessive and uncontrollable cytokine production. 
To test the hypothesis that B. fragilis, as a population, may play a vital role in SIRS, 
the ability of B. fragilis LPS to induce the major cytokine TNF -a from human 
mononuclear leucocytes was determined. 
PW -LPS samples of B. fragilis NCTC 9343 and MPRL 1504, B. uniformis MPRL 
1721 and B. thetaiotaomicron NCTC 10258 were assessed for inflammatory potential 
compared to an E. coli control. LPS samples were diluted in pyrogen free water to 
1 ng/ml and supernate was collected at 4h; determined as the optimal LPS 
concentration and time of collection in preliminary work by D. Delahooke, 
Department of Medical Microbiology, Edinburgh. The MNL cells were used at a 
concentration of 8 x 106 cells /ml. The specificity of the assay and the controls 
employed was as described in section 4.2. 
II B. fragilis NCTC 9343 
B. fragilis MPRL 1504 
B. uniformis MPRL 1721 
B. thetaiotaomicron NCTC 10258 









Figure 7.3 TNF -a levels produced from MNL in response to LPS preparations 
of B. fragilis, B. uniformis, B. thetaiotaomicron and E. coli. (a) The TNF -a 
response from Bacteroides strains only. (b) The TNF -a response from both 
Bacteroides strains and E. coli. LPS samples were used at a concentration of ing/ml. 
Supernate was collected at 4h. Results are mean of duplicates. 
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TNF -a induction levels varied between the Bacteroides species although no 
significant difference was measured, implying B. fragils, B. uniformis and 
B. thetaiotaomicron possess the same degree of inflammatory potential (Figure 7.3). 
E. coli LPS induced a significantly higher level of TNF -a (P <0.01) than LPS 
preparations from Bacteroides species. However, more importantly, E. coli induced 
on average only twenty -fold more cytokine compared to B. fragilis, considerably less 
activity than the 100 -1000 fold required to match, population for population, the 
potential of Bacteroides in the gut. This result contrasts with previous reports where 
B. fragilis was found to be 100 -1000 fold less active than E. coli. Thus, the findings 
of the present study confirm the hypothesis that as a population, Bacteroides hold as 
much if not more biological activity compared to E. coli. 
The influence of growth environment on TNF -a induction 
PW -LPS samples from two strains of B. fragilis grown in PPY, VT &W and VT &S 




B.fragilis NCTC 9343 B.fragilis MPRL 1504 
Figure 7.4 TNF -a levels induced by LPS samples of B. fragilis extracted from 
different growth conditions. LPS samples were used at a concentration of ing/ml. 
Supernate was collected at 4h. Results are the mean of duplicates. 
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No significant difference in TNF- induction between the LPS samples extracted from 
different growth conditions was observed. Therefore, although growth condition 
influenced the structure of B. fragilis LPS, inflammatory potential does not appear to 
be affected by the growth media tested in this study. 
7.3 INFLAMMATORY POTENTIAL OF B. FRAGILIS OM 
Initial experiments assessed the inflammatory potential of OM preparations from 
B. fragilis NCTC 9343 and MPRL 1504, B. vulgatus MPRL 1651 and 
B. thetaiotaomicron NCTC 10258. 
Dose response 
The OM preparation from B. fragilis NCTC 9343 was diluted in pyrogen -free water 
to a protein concentration of 800 tg/ml, 84ml, 8Ong/ml and 0.8ng/ml. Supernates 







-- B. fragilis NCTC 9343 
8ug /m1 8Ong/ml 0.8ng/m1 
OM concentration 
Figure 7.5 TNF -a levels produced from MNL in response to a protein 
concentration range of B. fragilis NCTC 9343 OM sample. Supernate was 
collected at 4h. Results are the n,..an of duplicates. 
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The OM concentration corresponding to optimal OD values was 8p.g/ml. OM 
samples, diluted to a protein concentration of 8 tg/ml, were assayed for their ability to 
induce TNF -a (Figure 7.6). 
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Figure 7.6 TNF -a levels induced from MNL in response to Bacteroides OM 
samples. OM samples were used at a protein concentration of 8p.g/ml. Supernate 
was collected at 4h. Results shown are the mean of duplicates. 
Levels of TNF -a induced by the OM samples varied between the Bacteroides strains. 
OMs from the B. fragilis strains induced more TNF -a compared to B. vulgatus 
MPRL 1651 and B. thetaiotaomicron NCTC 10582, which may be important for the 
greater virulence recognised with B. fragilis. However, further work is required to 
establish whether these differences are significant. 
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The influence of growth environment on TNF -a induction by OM samples 
The structure of the Gram -negative outer membrane is more susceptible to 
environmental changes than LPS. Thus, outer membrane preparations from two 
B. fragilis strains, extracted from growth in PPY, VT &W and VT &S, were assessed 
for TNF -a induction in order to determine the influence of growth environment on 
OM inflammatory potential. 
B.fragilis NCTC 9343 B.fragilis MPRL 1504 
Figure 7.7 TNF -a levels produced from MNL in response to B. fragilis OM 
preparations extracted from different growth conditions. OM samples were used 
at a protein concentration of 84g/ml. Supernate was collected at 4h. Results shown 
are the mean of duplicates. 
The growth environments tested in this study influenced the inflammatory potential of 
the OM samples (Figure 7.7). OMs extracted from both B. fragilis strains grown in 
VT &S induced the highest levels of TNF -a whereas OMs extracted from growth in 
VT &W produced the lowest amounts. As the greatest activity was observed in 
serum- supplemented media this suggests an increased pathogenic potential for 
B. fragilis in vivo, both in the gut and in the systemic circulation. Furthermore, this 
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finding leads to two suggestions. Firstly, TNF -a induction is dependent on the 
presentation of LPS within the outer membrane, highlighting the influence of 
extraction method on biological activity. Secondly, the protein present in the OM 
plays an important role in the virulence of Gram- negative bacteria. 
Thus, results gained in this section show that B. fragilis exhibits more biological 
activity than previously recognised; on average only seven -fold less than E. coli in the 
LAL assay and twenty -fold less in the TNF -a assay. If the same variation were 
reflected in vivo, population for population, B. fragilis would possess as much 
biological potential compared to E. coli. This finding implies that B. fragilis may be 
important as both an enteric pathogen in IBD and in extraintestinal diseases such as 
SIRS; disease states in which cytokine overproduction is a key pathological event. 
Interestingly, growth environment was shown to influence LPS structure but not 
inflammatory capacity, whereas in contrast the biological activity of the OM samples 
were dependent on growth conditions. This result suggests that the presentation of 
LPS within the Gram- negative membrane is susceptible to the surrounding 
environment (effecting biological activity) and/or that the virulence of the protein 





Historically, Bacteroides fragilis has been regarded primarily as a commensal of the 
human colon, despite being the most commonly isolated anaerobic bacterium from 
clinical specimens. Part of this paradoxical thinking is based on previous reports of 
the relative avirulence of B. fragilis in a variety of in vivo and in vitro models. For 
example Sveen et al (1977) found the doseage of B. fragilis LPS required to induce a 
local Shwartzman reaction in rabbits was over 1000 -fold greater than for a 
Salmonella control. However, in recent years B. fragilis has gained increasing 
prominance as a serious human pathogen implicated in disease states such as abscess 
formation, colonic cancer, inflammatory bowel disease and, most importantly, SIRS. 
In a large number of critically ill patients presenting with a septic clinical state there 
may be no positive bacterial culture or obvious foci of infection (Pape et al, 1994). It 
is now accepted that the probable source of bacteria for these patients is the gut 
microflora. Following episodes of shock -induced gut ischaemia, bacteria and their 
products may translocate from the intestine into the circulation via the portal vein. As 
a consequence, leucocytes, and in particular the liver macrophages or Kupffer cells, 
may become activated, stimulating production of proinflammatory cytokines, which 
may ultimately lead to the pathological changes associated with sepsis (Runcie & 
Ramsay, 1990). Escherichia coli has been considered previously the most important 
bacterium in SIRS by virtue of its extremely active LPS. However, the huge 
predominance of Bacteroides species in the intestine, outnumbering organisms such as 
E. coli by 100 -1000 fold, suggests that as a population Bacteroides may possess 
as 
much biological potential as E. coli. 
Progress into defining the potential pathogenic role of B. fragilis in disease 
has been 
hampered by the confusion and continuing controversy on the 
cell surface factors of 
this organism. For example, there remains debate on 
whether the LPS is rough or 
smooth. These problems are further emphasised by the 
discovery of Patrick et al 
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(1986) that a wild -type laboratory culture of B. fragilis is morphologically 
heterogeneous with growth conditions having a marked influence on cell surface 
structures. 
Thus, this section of work aimed to determine the influence of environmental growth 
conditions on the expression of B. fragilis cell surface factors and the possible role of 
these structures in SIRS. 
8.1 THE ENVIRONMENTAL MODULATION OF THE CELL SURFACE 
FACTORS OF BACTEROIDES FRAGILIS 
Lipopolysaccharide 
LPS preparations from B. fragilis and other representatives of the Bacteroides genus; 
B. uniformis, B. vulgatus and B. thetaiotaomicron, were analysed by SDS -PAGE and 
immunoblotting. Previous studies on B. fragilis have resulted in conflicting views on 
the LPS profile of this organism. Weintraub et al (1985) concluded that most strains 
of B. fragilis possessed a chemically and antigenically similar, if not identical, R -LPS 
type molecule. In contrast, Poxton & Brown (1986) found strains of B. fragilis to 
possess predominantly smooth, strain- specific LPS. In the present study the strains of 
B. fragilis tested exhibited core LPS, a series of high molecular weight bands and a 
high molecular weight moiety believed to be capsular antigen, highlighting the close 
association of B. fragilis cell surface factors. This finding agrees with the previous 
observations of Poxton & Brown (1986), although the common antigen defined by 
these authors was not always detected. B. uniformis and B. thetaiotaomicron 
possessed predominantly rough -LPS whereas B. vulgatus exhibited a ladder pattern 
characteristic of smooth LPS, emphasising the LPS heterogeneity between the 
different Bacteroides species. Whether the observed differences in LPS structure can 
be related to the reported variation in pathogenicity between Bacteroides species is 
discussed later. 
236 
In addition, growth environment was found to influence LPS structure. Two strains 
of B. fragilis showed variation in LPS structure between growth in rich and minimal 
media, furthermore, B. vulgatus exhibited a reduction in 0- antigen when grown in the 
nutrient rich medium. However, no obvious difference in antigenicity between LPS 
samples from different growth conditions was observed. These findings highlight the 
complexity involved in defining the profile of B. fragilis LPS expression in vivo. This 
problem is further emphasised by the poor resolution of B. fragilis LPS by 
conventional PAGE methods, although attempts have been made to improve this 
situation (Maskell, 1994). 
The most noticeable structural change in B. fragilis LPS was in minimal media 
supplemented with bile; a reduction in core LPS antigen and loss of the high 
molecular weight moiety, thought to be capsule, was observed. As bile salts are an 
important environmental factor in the gut, this finding leads to speculation on the co- 
ordinated expression of cell surface factors in vivo. For example, as capsular 
polysaccharide biosynthesis is increased in the presence of bile (section 6.3), the drain 
on energy resources may be compensated for by reducing LPS production. The 
genetic basis of these changes requires further investigation. 
LPS was also extracted from B. fragilis strains grown in a variety of minimal media 
supplemented with a range of sub -MIC concentrations of metronidazole and 
chloramphenicol. Chloramphenicol is an effective antimicrobial agent affecting 
protein synthesis. Metronidazole is one of the most active non -ß- lactam antibiotics 
used against anaerobes, effective when intracellular reduction of its nitro group 
produces cytotoxic compounds such as hydroxylamine, which inhibit nucleic acid 
synthesis. Metronidazole has been reported previously to increase both cell surface 
hydrophobicity and aniongenicity of B. fragilis strains, changing the B. fragilis -host 
interactions (Cavalcanti et al, 1991). In their study Cavalcanti et al concluded that 
237 
metronidazole may induce these alterations by interacting with negatively charged 
surface groups such as LPS. 
Silver- stained SDS -PAGE of the sub -MIC LPS extracts failed to reveal any variation 
in LPS structure although immunoblots did show some slight changes in antigenicity 
compared to an unsupplemented control. B. fragilis NCTC 9343 grown in sub -MIC 
media produced fewer bands compared to the control. In addition, both B. fragilis 
strains exhibited a greater expression of core -LPS antigen when extracted from 
' /g- and '/a -MIC compared to the control. These findings suggest that in the presence 
of sub -MIC concentrations of metronidazole and chloramphenicol, LPS 0- antigen is 
reduced and production of core LPS increased, implying that a more hydrophobic 
LPS is indeed expressed which may increase both binding efficiency to host cells and 
phagocytic engulfment. How the antibiotics regulate the LPS biosynthetic enzymes 
remains to be defined. 
To establish whether other growth environments shown in this study to influence LPS 
structure also altered cell surface hydrophobicity, strains of B. fragilis, B. vulgatus, 
B. thetaiotaomicron and B. uniformis grown in nutrient rich medium, minimal 
medium and serum- supplemented medium were assessed by HIC. Unfortunately, 
although all material was prereduced and kept as anaerobic as possible, the HIC 
procedure lasted approximately three hours and none of the strains tested gave viable 
counts from the VT &W and VT &S media, highlighting the oxygen- sensitivity of 
Bacteroides strains in these growth environments. Therefore, the influence of growth 
environment on cell surface hydrophobicity could not be ascertained. However, cell 
surface hydrophobicity measurements were made from the strains grown in PPY. 
Variations between different Bacteroides species and different B. fragilis isolates 
were noted. B. fragilis NCTC 9343 was found to be the most hydrophobic and 
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therefore, in theory, the most efficient at binding, whilst B. vulgatus MPRL 1651 was 
the least hydrophobic. Further experiments with more strains would be required to 
establish whether the cell surface hydrophobicity of these species correlated with their 
predominant association with either faecal or colonic wall material. However, the 
influence of oxygen- levels on these results is undetermined and should not be 
disregarded, as this may account for the observed differences. 
Outer membrane 
The OMPs of B. fragilis are not considered major virulence determinants although a 
4410 protein has been postulated as an iron -receptor and may play an important role 
in vivo (Otto et al, 1990). The OMP profile of four Bacteroides strains were shown 
to be distinct, although as expected, the two B. fragilis strains showed the most 
similarity. B. fragilis produced an unusually large number of bands, detectable both 
by Coomassie blue staining and by immunoblotting, implying that B. fragilis has a 
large number of transport mechanisms. 
The OMs of B. fragilis extracted from growth conditions likely to be encountered in 
vivo, influenced both OM structure and antigenicity. The function of many of the OM 
proteins that were induced or repressed have yet to be characterised, although a 
similar study in our laboratory showed such changes are unlikely to be related to 
serum -sensitivity (E. Allan, personnal communication). However, the observed 
variations in OM profile may be influencing the presentation and biological activity of 
LPS in the outer membrane, as discussed in section 8.2. The co- ordinated regulation 
of B. fragilis cell surface structures is possible as a signal transduction system in this 
organism, thought to be responsible for regulating outer membrane proteins, was 
initially identified because of increased antibiotic resistance (Rasmussen & Kovacs, 
1993), which, in this study, has been shown to alter LPS structure. 
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Exopolysaccharide 
The capsular polysaccharide of B. fragilis is well -known as a potentiating agent of 
abscess formation and is regarded as a major virulence determinant (Tzianabos et al, 
1992). The capsule of B. fragilis is heterogeneous, distinguished under the electron 
microscope, as large, small or an electron dense layer. Percoll discontinuous density 
centrifugation has been used to separate out these heterogeneous populations for 
further investigations and was used in this study to determine the influence of growth 
environment on EPS production. The particularly close association of the surface 
polysaccharides of B. fragilis and the flexibility of the LPS under different growth 
conditions suggests EPS may behave in a similar manner. Indeed, the results in this 
study show EPS to be highly influenced by growth condition, with different 
subpopulations apparent. However, no correlation with growth condition and capsule 
production between different strains was determined. For example, one B. fragilis 
isolate possessed a large capsule when grown in minimal media, whereas another 
B. fragilis isolate produced a small capsule. However, in bile -supplemented minimal 
media, the EPS profile of both B. fragilis isolates showed production of a large 
capsule. This may account for the absence of the high molecular weight moiety 
(speculated to be capsular antigen) in the LPS SDS -PAGE gels, as the larger capsule 
may simply have been too large to enter the gel. 
Once again these findings lend speculation to the co- ordinated environmental 
regulation of B. fragilis cell surface factors. It is interesting to consider that if indeed 
co- ordinated regulation occurs in vivo, then a relatively avirulent B. fragilis strain 
may express a more virulent form of surface structure when exposed to a suitable 
environmental stimulus, as may occur when bacteria move from inside to outside the 
gut. Co- ordinated environmental regulation of the cell surface would undoubtedly be 
an important intrinsic property contributing to B. fragilis pathogenesis. 
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In summary, all the cell surface factors of B. fragilis were shown to be flexible to 
growth conditions, reiterating the complexity of the surface of this organism which 
has not always been taken into account by previous workers investigating the 
biological potential. Thus, the following section reassessed the biological activity of 
B. fragilis cell surface factors from different growth environments and the potential 
role of B. fragilis in SIRS was determined. 
8.2 THE BIOLOGICAL ACTIVITY OF CELL SURFACE FACTORS OF 
BACTEROIDES FRAGILIS. 
In the present study the capacity to stimulate TNF -a from mononuclear leucocytes 
was determined. TNF -a is a major cytokine induced from monocytes and 
macrophages and is a prime mediator of the pathological changes observed in septic 
patients (section 1.3). 
LPS extracts from B. fragilis, B. uniformis and B. thetaiotaomicron were shown to 
induce variable TNF -a levels, although the variation could not account for the 
previously observed pathogenicity differences between these species. For example, 
B. fragilis has been reported to have a greater pathogenic potential compared to 
B. uniformis which was not reflected here by inflammatory capacity. Furthermore, 
TNF -a induction did not depend on LPS profile. Surprisingly, growth environment 
did not appear to influence the biological activity of the LPS samples. 
However, regardless of growth media, B. fragilis, and indeed all the Bacteroides 
isolates, induced on average only a 20 -fold lower TNF -a level compared to an E. coli 
control, far less than the 100 -1000 fold level that Bacteroides outnumber facultative 
anaerobes in the gut. This surprising result was further confirmed by endotoxicity 
measurements, as determined by the LAL assay, where B. fragilis and E. coli LPS 
differed by less than nine -fold. These findings are particularly important as they 
241 
suggest that in cases of intra- abdominal infection, and particularly in SIRS, where 
cytokine production is a major feature, B. fragilis, as a population, possesses more 
biological potential compared to E. coli. This theory is further confirmed by 
complementary studies in our laboratory investigating Bacteroides antibody levels in 
septic patients (Allan et al, 1995). In that study, Allan et al, found that in the majority 
of non -survivors tested, IgG levels against B. fragilis LPS were significantly higher 
than for a control mixture of enterobacteria and P. aeruginosa LPS. This finding 
implies that some septic patients, do indeed, have a high exposure to B. fragilis LPS. 
Furthermore, anaerobic bacteraemia comprises 5% to 25% of all bloodstream cases 
with B. fragilis stated as the most common cause, accounting for up to 65% of 
anaerobic isolates and with an attributable mortality of 19% (Redondo et al, 1995). 
However, B. fragilis still remains behind E. coli, Klebsiella, Serratia and 
P. aeruginosa in terms of overall blood culture isolates. The results of the present 
study show the importance of B. fragilis as a human pathogen and suggest that the 
lower culture frequency of this organism in bacteraemia may simply be due to the high 
redox potential of blood, especially considering the oxygen -sensitivity of this 
organism when grown in serum- supplemented media as was observed in this study. 
OM samples extracted from different growth conditions were also tested for 
inflammatory capacity. Different Bacteroides species induced variable TNF -a levels, 
highlighting once more the heterogeneity of this genus. In contrast to the 
observations made with the LPS samples growth environment influenced the 
inflammatory capacity of the OM samples. OMs extracted from both B. fragilis 
strains grown in VT &S induced the highest levels of TNF -a whereas OMs from 
growth in VT &W gave the lowest amounts. These findings suggest that the 
biological activity of B. fragilis and other Bacteroides species depends on the 
presentation of the LPS within the outer membrane. 
242 
It is important to stress that these studies show B. fragilis to be more biologically 
active than previously recognised. The discrepancy between the present study and 
previous reports may, in part, be due to extraction methods and culture conditions. 
However, the present study confirms that B. fragilis can play a vital role in gut - 
derived sepsis and any new anti -sepsis therapy should consider this organism. Studies 
on the pathogenic potential of B. fragilis have been extended in concurrent 
investigations by fellow laboratory colleagues and similar observations have been 
made. Furthermore, the presentation and surrounding environment of B. fragilis LPS 
is important to its biological activity, particularly the influence of closely- associated 
surface structures. To what extent, or if at all, co- ordinated regulation of B. fragilis 
cell surface factors occurs in vivo, remains to be defined. 
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CONCLUSIONS 
To the reader who has reached the end of this thesis it will be apparent that this study 
was a joint project, investigating two apparently diverse Gram- negative bacteria, 
Burkholderia cepacia and Bacteroides fragilis. As with most studies, results 
obtained from preliminary investigations and advances made by laboratory colleagues 
and other researchers within the field, has meant more emphasis has been placed on 
one particular area, in this case investigating B. cepacia, which accounts for the 
difference in volume of thesis dedicated to each organism. 
However, significant results were obtained for both B. cepacia and B. fragilis. The 
cell surface of both organisms was shown to be influenced by environmental 
conditions and the biological activity of constituent molecules much greater than was 
previously recognised. For B. cepacia, the ability to induce two major 
proinflammatory cytokines was greater than the other major CF pathogen 
Pseudomonas aeruginosa. In addition, this study has established the LPS of both 
B. cepacia and P. aeruginosa to signal via a CD 14- independent pathway and, 
surprisingly, the ability of P. aeruginosa to modulate the inflammatory response of 
B. cepacia. Therefore, the inflammatory potential of B. cepacia may contribute to the 
destructive immune- mediated damage observed in CF patients. For B. fragilis, the 
ability to induce TNF -ct was only twenty -fold lower than Escherichia coli, much less 
than the 100 -1000 fold excess required for E. coli to outnumber, population for 
population, B. fragilis. Thus, B. fragilis may play a vital role in disease states with an 
intestinal origin, including IBD and SIRS. Future studies should 
include 
investigations into the influence of anti -inflammatory cytokines and neutralising 
antibodies on the biological potential and hence pathogenesis 
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Abstract 
Burkholderia cepacia has emerged as an important multiresistant pathogen in cystic fibrosis (CF), associated in 20% of 
colonised patients with a rapid and fatal decline in lung function. Although knowledge of B. cepacia epidemiology has 
improved, the mechanisms involved in pathogenesis remain obscure. In this study, B. cepacia lipopolysaccharide (LPS) was 
assessed for endotoxic potential and the capacity to induce tumour necrosis factor (TNF). LPS preparations from clinical and 
environmental isolates of B. cepacia and from the closely related species Burkholderia gladioli exhibited a higher endotoxic 
activity and more pronounced cytokine response in vitro compared to preparations from the major CF pathogen 
Pseudomonas aeruginosa. This study may help to explain the vicious host immune response observed during pulmonary 
exacerbations in CF patients colonised by B. cepacia and lead to therapeutic advances in clinical management. 
Keywords: Burkholderia cepacia; Pseudomonas cepacia; Cystic fibrosis; Lipopolysaccharide; Tumour necrosis factor 
1. Introduction 
Chronic pulmonary infection leading to an intense 
host immune response and recurring episodes of 
exacerbation continue to be the major causes of lung 
disease in patients with cystic fibrosis (CF) [1]. 
Although Pseudomonas aeruginosa remains the 
leading CF pathogen affecting up to 90% of patients, 
Burkholderia (Pseudomonas) cepacia has recently 
emerged as a major cause for concern based on its 
multiresistance [2,3], transmissibility [4] and associa- 
tion with the `cepacia syndrome'; a rapid fatal de- 
cline in lung function seen in 20% of colonised 
Corresponding author. Tel: (0131) 650 3164; Fax: (0131) 650 
6531. 
patients, complicated on occasion by septicaemia 
[5,6]. B. cepacia produces few recognised virulence 
factors and the mechanisms of pathogenesis in the 
CF lung associated with this organism remain ob- 
scure [7]. 
Lipopolysaccharide (LPS; endotoxin) is a classic 
bacterial virulence factor the biological properties of 
which include potent immunostimulatory effects on 
mononuclear cells, granulocytes and B lymphocytes 
[8]. Activation of the immune cells results in the 
synthesis and secretion of inflammatory mediators or 
cytokines that are required for the development, 
maintenance and regulation of the host immune re- 
sponse [9]. However, the pathophysiological conse- 
quences of overproduction of cytokines can be se- 
vere as observed by the numerous clinical sequelae 
associated with endotoxic shock. Greally et al. [10] 
0928 -8244/95/$09.50 ® 1995 Federation of European Microbiological Societies. All rights reserved 
SSDI 0928-8244(95)00012-7 
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suggested that the cytokine response they observed 
to P. aeruginosa infection in CF patients contributed 
to the airways inflammation and airflow obstruction 
associated with acute lung injury. Similarly, Wilson 
et al. [11] found a strong association between in- 
creasing plasma levels of TNF -a and IL -1 ß (two 
pivotal cytokines produced early in infection) and 
pulmonary deterioration. 
The aim of our study was to assess the capacity of 
B. cepacia LPS to induce TNF from human mononu- 
clear cells and to compare this activity with LPS 
from the related phytopathogen, Burkholderia gladi- 
oli and from P. aeruginosa. B. gladioli was in- 
cluded because of controversy concerning its clinical 
significance in CF patients, including speculation 
that multiresistant, epidemic B. cepacia strains may 
be hybrids of both B. cepacia and B. gladioli [12,13]. 
The Limulus amoebocyte lysate (LAL) assay was 
used as an additional indicator of endotoxic activity. 
2. Materials and methods 
2.1. Bacteria and media 
The bacterial strains used in this study are de- 
scribed in Table 1. All isolates were identified as B. 
cepacia by the API 20NE system (bioMerieux, Marcy 
l'Etoile, France) and individual strains characterised 
further by bacteriocin typing [14] and pulse field gel 
electrophoresis (CHEF, BioRad Laboratories Inc.) 
[15] to ensure a lack of clonal relationship. Bacteria 
Table 1 
Bacterial strains, origin and LPS phenotype 
Strain Origin LPS Phenotype 
B. cepacia C1359 a 
B. cepacia C1409 
B. cepacia C1504 
B. cepacia ATCC 17762 
B. cepacia J2540 
B. gladioli ATCC 10248 
P. aeruginosa PAO1 

















a An epidemic strain isolated from several CF centres [4]. 
b R -LPS observed by silver- stained PAGE, S -LPS observed by 
immunoblot. 
R = rough -type LPS. 
S = smooth -type LPS. 
were grown in 51 batches of nutrient broth (Oxoid) 
+ 0.5% yeast extract (Difco) (NB + YE) at 37° C, in 
an orbital incubator at 200 rev min -' overnight. 
2.2. LPS extraction and analysis 
Bacterial LPS preparations were obtained by a 
version of the phenol -water (PW) method described 
by Westphal and Luderitz [16] which omitted ultra - 
centrifugation. LPS PW samples were resuspended 
to a concentration of 5 mg ml -' in pyrogen -free 
water. PAGE analysis was performed on 14% w/v 
acrylamide gels using the buffer system of Laemmli 
[17] with SDS omitted from the stacking and separat- 
ing gel buffers. Samples (15 Al for silver staining or 
45 µl for immunoblotting) were loaded onto gels. 
Gels were oxidised with periodic acid and silver - 
stained by the modified method of Tsai and Frasch 
[18] as described by Hancock and Poxton [19]. 
2.3. Immunoblotting 
Antigens separated by PAGE gels as described 
above were transferred to nitrocellulose membranes 
(0.2 µm pore size, Schleicher and Schuell, Dassel) 
overnight at 10 -12 V using the Tris, glycine, 
methanol buffer of Towbin et al. [20]. Blots were 
developed as described by Hancock and Poxton [19] 
using either rabbit sera raised against whole bacteria 
or human sera from colonised CF patients as the first 
antibody. Serum was diluted 1 in 200 in 1% gelatin 
Tris buffered saline. Anti- rabbit (ICN Flow) and 
anti -human (Sigma) IgG- horseradish peroxidase anti- 
bodies were used as the anti -first antibody conjugate. 
2.4. Limulus amoebocyte lysate (LAL) assay 
The endotoxicity of the LPS preparations was 
measured by the LAL assay using the kinetic method 
of the Coatest© Endotoxin Kit (Chromogenix). LPS 
samples (50 p.1) were diluted in pyrogen -free water 
(Blood Transfusion Service) to 5 ng ml -' -0.05 ng 
ml -t and added to a flat -bottomed microtitre plate. 
The control endotoxin (E. coli 0111:B4) was seri- 
ally diluted 1 in 5 to provide a standard range of 
24- 0.0384 EU ml -'. Chromogenic LAL reagent (20 
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plate to ensure that each well received the reagent at 
the same time. Plates were read kinetically every 19 
s for 90 min in a thermomax plate reader (Molecular 
Devices) at 405 nm. All material coming in contact 
with the sample was purchased as endotoxin -free or 
depyrogenated by heating to 250° C for 2.5 h. 
2.5. Induction and estimation of TNF from human 
leucocytes by LPS 
Human mononuclear leucocytes (MNL; approxi- 
mately 30% monocytes) from freshly collected 
buffycoats (supplied by the Blood Transfusion Ser- 
vice, Edinburgh, UK) were separated on lymphocyte 
separation medium (ICN Flow) following a two -fold 
dilution in RPMI 1640. Cells were harvested at 
1000 X g for 30 min and the monocyte layer washed 
three times in RPMI for 15 min. Leucocytes were 
counted in a haemocytometer and diluted in RPMI 
1 2 ygpirsr 5 
1 .2 3 
supplemented with 10% foetal calf serum (FCS), 
penicillin (100 µg m1 -1; Sigma), streptomycin (100 
µg m1 -1; Sigma) and 1 mM L- glutamine to a con- 
centration of 8 X 106 cells m1 -1. Cells (180 µl) and 
LPS samples (20 Al) diluted to the ng m1-1 range 
were added to a round -bottom microtitre plate and 
incubated at 37° C in a 5% CO2 atmosphere. Culture 
supemates (100 Al) were collected 3.5 h after incu- 
bation, except for the time -course experiments, and 
stored at - 20° C until required. 
The bioassay for TNF used a mouse fibroblastic 
cell line, L929, which is sensitive to the cytotoxic 
effects of TNF. Cells were grown in minimum essen- 
tial medium eagle (MEM; Sigma) supplemented with 
5% FCS, penicillin, streptomycin and L- glutamine as 
before. Cells were dislodged by 0.05% 
trypsin /0.02% EDTA digestion and resuspended to 
a concentration of 3 X 105 cells m1-1. L929 cells 
(100 Al) were added to the wells of a flat -bottom 
a 
Fig. 1. (A) Silver- stained PAGE (14% acrylamide) of PW preparations. Track 1, C1359; 2, C1409; 3, C1504; 4, ATCC 17762; 5, J2540; 6, 
ATCC 10248. (B) Immunoblot of PW preparations probed with rabbit serum raised against B. cepacia C1359. Track 1, C1359; 2, C1409; 3, 
C1504; 4, ATCC 17762; 5, J2540; 6, ATCC 10248. (C) Immunoblot of PW preparations probed with rabbit serum raised against B. cepacia 
C1409. Track 1, C1359; 2, C1409; 3, C1504; 4, ATCC 17762; 5, J2540; 6, ATCC 10248. 
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microtitre plate and incubated overnight at 37° C, 5% 
CO2. After the growth medium was discarded and 
replaced by MEM containing actinomycin D (2 µg 
m1 -1; Sigma), to stop growth of the L929 cells, 100 
µl of test supemate diluted 1 in 5 in MEM was 
added. Human recombinant TNF -a standard (Na- 
tional Institute for Biological Standards and Control) 
was serially diluted 1 in 5 in MEM to give a 
standard range of 1000 -0.0128 IU ml -' TNF. After 
overnight incubation at 37° C, 5% CO2, filtered crys- 
tal violet (0.5% CV in 20% methanol) was added at 
100 Al per well to stain surviving cells. Plates were 
washed under running tap water, dried and 100 Al of 
20% (v /v) acetic acid added to dissolve the CV 
crystals. Plates were read at 585 nm in a V1e% plate 
reader (Molecular Devices) and converted to TNF 
equivalents. 
2.6. Chemical analysis of LPS 
LPS preparations were assayed for 3- deoxy -D- 
manno-2- octulosonic acid (Kdo) by the standard 
thiobarbituric acid (TBA) method [19] and by hydro- 
fluoric acid dephosphorylation [21] to remove any 
phosphate substituent prior to assaying by the TBA 
method. The protein concentration was estimated by 
the Folin assay of Lowry et al. [22] with bovine 
serum albumin as standard. Phosphorus content was 
measured by the method of Chen et al. [23] and the 
presence of neutral sugars by the phenol -sulphuric 
acid method of Dubois et al. [24] with glucose as 
standard. Optical densities were read in a SP -6 Pye- 
Unicam spectrophotometer. 
2.7. Statistical analysis 
The Wilcoxon rank sum test for nonparametric 
data was used for comparison of results in the LAL 
and TNF assays. 
3. Results 
3.1. Silver -staining and immunoblot analysis of LPS 
Silver- stained polyacrylamide gels employed to 
visualise the content of the PW extracts used in the 
bioassays confirmed that clinical isolates of B. cepa- 
cia could possess either rough or smooth LPS (Fig. 
la). Immunoblots of the PW extracts showed some 
cross -reactivity between the LPS of different B. 
cepacia strains and other species including B. gladi- 
oli. Serum from a rabbit immunized with B. cepacia 
C1359 demonstrated a positive reaction with the low 
molecular mass core LPS of this strain (Fig. lb, 
track 1). Two other B. cepacia strains gave reaction 
with one band at the lower end of the high molecular 
mass ladder (Fig. lb, tracks 3 and 5). However, with 
serum from a rabbit immunized with B. cepacia 
C1409, the high molecular weight moiety of LPS 
from C1409, C1504, ATCC 17762, J2540 and B. 
gladioli showed a positive reaction (Fig. lc, tracks 
2 -6). Identical reactions were produced using serum 
from CF patients colonised with the C1359 or C1409 
strain (data not shown). P. aeruginosa LPS from 
strains PAO1 and C1250 did not exhibit cross -reac- 
tivity with any of the B. cepacia strains at the serum 
concentration used (data not shown). 
3.2. Endotoxicity of LPS PW samples 
The LAL assay was used to evaluate the endo- 
toxic activity of the PW extracts and the results 
obtained for LPS preparations at a concentration of 1 
ng ml -' are shown in Fig. 2. In all LAL assays, B. 
cepacia LPS was at least 4 -5 times more endotoxic 
than LPS preparations from the CF P. aeruginosa 
isolate C1250 and the well -characterised PAO1. No 
correlation was observed between R -LPS or S -LPS 
phenotypes and LAL activity. Although the results 
shown in Fig. 2 were for a LPS sample of 1 ng ml-' 
concentration the same trend in endotoxic activity 
was obtained when the preparations were examined 
in a range from 5 ng m1-1-0.5 pg m1-1 with the 
values decreasing in a dose -dependent manner. 
3.3. Induction of TNF by LPS PW preparations 
To ensure that the maximum cytokine response 
was assessed, preliminary experiments were per- 
formed to measure TNF induction by PW prepara- 
tions over time. TNF measurements were made at 
30 -min intervals from 0 -9 h. For all preparations, 
the peak TNF response was observed between ap- 
proximately 2.5 -4.5 h (Fig. 3). Further measure- 
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Fig. 2. The endotoxic activity of PW preparations diluted to 1 ng 
ml -1 as measured by the LAL assay. Each value is represented as 
the mean of three experiments. The endotoxic activity of P. 
aeruginosa differed significantly from B. cepacia (P <0.01). 
7 -day period but no TNF was detected after the 
initial 9 h period. For subsequent experiments, mea- 
surements of TNF were made 3.5 h after stimulation. 
Since MNL from different donors varied in their 
ability to produce TNF, Fig. 4 shows a representative 
study of TNF stimulation by different LPS prepara- 
tions at a concentration of 1 ng ml -1, previously 






0 2 3 4 5 
Hours 
1 6 7 8 9 
Fig. 3. Time -course of TNF induction by PW preparations. TNF 
released from MNL by PW samples (1 ng m1 -1) was measured 
from 0 -9 h at 30 min intervals. For clarity only B. cepacia C1359 
(IC, B. gladioli ATCC 10248 () and P. aeruginosa PAO1( ) 
are shown. 
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Fig. 4. TNF levels produced from MNL in response to PW 
preparations (1 ng m1 -1) after a 3.5 h stimulation. Each value is 
represented as the mean of duplicates. TNF production from 
P. aeruginosa differed significantly from B. cepacia (P < 0.01). 
B. cepacia PW preparations and that for B. gladioli, 
produced at least a nine -fold higher activity in terms 
of TNF induction compared to both P. aeruginosa 
PW preparations. This trend was reproducible and 
similar to that observed with the LAL assay. The PW 
samples themselves had no direct effect on the L929 
cells and TNF present in the culture supemate was 
shown to be solely responsible for the lysis of the 
L929 cells as an anti -TNF -a mAb (Genzyme) neu- 
tralised all observed cytotoxicity (Fig. 5). 
Fig. 5. Anti-TNF -a mAb neutralisation of lysis of L929 cells. The 
effect of the PW preparations alone is also shown for comparison. 
Each value represents the mean of duplicates. s/n = culture su- 
pernate. 
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Taole 2 
Chemical analysis of PW preparations 
Strain Kdo 
s Protein Carbohydrate Phosphorus 
TBA HF 
C1359 3.4 ± 0.3 b 3.3 ± 0.2 1.9 ± 0.1 210 ± 18 40.7 ± 3.5 
C1409 2.5 ± 0.2 2.7 ± 0.2 1.9 ± 0.1 344 t 12 25.0 ± 2.2 
C1504 3.4 ± 0.4 NT 2.1 ± 0.1 288 ± 9 30.1 t 0.6 
ATCC 17762 4.9 ± 0.4 2.9 ± 0.2 3.7 ± 0.2 282 t 15 49.2 ± 2.1 
J2540 6.5 ± 0.2 NT 2.1 t 0.1 290 ± 27 31.5 ± 2.0 
ATCC 10248 3.6 ± 0.2 2.8 ± 0.4 1.1 ± 0.1 243 ± 24 24.6 ± 2.3 
PAO1 23.4 ± 1.5 17.5 ± 1.3 2.9 ± 0.2 239 ± 11 57.3 ± 4.2 
C1250 19.9 ± 0.5 NT 3.7 ± 0.1 203 ± 16 37.0 ± 0.9 
a Kdo measured by the standard thiobarbituric acid method (TBA) or after prior dephosphorylation with hydrogen fluoride (HF). 
b All results are shown as µg (mg sample)-1. 
All results are given as the mean ± S.E. from at least three experiments. 
NT = not tested. 
3.4. Chemical analysis 
Chemical analysis of the PW LPS preparations is 
summarised in Table 2 and provides several interest- 
ing observations. Firstly, although the LAL data 
showed a greater endotoxic activity in the B. cepacia 
and B. gladioli preparations than in those from P. 
aeruginosa, the latter contained on average a five -fold 
greater concentration of Kdo. Secondly, there was no 
difference in Kdo content between B. cepacia and 
B. gladioli. Thirdly, the phosphorus, carbohydrate 
and protein content of the LPS preparations did not 
differ greatly between strains. 
4. Discussion 
Several putative virulence factors have been asso- 
ciated with clinical isolates of B. cepacia including 
exoenzymes, siderophores, exopolysaccharide and 
LPS [25,26]. However, the contribution of these 
products to the pathogenesis of B. cepacia in the CF 
lung remains unclear [7]. Previous studies [27 -29] 
have investigated the LPS structure of B. cepacia 
but little has been reported on a potential im- 
munopathological role. In this study, we provide the 
first evidence that B. cepacia LPS has endotoxic 
activity and the capacity to induce a high level of 
TNF. 
TNF -a is one of the major cytokines produced in 
response to LPS stimulation and plays a key role in 
regulating the secretion of other cytokines, thus am- 
plifying and diversifying the immune response [30]. 
The biological activity of LPS from P. aeruginosa 
has been studied previously and found to be highly 
active in both LAL and TNF assays [31]. In our 
study, we have established that B. cepacia and B. 
gladioli LPS, on a weight- for -weight basis, induces 
approximately nine times as much TNF compared to 
P. aeruginosa LPS indicating that B. cepacia has a 
greater potential than P. aeruginosa to cause and 
sustain immune- mediated damage in the lung. 
Several reports have described strains of B. cepa- 
cia to be an antagonist of fungal and bacterial plant 
pathogens capable of suppressing dry rot of potatoes 
[32], blue and grey mould of apples [33] and bacte- 
rial wilt disease in tobacco [34]. Other reports state 
that certain strains are able to break down pesticides 
and industrial waste materials [35]. Thus, B. cepacia 
has gained considerable attention as a potential bio- 
logical control agent. Bevivino et al. [36] reported 
that environmental strains of B. cepacia differed 
from clinical isolates in siderophore production, syn- 
thesis of proteases and binding to uroepithelial cells 
and concluded that their biological release posed 
little hazard to humans. The relevance of these viru- 
lence factors in CF lung disease, however, is debat- 
able. In our study, although clinical strains stimu- 
lated more TNF activity compared to the environ- 
mental isolate, all the B. cepacia and B. gladioli 
PW preparations showed a high potential to stimu- 
late TNF. Caution with respect to environmental 
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release of B. cepacia is also supported by the results 
of the LAL assay, which indicated that all the B. 
cepacia and B. gladioli LPS preparations, regardless 
of origin, are at least four times more endotoxic than 
preparations from P. aeruginosa strains. 
Interestingly, our study detected little difference 
in biological activity between LPS preparations from 
B. cepacia and B. gladioli supporting the close 
taxonomic relationship of these species, recently re- 
grouped into the new genus Burkholderia [37]. There 
are few reports on the clinical significance of B. 
gladioli isolates in CF although Christenson et al. 
[12] concluded that B. gladioli colonisation has no 
harmful consequences for CF patients. Our results of 
endotoxic potential by B. gladioli LPS support pre- 
vious comments from Simpson et al. [13] that until 
more is understood about these two species it would 
be prudent to treat isolates of B. gladioli from CF 
patients with the same caution reserved for B. cepa- 
cia. 
PW preparations from B. cepacia and P. aerugi- 
nosa differed not only in biological activity but also 
in structure and composition as observed by the lack 
of cross -reactivity in the immunoblots and the differ- 
ences in Kdo content. Although the structure of 
several B. cepacia LPS serotypes has now been 
investigated [27 -29] initial chemical analysis de- 
bated the relative absence of Kdo [38 -40]. In our 
study, Kdo was detectable in all the bacterial prepa- 
rations based on both the TBA assay and following 
dephosphorylation by hydrofluoric (HF) acid prior to 
assaying with TBA. HF acid dephosphorylation was 
employed in case any phosphorus substitution of the 
Kdo prevented a detectable reaction in the standard 
TBA assay. The average Kdo content of the B. 
cepacia extracts was 0.4% which agrees with other 
studies [29]. However, this Kdo concentration is still 
over five times less than the P. aeruginosa PW 
preparations which gave an average Kdo content of 
2.2 %. 
We conclude that stimulation of TNF by B. cepa- 
cia LPS may contribute to destructive pulmonary 
inflammation. This hypothesis is supported by recent 
in vivo evidence that B. cepacia stimulates a pro - 
nounced inflammatory response in mutant CF mice 
[41] and in CF patients as measured by levels of 
neutrophil elastase and C- reactive protein [42]. Fur- 
ther studies in our laboratory are investigating the 
stimulation of other cytokines, most notably IL-8, as 
well as the biological activity of other B. cepacia 
cell surface antigens. Meanwhile, since the character- 
istic multiresistance of B. cepacia denies CF patients 
effective antimicrobial therapy, anticytokine therapy 
may prove a worthwhile alternative strategy. 
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